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1. Introduction 
 
 
Chapter 1 
Introduction 
 
 
 
1.1. Hyaluronic acid 
1.1.1. Structure and properties 
Hyaluronic acid (HA), also known as hyaluronan or hyaluronate, is a high molecular weight 
polysaccharide of the extracellular matrix. Commonly, hyaluronan is known as a lubricant 
responsible for the viscoelastic properties of tissue fluids and as a stabilizing and hydrating 
component of soft connective tissue. The term hyaluronic acid originates from the material 
used for the first isolation of hyaluronic acid by Meyer and Palmer (Meyer and Palmer 1934), 
namely the vitreous humor (hyaloid) of the eyes, and uronic acid as a constituent. 
 
The chemical structure of hyaluronic acid is simple: a linear, negatively charged, unsulfated 
polymer composed of repeating disaccharide units linked by β-1,4 glycosidic bonds. Each 
disaccharide unit consists of D-glucuronic acid (GlcUAc) and N-acetyl-D-glucosamine 
(GlcNAc) connected by a β-1,3 glycosidic bond (Weissmann and Meyer 1954) (Fig. 1.1). 
 
Fig. 1.1 Hyaluronic acid is built of alternating units of D-glucuronic acid (GlcUAc) and N-acetyl-D-
glucosamine (GlcNAc). Axial H-atoms, marked in red, contribute to the hydrophobic patches in the 
polysaccharide. (Modified from Hascall and Laurent 1997). 
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The polymer comprises, depending on the source, 2,000 – 25,000 disaccharide units, which 
corresponds to a molecular mass of 106 – 107 Da and a length of 2 – 25 µm. The carboxyl 
groups of the glucuronic acid (pKa = 3 – 4) (Hascall and Laurent 1997) cause the high 
negative charge of the polymer under physiological conditions.  
 
Hyaluronic acid is a member of the family of glycosaminoglycans (GAGs) along with 
chondroitin-, keratan- and dermatane sulfate, heparin and heparin sulfate. These linear 
polysaccharides are generally composed of repeating disaccharide units of an uronic acid, D-
glucuronic acid (GlcUAc) or L-iduronic acid (IdoAc), and an amino sugar, either N-acetyl-D-
glucosamine (GlcNAc) or N-acetyl-D-galactosamine (GalNAc). Hyaluronic acid is an 
exception insofar as it is the only GAG, which is not covalently modified during its synthesis, 
especially not sulfated. Furthermore, in contrast to the other GAGs HA is not synthesized as a 
proteoglycan, i.e. covalently linked to a core protein, but is transferred during its synthesis 
directly through the plasma membrane into the extracellular space (Taylor and Gallo 2006). 
 
Although the structure of hyaluronan is rather simple, the specific arrangement of the 
functional groups within the macro-molecule accounts for its unusual properties. In solution 
HA adopts an extended, hydrogen-bonded structure with a twist of 180° between each of the 
disaccharide units (Scott 1998) (Fig. 1.2.a). This tape-like, two-fold helix exhibits extensive 
hydrophobic patches due to the accumulation of axial H-atoms (Fig. 1.1) on alternating sides 
of the helix extending over almost three carbohydrate units. 
 
In solution the hydrophobic interactions and H-bonds that can form between HA chains are 
counteracted by electrostatic repulsion of the carboxyl groups. Nuclear magnetic resonance 
and rotary shadowing electron-microscopy revealed honeycomb-like meshworks with 
neighboring HA chains arranged in an antiparallel fashion in very dilute solutions (1 µg/mL) 
(Scott 1998, Scott and Heatley 2002). However, the interactions responsible for aggregation 
are under physiological conditions insufficient for the formation of a specific tertiary 
structure. Moreover, hyaluronan is believed to be organized in a porous, dynamic network, 
resembling an expanded random coil with reversible formation and breakdown of tertiary 
structures (Sheehan and Almond 2001).  
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a)
b)
1.96 nm
Proteoglycan
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CD44
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1.96 nm
 
Fig. 1.2 a) Models of the extended, two-fold hyaluronan helix with hydrogen bonds (dotted lines) 
between the neighboring carbohydrate units. The models are shown at right angles to each other. 
(Modified from Scott 1998). b) Representation of HA attached to the cell membrane by the hyaluronan 
receptor CD44. The repulsion of the negatively charged proteoglycans connected to the HA chains 
supports the extended structure of HA. (Modified from Toole 2004). 
 
This dynamic meshwork provides the basis for the viscoelastic and hydrating properties of 
hyaluronan. Between the HA chains a huge amount of water can be trapped, which can be 
withdrawn upon application of an external pressure causing the resilience and malleability of 
substances like synovial joint fluids (Toole 2004). Dependent on the hydrodynamic volume 
molecules can move through the pores formed by the HA network, thus forming a diffusion 
barrier for some molecules. The constant re-organization of HA chains facilitates cell 
migration and tissue remodelling due to the creation of highly hydrated zones separating the 
cells from each other (Toole 2001). 
 
In the extracellular matrix the HA chains are non-covalently connected to multiple 
proteoglycans, which repel each other due to their high negative charge and thereby facilitate 
the extended structure of the HA chain. The interaction between hyaluronan and the 
proteoglycans is fostered by the link protein (Hardingham 1998). Additionally, hyaluronan 
can be tethered to the cell surface through receptors such as CD44 (Knudson et al. 1993) or 
through retention to the hyaluronate synthases located in the plasma membrane (Heldin and 
Pertoft 1993) (Fig. 1.2.b).  
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1.1.2. Occurrence and metabolism 
Hyaluronan is found in the extracellular matrix of all vertebrates and in the capsule of some 
bacteria such as Streptococcus and Pasteurella. Extraordinarily high concentrations of 
hyaluronan occur in rooster comb (7.5 mg/mL), in the synovial fluid (3 – 4 mg/mL), in 
umbilical cord (3 mg/mL), in the vitreous humor of the eye (0.2 mg/mL), and in the skin (0.5 
mg/mL. Both, the dermis and the epidermis of the skin, accommodate the largest amount of 
hyaluronan in the body (7 – 8 g, referring to ca. 50 % of the total HA in the body) (Prehm 
2002). In cartilage hyaluronan binds a large number of chondroitin sulfate proteoglycans 
called aggrecans, and thus forms huge aggregates of several hundred million Dalton 
(Hardingham 1998). 
 
Hyaluronan is a rapidly metabolized macromolecule with one third of the whole hyaluronan 
present in the human body (ca. 15 g) being turned-over every day (Stern 2004). The synthesis 
of HA differs, as mentioned above, distinctly from the synthesis of other GAGs: one of the 
three multipass transmembrane proteins, HA synthase-1, -2 or -3, extrudes the nascent HA 
chain from the reducing end through the plasma membrane into the extracellular space 
(Prehm 1984, Prehm 2006). In contrast to that, other GAGs are synthesized in the Golgi body 
from the non-reducing end, and are covalently linked to a protein.  
This mechanism of HA synthesis applies to vertebrates and Streptococci, the HA 
polymerization in Pasteurella, however, proceeds by a different mechanism (Prehm 2002). 
The synthesis of the HA chain on the surface of the intracellular membrane enables the 
unrestricted extension of the polymer reaching up to 25,000 disaccharide units, a size 
impossible to be synthesized intracellularly (Stern 2004). 
 
The high molecular weight HA chains are released from the synthases by dissociation or 
radical degradation (Prehm 1990), but stay in contact with the plasma membrane through 
interactions with cell surface receptors such as CD44 (Knudson et al. 1993) and, possibly, the 
membrane-anchored hyaluronidase Hyal-2 (Fig. 1.2.b). The concentration of HA in a tissue is 
maintained constant by balancing of the synthesis by catabolism. As proposed by Csoka et al. 
(Csoka et al. 2001) high molecular weight HA might be cleaved by the hyaluronidase Hyal-2 
on the cell surface into fragments of ca. 20 kDa and internalized while still bound to Hyal-2. 
The endocytotic vesicles then fuse with lysosomes providing the optimum pH conditions for 
the further degradation of the HA fragments through the action of the hyaluronidase Hyal-1. 
In addition to the hyaluronidases, two exoglycosidases, β-glucuronidase and β-N-
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acetylglucosaminidase, contribute to the catabolism of HA in lysosomes. Stern (Stern 2003) 
suggested the existence of a specialized mini organelle for the location of the HA metabolism, 
the so called hyaluronasome, similar to the glycogen granule. 
 
1.1.3. Physiological and pathophysiological role of hyaluronan 
The functions of hyaluronan directly originating from its physicochemical properties are well-
known: it acts as a lubricant and shock absorber, regulates water balance and osmotic pressure 
and occurs as a structure forming molecule in the vitreous humor of the eye, in Wharton’s 
jelly and in joint fluids. Besides these functions, that are long known, hyaluronic acid was 
found to interact with other GAGs (Turley and Roth 1980) and a multitude of specific HA-
binding proteins, referred to as hyaladherins (Day 2001). The hyaladherins can be divided 
according to their function into three groups: the hyaluronan-binding proteins responsible for 
the organization of the extracellular matrix, like the link protein and aggrecan (Hardingham 
1998), cell-surface receptors of HA with CD44 (Knudson and Knudson 1999) and RHAMM 
(Turley and Harrison 1999) being the best known ones, and intracellular hyaladherins. Since 
HA has also been detected intracellularly in proliferating cells (Evanko and Wight 1999) 
these HA-binding proteins within the cell, e.g. the intracellular variant of RHAMM, P-32, 
Cdc37 and IHABP4, gain importance (Evanko and Wight 2001).  
 
The diversity of interactions of hyaluronan is reflected in the great range of processes 
influenced by the polysaccharide. These processes are all involved in cell motility, cell 
migration and changes in cell-cell- and cell-matrix-adhesion. HA participates in many 
fundamental processes such as embryological development and morphogenesis (Toole 2001), 
wound healing (Longaker et al. 1991), inflammation (Weigel et al. 1986, Taylor and Gallo 
2006), angiogenesis (Liu et al. 1996) and tumor progression (Paiva et al. 2005, Boregowda et 
al. 2006). 
 
The size of the hyaluronan molecules plays a crucial role in the biological activity of the 
polysaccharide (Fig. 1.3). High molecular weight HA chains can provide hydrated pathways 
for the invasion and migration of cells due to their space-filling properties (Toole 2001). A 
hyaluronan-rich pericellular zone separates cells from each other and from matrix 
components, and protects cells from lymphocytes and viruses (Laurent and Fraser 1992). 
Thus, high molecular weight hyaluronan with a molecular weight of more than 500 kDa was 
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described as anti-inflammatory (Wang et al. 2006), immunosuppressive (Delmage et al. 1986) 
and anti-angiogenic (Feinberg and Beebe 1983). 
HA chains with a molecular weight of 10 – 500 kDa, referred to as low molecular weight 
hyaluronan, exhibit effects directly opposing the functions of high molecular weight HA (Fig. 
1.3) (Asari 2005). These low molecular weight HA fragments are angiogenic (West et al. 
1985) and stimulate inflammation, cellular infiltration and extracellular matrix degradation by 
induction of cytokines (El Maradny et al. 1997, Noble 2002) and chemokines (McKee et al. 
1996).  
While most of the functions described for low molecular weight HA were also observed with 
HA fragments smaller than 25 disaccharide units, these oligosaccharides show additional 
activities, e.g. the activation of Hsp72 and suppression of cell death under stress conditions 
(Xu et al. 2002). These effects are presumably related to size-dependent binding to specific 
receptor molecules. 
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Fig. 1.3 Hyaluronan changes its biological activity depending on its size. (Modified from Asari 2005). 
 
1.2. The six human hyaluronidase subtypes 
According to their catalytic mechanism Meyer classified three major families of 
hyaluronidases (Meyer 1971). The hyaluronidases of the first group, endo-β-N-
acetylglucosaminidases, including vertebrate hyaluronidases, catalyze the hydrolysis of the β-
1,4 glycosidic bond. The second group, termed β-eliminases or lyases, include bacterial 
hyaluronidases and catabolize HA in a β-elimination of the β-1,4 glycosidic bond, thereby 
introducing an unsaturated bond in position 4 of glucuronic acid. The third group of 
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hyaluronidases comprises endo-β-glucuronidases found in parasites like leeches and in some 
crustaceans. 
As this work focuses on the production and characterization of human hyaluronidases the 
following section will provide an overview of the characteristic features of the vertebrate-type 
hyaluronidases with special focus on the human hyaluronidases. 
 
1.2.1. Properties of mammalian hyaluronidases 
Mammalian hyaluronidases (E.C. 3.2.1.35) belong, according to the Carbohydrate Active 
Enzyme Database (CAZY) (Coutinho and Henrissat 1999), to the glycoside hydrolase family 
56. They cleave the β-1,4 glycosidic bond of hyaluronic acid by hydrolysis in a non-
processive endolytic process producing tetrasaccharides as the major final reaction products 
(Stern and Jedrzejas 2006). The process of degradation differs essentially between 
mammalian hyaluronidases and bacterial hyaluronate lyases. Lyases degrade HA after an 
initial endolytic cleavage step in a processive, exolytic fashion, thereby separating only one 
disaccharide unit from the reducing end of the HA chain at a time (Li et al. 2000, Li and 
Jedrzejas 2001). The degradation of HA by mammalian hyaluronidases, however, occurs in a 
random fashion with each endolytic cleavage step being accompanied by a new binding event 
at a random position within the HA chain (Stern and Jedrzejas 2006). 
 
In addition to the degradation of HA, vertebrate-like hyaluronidases are capable of 
catabolizing chondroitin, chondroitin-4-sulfate (ChS A), chondroitin-6-sulfate (ChS C) and 
dermatan sulfate (ChS B) as alternative substrates (Meyer and Rapport 1952). The conversion 
of these alternative substrates, however, is much slower than the degradation of HA.  
Furthermore, mammalian hyaluronidases exhibit not only hydrolytic activity but also 
transglycosidase activity (Weissmann 1955). During transglycosylation a HA fragment of at 
least one disaccharide unit is transferred from the non-reducing end of one oligosaccharide 
chain to the non-reducing end of another (Weissmann 1955, Highsmith et al. 1975, Takagaki 
et al. 1994) (Fig. 1.4).  
Using bovine testicular hyaluronidase preparations transglycosylation was observed to be 
favored at neutral pH values and low ionic strength (Gorham et al. 1975, Saitoh et al. 1995). 
The transglycosylation activity provides the potential ability to cross-link different GAG 
chains as proven in vitro by Saitoh et al. (Saitoh et al. 1995).  
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Fig. 1.4 Schematic presentation of the reactions catalyzed by mammalian hyaluronidases. Glycosidic 
residues are represented with symbols as indicated in the legend. The oligosaccharide chains are 
shown in the direction from the non-reducing terminus (left) to the reducing terminus (right). 
Transglycosylation is shown for one disaccharide unit marked in red, but can also occur with larger 
fragments. 
  
1.2.2. Structural features and catalytic mechanism of human hyaluronidases 
As no crystal structure of a mammalian hyaluronidase is available yet, information about the 
catalytic mechanism and the structure of human hyaluronidases can merely be transferred 
from the crystal structures of vertebrate-like hyaluronidases, being the bee venom 
hyaluronidase (1FCQ.pdb) (Markovic-Housley et al. 2000) and the wasp venom 
hyaluronidase (2ATM.pdb) (Skov et al. 2006).  
Bee venom hyaluronidase (BVH) and wasp venom hyaluronidase both consist of a single 
domain with a (β/α)7 topology similar to the classical (β/α)8 TIM-barrel found in many 
glycosyl hydrolases (Henrissat et al. 1995). The barrel formed by seven β-sheets is 
surrounded by seven α-helices and contains a large substrate binding groove (ca. 30 Å x 10 Å) 
perpendicular to the barrel axis (Markovic-Housley et al. 2000). A hyaluronan 
hexasaccharide, presumably the minimum substrate for BVH, fits into the dimensions of the 
binding cleft as concluded from the structure of BVH co-crystallized with a HA 
tetrasaccharide (1FCV.pdb).  
 
Based on the gene sequence six human hyaluronidase subtypes were identified with a 
sequence identity of ca. 40 %: Hyal-1, Hyal-2, Hyal-3, Hyal-4, PH-20 and a pseudogene, 
Phyal1 (Csoka et al. 2001). In contrast to BVH the human hyaluronidases contain at least one 
additional domain of 120 – 150 amino acids C-terminally to the catalytic domain (Fig. 1.5). 
Within the hyaluronidase catalytic domain the sequence identity between the human 
hyaluronidases and BVH averages 30 %. 
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BVH             --------MSRPLVITEGMMIGVLLMLAPINALLLGFVQSTPDNNKTVREFNVYWNVPTF 
Hyal2_human     -------------MRAGPGPTVTLALVLAVAWAMELKPTAPP--IFTGRPFVVAWDVPTQ 
Hyal1_human     ---------------MAAHLLPICALFLTLLDMAQG--FRGP--LLPNRPFTTVWNANTQ 
Hyal4_human     MKVLSEGQLKL-CVVQPVHLTSWLLIFFILKSISCLKPARLP--IYQRKPFIAAWNAPTD 
 PH20_human     MGVLKFKHIFFRSFVKSSGVSQIVFTFLLIPCCLTLNFRAPP--VIPNVPFLWAWNAPSE 
                                          .  :           *        *   *:. :  
BVH             MCHKYGLRFEEVSEKYGILQNWMDKFRGEEIAILYDPGMFPALLKDPNGNVVARNGGVPQ 
Hyal2_human     DCGPR-LKVPLDLNAFDVQASPNEGFVNQNITIFYRDRLGLYPRFDS--AGRSVHGGVPQ 
Hyal1_human     WCLER-HGVDVDVSVFDVVANPGQTFRGPDMTIFYSSQLGTYPYYTP--TGEPVFGGLPQ 
Hyal4_human     QCLIK-YNLRLNLKMFPVIGSPLAKARGQNVTIFYVNRLGYYPWYTS--QGVPINGGLPQ 
 PH20_human     FCLGK-FDEPLDMSLFSFIGSPRINATGQGVTIFYVDRLGYYPYIDSI-TGVTVNGGIPQ 
                 *           . : .  .      .  ::*:*   :       .     .  **:** 
BVH             LGNLTKHLQVFRDHLINQIPDKSFPGVGVIDFESWRPIFRQNWASLQPYKKLSVEVVRRE 
Hyal2_human     NVSLWAHRKMLQKRVEHYIRTQESAGLAVIDWEDWRPVWVRNWQDKDVYRRLSRQLVASR 
Hyal1_human     NASLIAHLARTFQDILAAIPAPDFSGLAVIDWEAWRPRWAFNWDTKDIYRQRSRALVQAQ 
Hyal4_human     NISLQVHLEKADQDINYYIPAEDFSGLAVIDWEYWRPQWARNWNSKDVYRQKSRKLISDM 
PH20_human      KISLQDHLDKAKKDITFYMPVDNL-GMAVIDWEEWRPTWARNWKPKDVYKNRSIELVQQQ 
                  .*  *     . :   :   .  *:.***:* *** :  **   : *:. *  ::    
BVH             HPFWDDQRVEQEAKRRFEKYGQLFMEETLKAAKRMRPAANWGYYAYPYCYNLTPNQ--P- 
Hyal2_human     HPDWPPDRIVKQAQYEFEFAAQQFMLETLRYVKAVRPRHLWGFYLFPDCYNHDYVQNWES 
Hyal1_human     HPDWPAPQVEAVAQDQFQGAARAWMAGTLQLGRALRPRGLWGFYGFPDCYNYDFLS--PN 
Hyal4_human     GKNVSATDIEYLAKVTFEESAKAFMKETIKLGIKSRPKGLWGYYLYPDCHNYNVYA--PN 
 PH20_human     NVQLSLTEATEKAKQEFEKAGKDFLVETIKLGKLLRPNHLWGYYLFPDCYNHHYKK--PG 
                            *:  *:  .: ::  *::     **   **:* :* *:*          
BVH             -SAQCEATTMQENDKMSWLFESEDVLLPSVYLRWNLTSGERVG-LVGGRVKEALRIARQM 
Hyal2_human     YTGRCPDVEVARNDQLAWLWAESTALFPSVYLDETLASSRHGRNFVSFRVQEALRVARTH 
Hyal1_human     YTGQCPSGIRAQNDQLGWLWGQSRALYPSIYMPAVLEGTGKSQMYVQHRVAEAFRVA-VA 
Hyal4_human     YSGSCPEDEVLRNNELSWLWNSSAALYPSICVWKSLGDSENILRFSKFRVHESMRISTMT 
 PH20_human     YNGSCFNVEIKRNDDLSWLWNESTALYPSIYLNTQQSPVAATL-YVRNRVREAIRVSKIP 
                 .. *      .*:.:.**: .. .* **: :                ** *::*::    
BVH             TTSR-KKVLPYYWYKYQDRRDTDLSRADLEATLRKITDLGADGFIIWGSSDDINTKAKCL 
Hyal2_human     HANHALPVYVFTRPTY-SRRLTGLSEMDLISTIGESAALGAAGVILWGDAGYTTSTETCQ 
Hyal1_human     AGDPNLPVLPYVQIFY-DTTNHFLPLDELEHSLGESAAQGAAGVVLWVSWENTRTKESCQ 
Hyal4_human     SHDYALPVFVYTRLGYRDEPLFFLSKQDLVSTIGESAALGAAGIVIWGDMNLTASKANCT 
 PH20_human     DAKSPLPVFAYTRIVFTDQVLKFLSQDELVYTFGETVALGASGIVIWGTLSIMRSMKSCL 
                  .    *  :    : .     *.  :*  :: : .  ** *.::*       :  .*  
BVH             QFREYLNNELGPAVKRIALNNNANDRLTVDVSVDQV------------------------ 
Hyal2_human     YLKDYLTRLLVPYVVNVSWATQYCSRAQCHGHGRCVRRNPSASTFLHLSTNSFRLVPGHA 
Hyal1_human     AIKEYMDTTLGPFILNVTSGALLCSQALCSGHGRCVRRTSHPKALLLLNPASFSIQLTPG 
Hyal4_human     KVKQFVSSDLGSYIANVTRAAEVCSLHLCRNNGRCIRKMWNAPSYLHLNPASYHIEASED 
 PH20_human     LLDNYMETILNPYIINVTLAAKMCSQVLCQEQGVCIRKNWNSSDYLHLNPDNFAIQLEKG 
                 . :::   * . : .::      .          :                         
    
BVH             ------------------------------------------------------------ 
Hyal2_human     PGEPQLRPVGELSWADIDHLQTHFRCQCYLGWS-GEQCQWDHRQAAGGASEAWAG--SHL 
Hyal1_human     GGPLSLR--GALSLEDQAQMAVEFKCRCYPGW----QAPWCERKSMW------------- 
Hyal4_human     G-EFTVK--GKASDTDLAVMADTFSCHCYQGY---EGADCREIKTADGCSG--------V 
 PH20_human     G-KFTVR--GKPTLEDLEQFSEKFYCSCYSTLSCKEKADVKDTDAVDVCIADGVCIDAFL 
                                                                  
BVH             ------------------------------------------ 
Hyal2_human     T--------------SLLALAALAFTWTL------------- 
Hyal1_human     ------------------------------------------ 
Hyal4_human     SP-------------SPGSL-MTLCLLLLASYRS-IQL---- 
 PH20 human     KPPMETEEPQIFYNASPSTLSATMFIWRLEVWDQGISRIGFF
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Fig. 1.5 Sequence alignment of BVH (Swiss-Prot code: Q08169) with the human hyaluronidases 
Hyal-1 (Q12794), Hyal-2 (Q12891), Hyal-4 (Q9UL99) and PH-20 (Q8TC30). Domains are marked 
according to their potential function: signal peptide (light grey), catalytic domain (blue), C-terminal 
domain with various function (yellow) and GPI-anchoring signal peptides (dark grey). C residues are 
marked in red, potential N-glycosylation sites with green boxes and the residues of the active site of 
the BVH are underlined (Botzki 2004). The secondary structural elements indicated above each line 
were inserted according to the crystal structure of BVH (1FCQ.pdb, the sequence crystallized is 
printed bold). The alignment was generated with ClustalW and the symbols ., : and * refer to the 
similarity code used by the alignment program (Chenna et al. 2003).  
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The occurrence of few gaps in the sequence alignment as well as the conservation of residues 
in the active site and of four cysteine residues linked by disulfide bridges in BVH indicate a 
similar structural organization of the enzymes (Fig. 1.5). Fold recognition studies revealed a 
significantly higher structural similarity than expected from the amino acid sequence enabling 
the construction of 3D model structures of the human hyaluronidases (Jedrzejas and Stern 
2005) and bovine PH-20, which exhibits a sequence identity of 65 % to human PH-20 (Botzki 
et al. 2004). The overall model structures of the human hyaluronidases resemble each other 
closely with the typical barrel-shaped catalytic domain exhibiting a broad binding groove for 
the substrate and a linker region connecting the catalytic domain to the C-terminal domain 
(Jedrzejas and Stern 2005).  
 
In all hyaluronidases the binding groove is lined by electropositive and hydrophobic residues 
favoring the binding of substrate molecules with electronegative and hydrophobic patches 
such as HA and ChS. Model structures of the C-terminal domains were predicted by an ab 
initio approach due to missing similarity to any of the known 3D structures and are therefore 
rather unreliable. A common feature found in all human hyaluronidase models is the 
formation of a separate C-terminal domain connected to the catalytic domain by a flexible 
linker (Jedrzejas and Stern 2005). The C-terminal domains, which exhibit - except for the 
presence of an extraordinarily high amount of C residues - low similarity to each other, are 
speculated to be involved in either facilitating the HA binding, positioning of the substrate or 
in disruption of non-covalent interactions of substrate chains (Jedrzejas and Stern 2005, Stern 
and Jedrzejas 2006). 
Although the structure of the human hyaluronidases remains speculative, the catalytic 
mechanism for the degradation of hyaluronic acid is very likely to follow the double- 
displacement mechanism derived from the X-ray structure of BVH co-crystallized with a HA 
tetrasaccharides (1FCV.pdb) (Markovic-Housley et al. 2000).  
The active site is located approximately in the middle of the binding groove with E145 (BVH 
numbering in Fig. 1.5) being the only residue that participates in the catalytic mechanism. 
The surrounding amino acids D143, Y216, Y259 and W333 (BVH numbering in Fig. 1.5) that 
are highly conserved in the human hyaluronidases contribute to the positioning of the 
substrate moiety (Markovic-Housley et al. 2000, Jedrzejas and Stern 2005). Intriguingly, 
Y259, which is otherwise strictly conserved in the human hyaluronidases, is replaced in Hyal-
4 by C163 indicating a specialized function of Hyal-4 (Fig. 1.5) (Jedrzejas and Stern 2005, 
Stern and Jedrzejas 2006). 
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Generally, glycosidases utilize two acid amino acids for cleavage of the glycosidic bond, one 
acting as an acid/base catalyst and one as a nucleophile. The mechanism of the hyaluronidases 
is an exception insofar as only a single carboxylate of the enzyme acts as an acid/base catalyst 
and the substrate itself acts as the nucleophile (Markovic-Housley and Schirmer 2002).  
The substrate-assisted mechanism shown in Fig. 1.6 is initiated by distortion of the GlcNAc 
residue in position -1* to a 1,4B-boat conformation (A). This positioning enables the 
nucleophilic attack of the N-acetyl group on the anomeric C-atom and the formation of the 
oxazolinium ion intermediate (B). Simultaneously, E145 donates its proton to the sugar chain 
in position +1 resulting in the release of the first reaction product. The covalent intermediate 
(B) is subsequently hydrolyzed by exchange of the reaction product in position +1 by a water 
molecule. The hydrolysis thus results in retention of the configuration of the anomeric C-atom 
at the reducing end of GlcNAc (Markovic-Housley and Schirmer 2002).  
145 145 145
A B C  
Fig. 1.6 Double-displacement mechanism of bee venom hyaluronidase. The GlcNAc residue of the 
HA disaccharide bound in position -1 (Davies et al. 1997) forms a boat conformation (A), Glu145 acts 
as a acid/base catalyst and the carbonyl group of the N-acetyl-moiety acts as a nucleophile. The 
intermediate is an oxazolinium ion (B), that is subsequently hydrolyzed to form the reaction product 
(C). (Modified from Markovic-Housley and Schirmer 2002). 
 
1.2.3. Subtype specific differences 
The sequence similarity between the six subtypes of human hyaluronidases varies between 33 
and 42 % (Stern and Jedrzejas 2006). The genes coding for the hyaluronidase subtypes are 
clustered on two different chromosomes: hyal-1, -2 and -3 are clustered on chromosome 
3p21.3, hyal-4, ph-20 and phyal1 on chromosome 7q31.3 (Csoka et al. 2001).  
 
PH-20, also termed SPAM1 (sperm adhesion molecule 1), was the first hyaluronidase 
identified by its function as a “spreading factor” in testicular extracts (Duran-Reynalds 1929). 
                                                 
* According to the convention for labelling of an enzymatic substrate the position at the non-reducing end of the 
sugar chain is numbered with –n and at the reducing end with +n. Enzymatic cleavage occurs between -1 and +1 
(Davies et al., 1997). 
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The major role of PH-20 is to facilitate penetration of the sperm through the HA-rich matrix 
of the oocyte. It thereby occurs as a multifunctional protein in a membrane-anchored and in a 
soluble isoform (Cherr et al. 2001) (cf. Chapter 6). Commercially available PH-20 
preparations from bovine testes have been used for many years for experimental and 
therapeutic purposes, e.g. in orthopedia, ophthalmology and internal medicine (Baumgartner 
and Moritz 1988, Spruss et al. 1995, Menzel and Farr 1998, Muckenschnabel et al. 1998). 
 
Hyal-1, which is alternatively named LUCA-1 (lung cancer protein 1), and Hyal-2, termed 
LUCA-2, represent the two major hyaluronidases in somatic tissue. Hyal-1 is an acid-active, 
soluble haluronidase found in lysosomes, in plasma and in urine with a high specific 
enzymatic activity (cf. Chapter 5). In contrast to Hyal-1, the catalytic activity of Hyal-2, a 
GPI-anchored hyaluronidase, is discussed controversially ranging from no hyaluronidase 
activity at all to the degradation of high molecular weight HA to fragments of 20 kDa and 
smaller fragments at various pH values. Yet, hints accumulate that the main function of Hyal-
2 might not be the degradation of hyaluronic acid (cf. Chapter 7). 
 
Hyal-3 was found to be expressed ubiquitously with extraordinarily high expression patterns 
detected in mammalian testis and bone marrow (Stern and Csoka 2000). The stem-cell like 
state of these cell types indicates a role of Hyal-3 in embryogenesis and stem-cell regulation 
(Csoka et al. 2001). The catalytic properties of Hyal-3 are currently unknown (Stern and 
Jedrzejas 2006). 
 
Hyal-4 is probably a GPI-anchored protein like PH-20 and Hyal-2 and is exclusively 
expressed in muscle and placenta. It was proposed to be the first vertebrate chondroitinase 
with no activity against HA (Csoka et al. 2001). However, experimental evidence is still 
lacking, and the only hint for a specialized function of Hyal-4 is the presence of a C residue 
(C163) in a position close to the active site and strictly conserved in other hyaluronidases (cf. 
Fig. 1.5).  
 
The pseudogene, phyal-1, is transcribed, yet the mRNA contains an internal stop codon 
resulting in preliminary abortion of translation. However, translation of phyal1 into an active 
enzyme might occur in other species (Stern 2003). 
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Furthermore, MGEA5, a cytoplasmic β-N-acetylglucosaminidase, was described to exhibit an 
additional hyaluronidase activity (Comtesse et al. 2001). However, no sequence similarity 
could be found between the six human hyaluronidases and MGEA5. 
 
1.2.4. Relevance of hyaluronidases in the development of cancer 
There is no doubt about the involvement of both hyaluronan and the catabolizing enzymes, 
the hyaluronidases, in tumor development and progression. However, data about the effects of 
hyaluronidases on cancer growth, progression, spread and outcome are controversial. 
Hyal-1 and Hyal-2 can in some cases like in tobacco-related lung cancers and cancers of the 
upper airways function as tumor suppressor genes (Frost et al. 2000, Chang 2002), but were in 
other types of tumors described as oncogenes (Novak et al. 1999, Lokeshwar et al. 2001, 
Lokeshwar et al. 2005). Hyal-2 is assumed to be responsible for the strong oncogenic 
potential of Jaagsiekte sheep retrovirus as it acts as the cell surface receptor for the virus (Rai 
et al. 2001). 
 PH-20 was expressed in a series of malignant tumors, e.g. breast, prostate and laryngeal 
cancers and also in cell lines derived from melanomas, glioblastomas and colon carcinomas 
(for review see Stern 2005).  
 
Abnormalities in the deposition of HA have been found in the stroma surrounding tumors 
indicating an aberrant HA metabolism. However, the contribution of stromal HA to the tumor 
mass varies significantly dependent on the kind of tumor. In the course of tumor progression 
the HA metabolism is also very likely to change dependent on the different stages of 
initiation, growth and metastasis (Stern 2005). At the initial stage of tumor formation high 
molecular weight HA can provide hydrated pathways for cell migration and diffusion of 
nutrients. If supply by diffusion becomes insufficient low molecular weight HA fragments 
(Fig. 1.3) produced through the action of Hyal-2 could promote angiogenesis (West et al. 
1985). This phenomenon of the angiogenic switch (Folkman 2002) could account for some of 
the anomalies described in literature. 
The situation is severely complicated by the fact that HA is under normal conditions turned-
over quickly and abnormalities in the concentration of HA can reflect aberrations both in the 
anabolic and in the catabolic pathways. Furthermore, the hyaluronidase activity is controlled 
in the tissue by biological inhibitors that are hardly characterized (Mio and Stern 2002).  
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In addition to the effects mediated by the degradation products of HA, GPI-anchored 
hyaluronidases (PH-20, Hyal-2 and, presumably Hyal-4) themselves can participate in signal 
transduction events. As shown for PH-20 the interaction between HA and a hyaluronidase can 
increase intracellular Ca2+ levels resulting in an amplification of the zona-pellucida induced 
acrosome reaction (Sabeur et al. 1998, Cherr et al. 2001). The interaction of signaling 
molecules like Src-family tyrosine kinases with GPI-anchored proteins appears to take place 
in glycosphingolipid-cholesterol microdomains, so called “lipid rafts” (Kasahara and Sania 
2000). Within these membrane domains aggregation and cross-linking of GPI-anchored 
proteins, e.g. upon binding to hyaluronic acid, are supposed to trigger intracellular signaling 
events (Cherr et al. 2001).  
Although rather little is known about the oncogenic potential of PH-20, Hyal-2 was shown to 
mediate transformation of fibroblasts by virus-induced disturbance of the interaction between 
Hyal-2 and RON receptor tyrosine kinase (Danilkovitch-Miagkova et al. 2003).  
 
Many of the contradictory data accumulated during the last years could be resolved if the 
differential functions of the hyaluronidase subtypes and the interactive pathways of the HA 
catabolism were better understood. 
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Scope and objectives 
 
 
Hyaluronan is recently gaining increasing importance in many areas of cell biology, oncology 
and immunology. Yet the knowledge about the synthetic and catabolic pathways involved in 
the control of hyaluronic acid maintenance is limited. This is in part due to the lack of in-
depth information on the catabolizing enzymes, the hyaluronidases. Human hyaluronidases 
have been isolated from human tissue and fluids in very low quantities insufficient for 
enzymatic and structural characterization studies. Therefore, the aim of this thesis was the 
recombinant production of human hyaluronidases, the establishment of efficient purification 
strategies and the identification of biochemical and enzymatic properties of these hardly 
characterized enzymes. 
 
As a first approach, the human hyaluronidases Hyal-1, Hyal-2, Hyal-4 and PH-20 were 
intended to be produced in E. coli as expression system and, if necessary, refolded in vitro. 
The presence of several cysteine residues probably all linked by disulfide bridges in the native 
hyaluronidases indicated the formation of inclusion bodies in the reducing cytoplasm of 
standard E. coli strains. However, in vitro folding systems have been intensively improved 
during the last years providing general strategies for the folding of unknown proteins. 
Alternatively, the use of E. coli strains optimized for the production of disulfide-linked 
proteins in the cytoplasm was planned to be tested for the expression of human 
hyaluronidases. 
 
Insect cells have previously proven to be suitable for the expression of recombinant bee 
venom hyaluronidase, an enzyme with significant homology to the human hyaluronidases. 
Therefore, Drosophila Schneider-2 cells were suggested as a eukaryotic expression system 
with the ability to introduce mammalian-like glycosylation patterns.  
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Biochemical characterization studies with respect to the pH-dependent activity of the human 
hyaluronidases against the natural substrate, hyaluronic acid, and other glycosaminoglycans 
as alternative substrates should provide further insight into the specific functions of the 
human hyaluronidase subtypes. The degradation of HA should be followed by various 
hyaluronidase activity assay systems including colorimetric, turbidimetric, viscosimetric and 
electrophoretic techniques in order to gain more detailed information about the subtype 
specific differences of the catalytic process. 
 
The unique properties of hyaluronic acid as a macro-molecular substrate complicate the 
observation of enzyme kinetics in terms of Michaelis-Menten kinetics. Therefore, kinetic 
parameters were intended to be determined by the conversion of the suspected minimum 
substrate, the hyaluronic acid hexasaccharide. Oligosaccharides comprising one to four 
[GlcUAc(β1-3)GlcNAc(β1-4)] units were to be produced enzymatically and separated in a 
preparative scale by size exclusion chromatography.  
A capillary zone electrophoresis (CZE) method was to be established for a qualitative and 
quantitative separation of hyaluronic acid oligosaccharide mixtures produced through the 
time-dependent action of different hyaluronidase subtypes. Analysis of these oligosaccharide 
mixtures produced by the hyaluronidases can provide important information about the affinity 
of low molecular weight compounds towards the binding pocket of hyaluronidases. 
Furthermore, the transglycosylation catalyzed in addition to the hydrolysis of hyaluronic acid 
fragments could be studied in detail by this method. 
 
The production of catalytically active human hyaluronidases in recombinant expression 
systems was planned as a basis for enzymological and biophysical studies of these poorly 
characterized enzymes. Furthermore, the hyaluronidases can be used for the development of 
specific inhibitors, which can be employed, for example, as pharmacological tools. 
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3. Heterologous expression of human hyaluronidases in 
bacteria 
 
Chapter 3 
Heterologous expression of the 
human hyaluronidases PH-20, Hyal-1, 
Hyal-2 and Hyal-4 in bacteria 
 
 
 
3.1. Introduction 
In consequence of the sequencing of the human genome in 2003 (Rogers 2003), databases 
containing human gene sequences as well as cDNA libraries are available nowadays. This 
enables the heterologous production of any human protein in host organisms like bacteria, 
yeast, insect cells or mammalian cells. The E. coli system, being the most convenient and best 
characterized recombinant expression system, is often the first choice, due to its easy 
handling, the fast production of high amounts of protein and the possibility for scaling-up 
(Graumann and Premstaller 2006).  
The great evolutionary distance between human and bacterial protein transcription and 
translation causes several problems. However, those have mainly been overcome in the past 
years by selective improvement of bacterial strains. Exemplarily: insertion of additional 
tRNAs for codons rarely used in E. coli improves expression of proteins utilizing these 
codons, stringent control of basal expression levels enables the production of toxic proteins, 
deficiencies in proteases like lon and ompT reduce the intracellular degradation of foreign 
proteins (for review see Terpe 2006).  
The major disadvantage of bacterial expression systems is the absence of post-translational 
modifications like glycosylations, disulfide bridge formation or lipid modifications 
(palmitoylation, myristoylation). This often leads to misfolding of mammalian proteins and 
the formation of insoluble, inactive protein aggregates, so called inclusion bodies (IBs) 
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(Baneyx and Mujacic 2004). Production of disulfide-bonded, soluble proteins can sometimes 
be achieved by secretion of the protein into the periplasm (Georgiou and Segatori 2005) or in 
the cytoplasm of glutathione reductase/thioreductase-deficient bacterial strains (Bessette et al. 
1999).  
 
If post-translational modifications are known to influence the activity of the protein of 
interest, eukaryotic expression systems are generally preferred. While the expression in yeast 
(Saccharomyces cerevisiae, Pichia pastoris) is also easy and fast, the glycosylation pattern 
introduced by normal yeast strains differs to a great extent from the glycosylation in mammals 
(Sethuraman and Stadheim 2006). Insect cells (Sf9, DS-2) are an alternative for mammalian 
cell lines due to their relatively simple cultivation, fast growth and the production of high 
amounts of protein with a glycosylation pattern similar to human proteins (Schmidt 2004). 
Among mammalian expression systems CHO (chinese hamster ovary) cells are the most 
common ones (Schmidt 2004). For reasons of completeness cell-free translation systems 
should be mentioned, which have evolved during the last years as promising tools for the 
production of proteins difficult to access with “in vivo” expression systems (Yoshihiro et al. 
2006). 
 
The choice of the expression system depends on the characteristics of the foreign protein. The 
primary structures of the human hyaluronidases Hyal-1, Hyal-2, Hyal-4 and PH-20 contain 
four and five cysteine residues, respectively, within the hyaluronidase domain and 6 – 8 
cysteine residues in the C-terminal domain (cf. Chapter 1). Due to the localization of 
hyaluronidases in the extracellular matrix or in lysosomes these cysteine residues are assumed 
to be at least partially linked by disulfide bridges. The strict conservation of the four cysteine 
residues within the catalytic domain in all human hyaluronidases indicates disulfide linkage 
similar to the one in bee venom hyaluronidase (Markovic-Housley et al. 2000). Hyal-4 
contains an additional cysteine residue (C263) within the hyaluronidase domain with yet 
unknown function and oxidation state. 
 
Although the human hyaluronidases were expected to form IBs due to the presence of 
disulfide bridges, they were expressed in the cytoplasm of E. coli BL21(DE3)RIL and in 
Rosetta-gamiTM(DE3), a glutathione reductase/thioreductase-deficient strain. The formation 
of IBs can be advantageous for the production of very high quantities of heterologous protein 
(exceeding 50 % of the total cell protein) with minimal impurities (Baneyx and Mujacic 
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2004). However, complete denaturation, solubilization and re-folding are necessary to gain 
catalytically active protein (Jaenicke and Rudolph 1989).  
 
3.2. Materials and Methods 
3.2.1. Enzymes, chemicals and standard techniques 
Primers were synthesized by MWG Biotech AG, Ebersberg, Germany. DNA sequencing was 
performed by Entelechon, Regensburg, Germany. Restriction enzymes, dNTPs, T4 ligase, 
RNase A, polymerases and respective buffers were purchased from Fermentas, St. Leon-Rot, 
Germany. Lysozyme and CIP (calf intestine alkaline phosphatase) were from Roche 
Diagnostics, Mannheim, Germany. Antibiotics, IPTG (isopropylthiogalactoside) and 
dimethylamminobenzaldehyde (DMAB) were purchased from Sigma-Aldrich, Munich, 
Germany. Substances for microbiological experiments (tryptone, yeast extract, agar) and 
cetyltrimethylammoniumbromide (CTAB) were purchased from Roth, Karlsruhe, Germany. 
BTH (Neopermease®) was a gift from Sanabo, Vienna, Austria. BSA was purchased from 
Serva, Heidelberg, Germany, and all other chemicals were from Merck, Darmstadt, Germany. 
3.2.2. Amplification of hyaluronidase cDNAs by PCR 
Clones carrying cDNA sequences of the human hyaluronidases hyal-1, hyal-2, hyal-4 and ph-
20 were purchased as I.M.A.G.E. clones (Lennon et al. 1996) from RZPD (Deutsches 
Ressourcenzentrum für Genomforschung GmbH, Berlin, Germany) (Tab. 3.1). 
 
Tab. 3.1 cDNAs of human hyaluronidases from arrayed cDNA libraries as purchased by RZPD. 
 
cDNA RZPD clone I.D. Library vector Tissue 
ph-20 IMAGp998N231077Q3 pBluescriptR testis 
hyal-1 IRAKp961O1779Q2 pCMV-SPORT 6.0 stomach, colon, kidney 
hyal-2 IMAGp958H01139Q2 pOTB7 kidney 
hyal-4 IMAGp998G15205Q3 pT7T3d-PacI spleen 
 
All cDNAs were completely sequenced using standard primers (T7, sp6) and specific internal 
primers if necessary. The hyaluronidase cDNAs were analyzed for a signal peptidase cleavage 
site by the program SignalP 3.0 (Bendtsen et al. 2004). Signal peptides identified thereby 
were not included in the following cloning steps. Each of the four hyaluronidase subtypes was 
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cloned as a truncated (short, S) and full-length variant (long, L). Fragments were amplified by 
PCR with primers containing additional restriction sites for NdeI and BamHI (Tab. 3.3 and 
Tab. 3.4). The general PCR reaction mixture used is shown in Tab. 3.2, while conditions 
with respect to the annealing temperature and the MgSO4 concentration were optimized for 
each reaction separately (Tab. 3.3 and Tab. 3.4).  
 
Tab. 3.2 PCR reaction mixture for amplification of ph-20, hyal-1, hyal-2 and hyal-4 cDNAs for 
cloning into pET15b.  
 
4 µL Template DNA (25 µg/mL) 
2 µL Forward primer (25 µM) 
2 µL Reverse primer (25 µM) 
5 µL Pfu reaction buffer containing 15 mM MgSO4 (10 x) 
5 µL dNTP Mix (2 mM/dNTP) 
1 µL Pfu DNA-polymerase (2.5 U/µL) 
x µL MgSO4 (25 mM) 
ad 50 µL H2O 
  
Tab. 3.3 PCR primers (5’-3’-direction) for cloning of different hyaluronidase variants into NdeI and 
BamHI restriction sites of pET15b. Underlined sequences indicate these restriction sites within the 
primers, bold letters indicate additionally introduced stop codons. MgSO4 refers to the final 
concentration in the PCR reaction mixture and Ta indicates the annealing temperature. 
 
Hyaluro-
nidase  
Forward primer Reverse primer MgSO4  Ta 
PH-20/S 
ACTGGATCCTTACATTTT
GGCTGCTAG 
2.5 mM 59.5 °C 
PH-20/L 
CGAGTGTCATATGCTG
AATTTCAGAG ATCGGATCCTCAGAAGA
AACCAATTC 
2.0 mM 58.0 °C 
Hyal-1/S 
TAAGGATCCTTAGAGAA
GGGCCCCACTG 
2.5 mM 59.5 °C 
Hyal-1/L 
CTTAATTCATATGTTT
AGGGGCCCCTTGC TAAGGATCCTCACCACA
TGCTCTTCCG 
2.0 mM 58.0 °C 
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Hyal-2/S 
AATGGATCCTCAATATT
GGGTGGCCC 
1.5 mM 59.5 °C 
Hyal-2/L 
TAGAATTGCATATGG
AGCTCAAGCCC ATAGGATCCCTACAAGG
TCCAGGTAAAG 
2.0 mM 60.5 °C 
 
The PCR was performed in a Mastercycler gradient Thermocycler (Eppendorf, Wesseling-
Berzdorf, Germany) and comprised the following steps: 
1) 5 min, 90 °C, 2) 30 s, 95 °C, 3) 30 s, Ta, 4) 1 min/kb PCR-product, 72 °C 5) 30 cycles 
repeating step 2)-4), 6) 5 min, 72 °C.  
PCR-fragments were analyzed by agarose gel electrophoresis (cf. 3.2.10) and purified either 
directly from the PCR mix using a PCR Purification Kit (Quiagen, Hilden, Germany) or, if 
side products were identified by gel electrophoresis, by excision of the relevant band from the 
gel and subsequent purification from the agarose gel slice (QIAEX II Purification Kit, 
Quiagen, Hilden, Germany). All DNA purifications were performed according to the 
manufacturer’s instructions. 
3.2.3. Overlap extension PCR of hyal-4 cDNA 
For insertion of a G227C mutation the hyal-4 cDNA was amplified by overlap extension 
PCR. In the first step PCR reactions I and II were performed under the conditions summarized 
in Tab. 3.2 with pT3T7D/hyal-4 as template DNA and primers shown in Tab. 3.4.  
 
Tab. 3.4 PCR primers (5’-3’-direction) for the amplification of hyal-4 cDNA in the first PCR step of 
an overlap extension PCR. Additionally introduced NdeI and BamHI restriction sites are underlined 
and new stop codons are printed bold. 
 
 Hyaluronidase 
subtype 
Forward primer Reverse primer 
PCR I 
Hyal-4/S and 
Hyal-4/L 
CTGGATCATATGCTAAAA
CCTGCTCGAC 
CAAGGGATTTCCAGACAC
AGATAGAAGG 
PCR II Hyal-4/S 
ATTGGATCCTCATACCTC
AGCAGCTCTG 
PCR II Hyal-4/L 
CCTTCTATCTGTGTCTGG
AAATCCCTTG GATGGATCCTCACAACTG
AATGCTTCG 
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All reactions were performed at an annealing temperature of 58 °C and a MgSO4 
concentration of 1.5 mM. PCR products were analyzed by agarose gel electrophoresis and 
extracted from the gel. The conditions of the subsequent overlap extension PCR are shown in 
Tab. 3.5. 
 
Tab. 3.5 Overlap extension PCR for amplification of Hyal-4/S and Hyal-4/L with a G227C mutation. 
 
12 µL Gel extract PCR I (from 2 x 50 µL PCR reaction I) 
12 µL Gel extract PCR II (from 2 x 50 µL PCR reaction II) 
10 µL Forward primer PCR I 
10 µL Reverse primer PCR II 
10 µL Pfu reaction buffer containing 15 mM MgSO4 (10 x) 
10 µL dNTP mix (2 mM/dNTP) 
2.5 µL Pfu polymerase (1 U/µL) 
Ad 100 µL H2O 
 
The overlap extension reaction was achieved by the following thermocycle:  
1) 5 min, 90 °C, 2) 1 min, 95 °C, 3) 1 min, 50 °C, 4) 1 min, 72 °C, 5) 25 cycles repeating 
steps 2) – 4), 6) 5 min, 72 °C. 
The final PCR products were purified by gel extraction (cf. 3.2.2). 
3.2.4. Restriction digest and ligation of PCR fragments and pET15b 
For sub-cloning the vector pET15b (Novagen®, Merck, Darmstadt, Germany) and the PCR 
products were both digested with NdeI and BamHI. The first restriction step was performed in 
a reaction mixture containing 2 µL of plasmid DNA (1.0 mg/mL) and 20 µL of purified PCR 
product, respectively, 8 µL of 10 x Y+/TANGOTM buffer, 3 µL of NdeI (10 U/µL). Then 
water was added to reach a final volume of 40 µL. After incubation at 37 °C overnight 1 µL 
of BamHI (10 U/µL) was added and the digestion was continued for 1 h. To avoid self- 
ligation of the vector the DNA was additionally treated for 1 h at 37 °C with 0.05 U CIP per 
pmol DNA ends present in the reaction mixture. Enzymatic restriction and dephosphorylation 
of 3’-ends were stopped by 20 min incubation at 80 °C. Restriction digests were purified by 
agarose gel electrophoresis (cf. 3.2.2).  
Ligation was performed in a total volume of 18 µL containing 50 – 150 ng of pET15b DNA 
and 5 – 10 times the molar amount of insert DNA. The reaction mixture was incubated for 5 
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min at 45 °C. Then 2 µL of 10 x ligase buffer containing ATP and 1 Weiss U of ligase were 
added on ice. After incubation overnight at 4 °C ligation was stopped by heating at 65 °C for 
10 min. The ligation mixture was transformed into E. coli Top10 (Invitrogen, Karlsruhe, 
Germany) and colonies were screened for the ligation product by colony PCR (cf. 3.2.7). 
After preparation of the pET15b/hyaluronidase constructs the correctness of the inserts was 
confirmed by sequencing. 
3.2.5. Generation of competent E. coli cells 
All competent E. coli strains used in this work were prepared by CaCl2 treatment. 200 mL 
LB-medium (Luria-Bertani medium) were inoculated with 2 mL of an overnight culture of the 
respective E. coli strain and the culture was grown at 37 °C and 200 rpm until a cell density of 
OD600 = 0.2 was reached. Bacteria were placed on ice for 10 min, centrifuged for 7 min 
(4,000 g, 4 °C) and resuspended in 32 mL of ice-cold, sterile CaCl2-solution (60 mM CaCl2, 
15 % (v/v) glycerol, 10 mM PIPES, pH 7.0). After incubation on ice for 30 min the bacteria 
were again pelleted (5 min, 4,000 g, 4 °C) and resuspended in 6.4 mL of ice-cold CaCl2-
solution. This concentrated bacteria suspension was incubated in aliquots of 200 µL for 2 h on 
ice, frozen in liquid N2 and stored at -80 °C until transformation. 
3.2.6. Transformation of competent E. coli  
200 µL of freshly thawed competent E. coli cells were incubated with 5 ng of plasmid DNA 
or 10 µL of ligation mix (cf. 3.2.4) for 30 min on ice. A heat shock of 1.5 min at 42 °C was 
applied to allow DNA uptake by the cells. After 2 min on ice 1 mL of sterile SOC-medium 
(0.5 % (w/v) yeast extract, 2 % (w/v) trypton, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 
mM MgSO4, 20 mM glucose) was added and the bacteria were shaken for 45 min at 37 °C 
and 200 rpm. 20 - 50 µL of this suspension were plated on LB-agar plates containing 100 
µg/mL of ampicillin. Colonies formed after incubation at 37 °C overnight.   
3.2.7. Colony PCR for the selection of positive clones 
To check for clones containing the insert DNA 10 colonies were picked from an agar plate 
and transferred to 1 mL of LB-medium. Bacteria were grown for 2 h (37 °C, 200 rpm), 
pelleted (4,000 g, 3 min) and resuspended in 50 µL of water. Bacteria were lyzed by boiling 
for 5 min and used as a template for an analytical PCR reaction with primers hybridizing with 
vector sequences framing the multiple cloning site (T7 primers for pET15b) (Tab. 3.6). 
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The thermocycle was performed as follows:  
1) 5 min, 90 °C, 2) 1 min, 94 °C, 3) 1 min, 50 °C, 4) 2 min, 72 °C, 5) 35 cycles repeating 
steps 2) – 4), 6) 6 min, 72 °C. 
The complete PCR mixture was analyzed on a 1 % agarose gel.  
 
Tab. 3.6 PCR reaction mix for colony PCR of pET15b/hyaluronidase clones. 
 
10 µL Template (lysed bacteria) 
1 µL T7 promotor primer (5 µM) 
1 µL T7 terminator primer (5 µM) 
2 µL dNTP mix (2 mM) 
2 µL 10 x Taq reaction buffer with MgCl2 
3.8 µL H2O 
0.2 µL Taq polymerase (5 U/µL) 
 
3.2.8. Preparation of plasmid DNA from E. coli 
Small scale isolation of plasmid DNA (“Mini-prep”) from E. coli was performed as follows:  
4 mL of an overnight culture were centrifuged for 15 min at 3,000 rpm, the pellet was 
resuspended in 200 µL of GTE-buffer (1 % (w/v) glucose, 25 mM Tris/HCl, 10 mM EDTA, 
pH 7.5) supplemented with 5 µL of RNase A (10 mg/mL). After addition of 400 µL of freshly 
prepared “lysis buffer” (200 mM NaOH, 1 % (w/v) SDS) the solution was mixed by inverting 
several times and incubated on ice for exactly 5 min. Cell lysis was stopped by addition of 
300 µL of 3 M potassium acetate and incubation on ice for 10 min. Cellular debris and 
chromosomal DNA were pelleted by 10 min centrifugation at 13,000 rpm. Plasmid DNA 
remaining in the supernatant was precipitated by addition of 1 mL of cold 70 % (v/v) ethanol. 
After incubation on ice for 30 min and centrifugation (10 min, 13,000 rpm at 4 °C) the 
plasmid DNA was washed once with 200 µL of ethanol. The resulting pellet was dried for ca. 
15 min at RT and then solubilized in 50 µL of H2O.  
Large scale isolation (“Maxi-prep”) of plasmid DNA was performed with a Quiagen Plasmid 
Purification Kit (Quiagen, Hilden, Germany) following the manufacturer’s instructions.  
Plasmid DNA concentrations and purity were determined photometrically. If the quotient 
A280/A260 was < 0.59, the DNA was considered to contain no protein impurities and the DNA 
concentrations were calculated by the following equation: 
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280260 4070)( AADNAc ⋅−⋅=    with c(DNA) in µg/mL.  Eq.3.1 
3.2.9. Overnight cultures, glycerol stocks and LB-agar plates  
Bacterial overnight cultures were shaken for 12 – 15 h at 200 rpm in LB-medium containing 
the necessary antibiotics.  
For long term storage of bacteria 850 µL of an overnight culture were added to 150 µL of 
sterile, 87 % (v/v) glycerol. This glycerol stock culture was stored at -80°C. 
LB-agar plates were prepared by heating LB-agar (1 % (w/v) tryptone, 0.5 % (w/v) yeast 
extract, 1 % (w/v) NaCl, 1.35 % (w/v) agar, pH 7.0) under stirring until the agar was 
completely dissolved. Then the agar was cooled to 55 °C in a water bath before the 
appropriate antibiotics were added. Finally, 20 – 30 mL of agar were poured into a sterile 
culture plate, which was stored at 4 °C until use. 
3.2.10. Agarose gel electrophoresis 
Agarose (Peqlab, Erlangen, Germany) was added to 50 mL of 1 x TBE-buffer (89 mM Tris, 
89 mM boric acid, 2 mM EDTA) to achieve a final concentration of 1 % (w/v) and 1.7 % 
(w/v), respectively. Under stirring the agarose was completely melted at 80 °C, then 2 µL of 
ethidium bromide (10 mg/mL, Sigma-Aldrich, Munich, Germany) were added and the gel 
mixture was poured into a gel chamber (10 cm x 10 cm). After placing the comb the agarose 
was allowed to solidify at room temperature for 15 – 20 min. Then the gel was placed into the 
electrophoresis chamber filled with 1 x TBE-buffer.  
All DNA samples were mixed with 10 x PCR loading buffer (Peqlab, Erlangen, Germany) to 
yield a final concentration of 1 x PCR loading buffer. 5 µL of GeneRulerTM DNA Ladder Mix 
(Fermentas, St. Leon-Rot, Germany) were added to 15 µL of water and 5 µL of 10 x PCR 
loading buffer. Gel pockets were filled with 25 µL of sample and electrophoresis was 
performed at 90 V for 1.5 h. 
Gels were photographed in a Gel-Doc detection system (Bio-Rad, Munich, Germany) with an 
excitation wavelength of 254 nm. Data were analyzed using Quantity One quantification 
software, version 4.0.3. (Bio-Rad, Munich, Germany).  
3.2.11. Hyaluronidase expression in E. coli BL21(DE3)RIL 
For protein expression E. coli BL21(DE3)RIL cells (Stratagene, Cedar Creek, USA) were 
transformed with the pET15b/hyaluronidase vectors. Hyaluronidase expression was achieved 
by inoculation of LB-medium supplemented with 100 µg/mL of ampicillin to an OD600 of 
0.15 with an overnight culture. For efficient protein expression it proved to be essential to use 
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overnight cultures containing freshly transformed bacteria and overnight culture incubation 
times of less than 15 h. Bacteria were grown for 2 – 3 h at 200 rpm and 37 °C until an OD600 
of 0.6 ± 0.5 was reached, then recombinant protein expression was induced by addition of 1 
mM of IPTG (if not indicated otherwise). Generally, bacteria were harvested 3 – 4 h after 
induction of expression by centrifugation (30 min, 5,000 g, 4 °C). Cell pellets could be stored 
at -20 °C for a few months. 
For total cell protein analysis by SDS-PAGE 1 mL of cell suspension was centrifuged (1 min, 
13,000 rpm, 4 °C) and resuspended in 100 µL of 1 x PBS and 100 µL of 5 x SDS sample 
buffer (cf. 3.2.14). Cell lysis and complete denaturation of proteins was achieved by boiling 
of the samples for 15 min. To compare the total cell protein before and after induction with 
IPTG the samples were normalized with respect to cell density. 
3.2.12. Hyaluronidase expression in Rosetta-gamiTM(DE3) 
The E. coli strain Rosetta-gamiTM(DE3) (Novagen®, Merck, Darmstadt, Germany) was 
transformed with the pET15b/hyaluronidase constructs. Expression and analysis of total cell 
protein was performed as described for E. coli BL21(DE3)RIL (cf. 3.2.11).  
All media and agarose plates used for the growth of E. coli Rosetta-gamiTM(DE3) were 
supplemented with 15 µg/mL kanamycin, 12.5 µg/mL tetracycline and 34 µg/mL 
chloramphenicol.  
3.2.13. Separation of soluble and insoluble cell fractions 
Bacterial pellets were resuspended in 1/10 of the original culture volume of bacterial lysis 
buffer (20 mM Tris/HCl, pH 7.5, 0.5 mg/mL lysozyme), e.g. 2 mL of lysis buffer were added 
to a pellet from 20 mL of bacterial culture. After incubation on ice for 1 h cell lysis was 
enhanced by sonication on ice (15 bursts, microtip, power level 4 – 5, 40 – 50 % duty, 
Branson-Sonifier B15, G. Heinemann, Schwäbisch-Gmünd, Germany). By centrifugation (30 
min, 10,000 g, 4 °C) the suspension was separated into a supernatant with soluble proteins 
from the cytoplasm and an insoluble pellet containing fragments of membranes and insoluble 
proteins.  
The pellet was washed twice with 20 mM Tris/HCl, pH 7.5, and pelleted after each washing 
step by centrifugation (5 min, 10,000 g, 4 °C). For SDS-PAGE the pellet was resuspended in 
1 % (w/v) SDS, a sample was taken and mixed with an equal volume of 5 x SDS sample 
buffer (cf. 3.2.14) before boiling for 3 min at 100 °C.      
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3.2.14. Discontinuous SDS-PAGE 
12 % separation gel mixtures contained 2.1 mL of water, 1.5 mL of 1.5 M Tris/HCl, pH 8.8, 
60 µL of 10 % (w/v) SDS and 2.4 mL of acrylamide/bisacrylamide (30 % solution, 
acrylamide/bisacrylamide = 29/1, Sigma-Aldrich, Munich, Germany) per gel. Polymerization 
was started by addition of 3 µL of N,N,N',N'-tetramethylethylenediamine (TEMED) and 40 
µL of freshly prepared 10 % (w/v) ammonium peroxodisulfate (APS). The mixture was filled 
into gel chambers (10 x 10 x 0.8 cm) and covered with a layer of water-saturated isobutyl 
alcohol. After 15 – 20 min the gel was completely polymerized and the stacking gel was 
pipetted on top of the separation gel after the isobutyl alcohol had been washed away with 
water. 4 % stacking gel mixtures contained 1.8 mL of water, 0.75 mL of 0.5 M Tris/HCl, pH 
6.8, 30 µL of 10 % (w/v) SDS and 0.4 mL of acrylamide/bisacrylamide (30 %, see above). 3 
µL of TEMED and 10 µL of 10 % (w/v) APS were added to initiate polymerization.  
Electrophoresis was performed in a PerfectBlueTM Double gel system Twin S (Peqlab, 
Erlangen, Germany) at 150 V for 1 – 1.5 h with the electrode chambers filled with 1x running 
buffer. 5 x running buffer contained 9 g Tris, 43.2 g glycine and 3 g SDS in 600 mL of water. 
If not indicated otherwise protein samples were mixed with 0.2 – 0.5 volumes of 5 x SDS 
sample buffer (0.2 M Tris/HCl, pH 6.8, 10 % (w/v) SDS, 10 mM DTT, 20 % (v/v) glycerol, 
0.05 % (w/v) bromphenol blue) and heated for at least 3 min at 100 °C.  
Gels were analyzed with a Bio-Rad gel detection system (GS-710 Imaging Densitometer) 
using Quantity One quantification software, version 4.0.3. (Bio-Rad, Munich, Germany).  
3.2.15. Turbidimetric hyaluronidase activity assay 
The turbidimetric hyaluronidase activity assay described by Di Ferrante (Di Ferrante 1956) 
was slightly modified for the 96-well plate format. The incubation mixture contained the 
following components: 
31 µL of incubation buffer, 8 µL of BSA (0.2 mg/mL), 8 µL of HA (2 mg/mL), 13 µL of 
H2O, 10 µL of sample containing the enzyme.  
As incubation buffer McIlvaine’s buffer (McIlvaine 1921) was used. The buffer was prepared 
by mixing solution A (0.2 M NaH2PO4, 0.1 M NaCl) and solution B (0.1 M citric acid, 0.1 M 
NaCl) in appropriate portions to adjust the required pH. In general a mixture containing the 
incubation buffer, BSA, HA and H2O was prepared and 60 µL of this mixture were pipetted 
into each well before addition of the sample.  
The 96-well plates were incubated at 37 °C for a defined reaction time. Then high molecular 
weight HA was precipitated with 200 µL of alkaline CTAB solution (2.5 % (w/v) CTAB in 
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0.5 M NaOH) and the plates were incubated for 20 min at room temperature. The extent of 
precipitation was measured by the optical density at 580 and 355 nm, respectively, in a Tecan 
GENios Pro microtiter plate reader (Tecan, Crailsheim, Germany) with XFluorGeniosPro 
Software, version V.4.55. The plate was shaken in the reader for 10 s in the orbital mode and 
the OD was measured with 10 flashes in the centre of each well after a settle time of 2 s.  
The optical density values given in the experimental section are mean values ± SEM (standard 
error of means) of triplicates. 
3.2.16. Colorimetric hyaluronidase activity assay 
A detailed description of the colorimetric hyaluronidase activity assay is given in Chapter 4. 
Incubation buffers were identical to the buffers used in the turbidimetric activity assay 
(3.2.15).  
 
3.3. Results and Discussion 
3.3.1. Analysis of hyaluronidase cDNA sequences 
The sequences of the cDNA inserts derived from the arrayed cDNA libraries were only 
partially sequenced by the I.M.A.G.E. consortium yet. Therefore, all purchased cDNA 
sequences were compared to the hyaluronidase cDNA sequences in the Gene Bank (Benson et 
al. 2006). 
The sequence of the ph-20 cDNA was identified to be identical to BC026163 (Gene Bank 
Accession number). The ORF included in this cDNA codes for a protein registered as 
Q8TC30 in the Swiss-Prot/TrEMBL database (Swiss-Prot/TrEMBL, Boeckmann 2003), 
which is a PH-20 variant differing from the registered PH-20/SPAM-1 (HYAP_HUMAN, 
accession number P38567) in its C-terminal propeptide. As this propeptide most probably 
functions as the signal sequence for addition of a GPI-anchor (cf. Chapter 1) it is not 
supposed to influence enzymatic activity. However, analysis of the C-terminal sequence of 
Q8TC30 revealed no GPI-anchorage signal.  
The cDNA of hyal-1 showed 99 % sequence identity to BC035695. The two bases mutated in 
comparison to the reference sequence were located in the 3’-UTR and did not affect further 
recombinant protein expression experiments (cf. Appendix 1). The encoded protein sequence 
was identical to the database entry Q12794 (Hyal-1/LUCA-1). 
The sequence of the hyal-2 cDNA was identical to BC000692 coding for Q12891. 
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Putative hyal-4 cDNA was compared to NM_012269. Three mutations were found within the 
ORF, but only one coded for an amino acid substitution while the other ones were silent 
mutations (cf. Appendix 1). The amino acid substitution would have resulted in an exchange 
of C227 in Hyal-4 (Q9UL99) by G227. This amino acid sequence is registered at Swiss-Prot 
as Q9Y6T9 (Gene Bank Acc. BC_104788 and BC_104790), however, no further information 
is available about this protein. Furthermore, the hyal-4 cDNA was truncated at the 5’-end 
lacking the codons for the amino acids M1 and K2 (Q9UL99) at the N-terminal end. Both 
amino acids were located within the signal peptide and had therefore no effect on the 
recombinant expression experiments. 
The complete ORFs coding for human PH-20, Hyal-1 and Hyal-2 were thus available for 
cloning into recombinant expression vectors. The C227G mutation in Hyal-4 was re-mutated 
during sub-cloning to the original C residue by overlap extension PCR in order to receive the 
coding sequence for human Hyal-4 as reported at the Swiss-Prot database. 
 
3.3.2. Construction of pET15b/ph-20, pET15b/hyal-1 and pET15b/hyal-2  
Homology studies suggest the existence of several domains in the primary sequence of human 
hyaluronidases (cf. Chapter 1). At the N-terminus of the proteins a signal peptide sequence is 
responsible for the transport of the nascent peptide chain to the ER (endoplasmic reticulum). 
After insertion of the N-terminus into the ER the signal peptide is cleaved off and is therefore 
not present in the mature protein. Analysis of the N-terminal sequence of all hyaluronidases 
by neuronal networks and Hidden Markov Models confirmed the length of the signal peptides 
in PH-20, Hyal-1 and Hyal-2 (cf. Chapter 1.). For Hyal-4 a unique signal peptidase restriction 
site was found by both models. Signal peptides were not included in the recombinant 
hyaluronidases expressed in E. coli. 
The hyaluronidase domain containing the active site is linked to the C-terminal domain by a 
short linker sequence. For construction of the short enzyme variants this linker was included, 
but not the following C-terminal domain with yet unknown function. The size of these short 
variants’ PCR products was ca. 1.0 kb (Fig. 3.1). 
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Fig. 3.1 PCR products of short (left) and long constructs (right) of ph-20, hyal-1 and hyal-2. After 
mixing with 10 x PCR loading buffer 5 µL of the original PCR mixtures of the short variants were 
applied to the gel and 10 µL of the original PCR mixtures of the long variants were applied to the gel. 
 
The long variants comprised the whole cDNA except for the signal peptide. PH-20 and Hyal-
2 are known to contain propeptides at the C-terminus, which are presumably cleaved off after 
linkage to a GPI-anchor. However, it is not clear whether these propeptides are necessary for 
proper folding of the protein in the ER, where the propeptide is still present. As several 
examples of folding enhancement by propeptides exist in literature (Hahm and Chung 2001, 
Rattenholl et al. 2001), the long variants of PH-20 and Hyal-2 were both cloned including the 
propeptide coding sequences. The resulting PCR products exhibited a size of ca. 1.4 kb. The 
PCR product of the long variant of Hyal-1 (Hyal-1/L) is shorter compared to PH-20 and Hyal-
2 as this hyaluronidase lacks the propeptide for GPI-anchorage and contains a shorter C-
terminal domain. 
The PCR products were digested with BamHI and NdeI and ligated into pET15b to yield the 
bacterial expression vectors pET15b/ph-20, pET15b/hyal-1 and pET15b/hyal-2 (Fig. 3.2). 
The expression vector pET15b is a 5.7 kb plasmid carrying at its expression site an N-
terminal His-tag followed by a thrombin cleavage site and three cloning sites (NdeI, XhoI and 
BamHI). The whole expression site is under control of a T7 promotor. Additionally, the 
plasmid contains the ampR and the lacI gene. 
Ampicillin
ori
lacI
T7 promoter
lac operator
His-tag
Hyaluronidase cDNA
T7 terminator
pET15b/hyal
 
 
 
 
Fig. 3.2 Plasmid map of the 
pET15b/hyaluronidase expression 
vector. 
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3.3.3. Construction of pET15b/hyal-4 expression vectors by overlap extension PCR 
Sequencing of cDNA clone IMAGp998G15205Q3 showed that this vector contained a cDNA 
coding for Hyal-4 with a C→G mutation at amino acid 227. This residue seems essential for a 
completely functional Hyal-4, therefore the codon GGT coding for G227 was mutated into 
TGT coding for C227 by overlap extension PCR (Fig. 3.3).  
5‘... ... 3‘
hyal-4 cDNA
TGT
ACA
NdeI
BamHI
PCR I_fwd PCR II_fwd
PCR I_rev PCR II_rev  
Fig. 3.3 Schematic presentation of the amplification and mutation of hyal-4 cDNA. Two separate PCR 
reactions, PCR I (primers shown in grey) and PCR II (primers shown in black) were performed in 
order to introduce a mutation (GGT → TGT) in the middle of the gene.  
 
Primers were chosen as described for ph-20, hyal-1 and hyal-2 (3.3.2). As determined by 
primary sequence analysis Hyal-4 also contains a catalytic and a C-terminal domain. 
Therefore, a short variant comprising only the catalytic domain plus a putative linker at the C-
terminus as well as a long variant comprising both domains were amplified (cf. Tab. 3.7). 
The reaction product of PCR I was identical for both variants while in PCR II a different 
reverse primer (PCR II_rev in Fig. 3.3) had to be used. 
PCR I      PCR II        OE-PCR 
2.0 
1.5
1.2
1.0
0.8
0.6
0.5
0.4
S       L          S        L
0.72 kb
1.37 kb
0.36 kb
0.68 kb
1.05 kb
kb
 
 
 
 
Fig. 3.4 PCR products of the short (S) 
and long (L) variants of hyal-4 during 
amplification and mutation by overlap 
extension PCR (OE-PCR). Each lane 
contained 20 µL of the PCR mixture. 
Overlap extension PCR yielded for both the short and the long variant of hyal-4 a PCR 
product of 1.05 and 1.37 kb, respectively (OE-PCR in Fig. 3.4), though the product still 
contained a high amount of the original PCR I product (0.72 kb). The high amount of PCR I 
product remaining in the mixture was probably due to inaccuracies in the amount of PCR I 
and II products used, as the DNA concentrations were estimated by comparison of the bands 
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on the gel with the amounts of DNA of the respective bands of the marker. However, as the 
products of the overlap extension PCR were purified from the gel the impurities did not 
impede the following cloning steps. 
 
3.3.4. Expression of human hyaluronidases in E. coli BL21(DE3)RIL 
E. coli BL21(DE3)RIL were transformed with pET15b plasmids containing the human 
hyaluronidase cDNAs. Tab. 3.7 gives an overview of the expected recombinant enzymes. E. 
coli BL21(DE3)RIL is a specialized protein expression strain with tRNAs for R, I and L 
codons rarely used in bacteria. The expression system is based on a T7-RNA polymerase 
encoded by the E. coli strain and controlled by a lac promoter, thus ensuring a tight and 
IPTG-inducible expression control of genes controlled by a T7 promotor. 
 
Tab. 3.7 Sequence length and molecular weight of recombinant hyaluronidases in the truncated (S) 
and full-length variants (L). The protein I.D. refers to the amino acid sequences described in the 
Swiss-Prot database (Boeckmann 2003).  
 
Hyaluronidase 
variant 
Hyaluronidase 
amino acids 
Complete 
sequence length 
Molecular 
Weight 
Protein I.D. 
(SwissProt) 
PH-20/S L36 - M375 361 aa 39.3 kDa 
PH-20/L L36 - F511 497 aa 56.7 kDa 
Q8TC30 
Hyal-1/S F22 - L357 357 aa 39.9 kDa 
Hyal-1/L F22 - W435 434 aa 48.3 kDa 
Q12794 
Hyal-2/S M21 - Y364 364 aa 39.6 kDa 
Hyal-2/L M21 - L473 473 aa 51.4 kDa 
Q12891 
Hyal-4/S L35 - V375 362 aa 41.1 kDa 
Hyal-4/L L35 - L480 467 aa 52.7 kDa 
Q9UL99 
 
All eight hyaluronidase subtypes were expressed in E. coli and the cell lysates were analyzed 
by SDS-PAGE. Comparison of cell lysates before and after induction of expression revealed 
the occurrence of a band increasing in intensity after induction (Fig. 3.5). Analysis of the 
molecular weight of the respective proteins indicated the expression of the recombinant 
enzymes with the molecular mass expected from the amino acid sequence (Tab. 3.7).  
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Fig. 3.5 SDS-PAGE analysis of the cell lysates of E. coli BL21(DE3)RIL/pET15b/hyaluronidase 
before (-) and 3 – 4 h after induction of expression (+). Separation of the cell lysate into a soluble 
fraction (supernatant, S) and an insoluble fraction (pellet, P) proved the expression of human 
hyaluronidases as insoluble aggregates. 
a) PH-20/S was determined to have a molecular mass of 38.5 kDa (theoretical: 39.3 kDa) and PH-20/L 
54.3 kDa (theoretical: 56.7 kDa).  
b) Hyal-1/S was determined to have a molecular mass of 36.7 kDa (theoretical: 39.9 kDa) and Hyal-
1/L 46.6 kDa (theoretical: 48.3 kDa)  
c) Hyal-2/S was determined to have a molecular mass of 40.2 kDa (theoretical: 39.6 kDa) and Hyal-
2/L 50.1 kDa (theoretical: 51.4 kDa). 
d) Hyal-4/S was determined to have a molecular mass of 42.3 kDa (theoretical: 41.1 kDa). Hyal-4/L 
was found on the SDS-PAGE at a molecular mass of 51.9 kDa (theoretical: 52.7 kDa).  
 
Although the T7-controlled pET-expression system in E. coli is known to be a very tight 
system, low basal expression of some of the human hyaluronidases was observed (Fig. 3.1, 
e.g. PH-20/L and Hyal-4/S).  
Furthermore, the strength of expression varied for the various subtypes and S/L variants, 
respectively. The level of expression of a recombinant protein can be influenced by the 
growth conditions or by the efficiency of translation due to the use of specific amino acid 
codons. Overall expression levels of the hyaluronidases calculated by densitometry varied 
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between 11 % (Hyal-4/S) and 42 % (Hyal-1/S) of the total cell protein. All recombinant 
hyaluronidases were exclusively found in the insoluble cell fraction, supporting the idea that 
most or all of the C residues are linked by disulfide bridges in the native hyaluronidases. The 
molecular masses calculated from the over-expressed proteins were found to be in accordance 
with the molecular masses calculated from the respective amino acid sequences (Tab. 3.7) 
within an error range of < 10 %.  
The isolation of the IBs resulted in a partial purification effect due to the separation from 
soluble cell proteins. The content of recombinant enzyme determined by densitometric 
analysis of the SDS-PAGE reached up to 60 % of the protein present in the IBs, e.g. Hyal-4/L 
in Fig. 3.5.  
 
3.3.5. Optimization of Hyal-1/L expression in E. coli BL21(DE3)RIL  
As the expression level of Hyal-1/L was found to be rather low compared to the other 
hyaluronidase subtypes (Fig. 3.5), experiments were performed with varying IPTG 
concentrations and induction times (Fig. 3.6).  
 
Fig. 3.6 SDS-PAGE analysis of cell lysates of E. coli BL21(DE3)RIL/pET15b/hyal-1/L at various time 
points (tind) after induction of Hyal-1/L expression by IPTG at various concentrations.  
 
Variations in the IPTG concentration used for the induction of expression did not influence 
the amount of recombinant protein significantly. Elongation of the periods of induction for 
more than 3 h resulted in an increased expression of low molecular weight impurities, mainly 
a protein of ca. 28 kDa (Fig. 3.6) possibly being a degradation product of the recombinant 
Hyal-1/L. 
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In comparison to the expression of Hyal-1/L observed in 3.3.4 the expression in the 
optimization experiments was much stronger due to the use of an overnight culture grown for 
only 10 h from a freshly transformed bacterial colony. In the experiments shown in 3.3.4 
glycerol stocks were used for the preparation of overnight cultures, which were incubated for 
ca. 15 h. Therefore, standard expression of Hyal-1/L was performed with 1 mM IPTG and an 
induction time of 3 h. As the overnight culture conditions influenced the protein expression 
levels significantly overnight cultures were induced with colonies of freshly transformed 
bacteria and grown for < 12 h. The decrease in expression levels after long periods of 
incubation was probably due to depletion of ampicillin allowing the growth of bacteria 
lacking the pET15b plasmid.  
Proteins expressed as insoluble, inactive aggregates are known to be hardly toxic for E. coli 
(Baneyx and Mujacic 2004), a problem that occurs rather often when working with soluble 
recombinant proteins. However, bacterial growth could be inhibited by the presence of 
insoluble aggregates of foreign protein expressed under control of the strong T7 promotor, 
which is, as shown above, not completely tight.  
 
3.3.6. Expression of the human hyaluronidase subtypes in E. coli Rosetta-
gamiTM(DE3)  
To allow for disulfide bond formation in the cytoplasm of bacteria E. coli strains have been 
developed, which are deficient in glutathione reductase and thioredoxin reductase. The E. coli 
strain Rosetta-gamiTM(DE3) exhibiting this deficiency additionally enhances the expression of 
proteins containing codons rarely used in bacteria.  
Therefore, the human hyaluronidases were expressed in E. coli Rosetta-gamiTM(DE3) using 
the pET15b plasmid, which already proved high expression levels in E. coli BL21(DE3)RIL. 
Rosetta-gamiTM(DE3) grew much slower than other strains (24 h till colony formation on agar 
plates). As this bacteria strain contains several plasmids, e.g. for the expression of rare 
codons, growth was performed in the presence of multiple antibiotics (kanamycin, 
tetracycline, chloramphenicol), which possibly slows down bacterial growth. Nevertheless, 
expression of the foreign genes could be achieved 3 h after induction of expression (Fig. 3.7).  
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Fig. 3.7 Recombinant expression of the long (L) and short (S) variants of the human hyaluronidases 
PH-20, Hyal-1, Hyal-2 and Hyal-4 in Rosetta-gamiTM(DE3). The SDS-PAGE analysis shows total cell 
lysates before (-) and 3 h after induction (+) as well as the soluble cell lysate fraction (supernatant, S) 
and the insoluble cellular fraction (pellet, P). Molecular masses of the proteins were calculated using 
the molecular weight markers.  
 
Separation of the total cell lysates into soluble and insoluble fractions revealed that the main 
fraction of all hyaluronidases was found in the cell pellet. To investigate if any properly 
folded hyaluronidase was present in the soluble cell fraction the soluble cell fractions were 
assayed for hyaluronidase activity in the turbidimetric activity assay at pH 4.0 and 5.0, 
respectively (Fig. 3.8).  
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Fig. 3.8 Turbidimetric hyaluronidase activity assay at pH 4.0 (a) and pH 5.0 (b) using soluble cell 
fractions from Rosetta-gamiTM(DE3)/pET15b/hyaluronidase as samples. Incubation was stopped after 
0 (black bars) and 24 h incubation (grey bars) at 37 °C. As a control lysis buffer was treated identical 
to the samples.  
 
As Hyal-1 and Hyal-2 are presumably acid active enzymes (Frost et al. 1997, Lepperdinger et 
al. 1998) they were assayed for hyaluronidase activity at pH 4.0. Bovine PH-20 is known to 
have an activity optimum at pH 5.0 – 6.0 in the turbidimetric assay (Hoechstetter 2005). 
Therefore, cell fractions containing human PH-20 were tested for hyaluronidase activity at pH 
5.0. None of the soluble cell fractions showed hyaluronidase activity in the turbidimetric 
activity assay, i.e. turbidity was not found to be reduced after 24 h of incubation compared to 
the turbidity measured directly after addition of the sample to the assay system. Since not 
even the hyaluronidases with well known activity profiles (Hyal-1 and PH-20) showed any 
enzymatic activity, no further variations of pH or substrate were tested for Hyal-2 and Hyal-4. 
  
The results obtained in the turbidimetric assay were confirmed in the colorimetric activity 
assay (data not shown), which revealed a significantly increased absorbance of 0.05 – 0.2 A585 
for the reference samples (incubation time 0). This observation could be explained by the 
presence of sugar moieties in the cytoplasm of bacteria reacting in the Morgan-Elson assay. 
However, no increase in the absorbance at 585 nm was observed after 24 h of incubation of 
HA with the soluble cell fractions. 
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3.4. Summary and conclusions 
 
The human hyaluronidases PH-20, Hyal-1, Hyal-2 and Hyal-4 were expressed in E. coli as 
fusion proteins with an N-terminal His-tag. All enzymes were expressed in their whole length 
as well as in C-terminally truncated variants and were found to be expressed in high levels in 
E. coli BL21(DE3)RIL. The human hyaluronidases formed insoluble aggregates in the 
cytoplasm of the bacteria as anticipated from the presence of several disulfide bridges in the 
native hyaluronidases. During isolation of the inclusion bodies partial purification of the 
hyaluronidases could be achieved. 
Furthermore, the E. coli strain Rosetta-gamiTM(DE3) facilitating the formation of disulfide 
bonds in the cytoplasm was tested for the expression of active hyaluronidases, but yielded 
only insoluble protein aggregates as well. Possibly, disulfide bridge formation in the 
cytoplasm was insufficient or incorrect, thus resulting in wrong folding of the hyaluronidases. 
 
Since no active hyaluronidases could be expressed in the bacterial systems in vitro protein 
folding experiments were necessary to gain enzymatically active human hyaluronidases. Due 
to the absence of reliable activity assays for Hyal-2 and Hyal-4 folding experiments were 
attempted for Hyal-1 and PH-20 only as described in the following chapter. 
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4. In vitro folding of PH-20 and Hyal-1 expressed in E. coli 
 
 
Chapter 4 
In vitro folding experiments  
with the human hyaluronidases PH-20 and 
Hyal-1 expressed in E. coli 
 
 
 
4.1. Introduction 
Eukaryotic proteins over-expressed in E. coli often form insoluble, dense aggregates, so-
called inclusion bodies (IBs) (Marston 1986). IBs consist almost exclusively of the over-
expressed protein and can amount to more than 50 % of the total cell protein (Lilie et al. 
1998). Proteins, such as the human hyaluronidases, which contain disulfide bridges, form IBs 
in the majority of cases if they are produced in the reducing cytoplasm of E. coli (Lilie et al. 
1998, Tsumoto et al. 2004). As solubilization of IBs can only be achieved after complete 
denaturation of the protein (Lange and Rudolph 2005) great efforts have been undertaken to 
provide general methods for the renaturation of proteins from IB material under in vitro 
conditions.  
 
Urea and guanidinium chloride (GdmCl) are the most frequently used denaturing (chaotropic) 
agents as they are assumed to keep proteins in a disordered, flexible and soluble state 
(Tsumoto et al. 2003) due to their preferential binding to the unfolded protein (Timasheff 
1992, Bhuyan 2002). To bring the denatured proteins into a compact, properly folded 
conformation the denaturing agent is removed while the protein is transferred to an aqueous 
solvent (Tsumoto et al. 2003).  
The concentration of the chaotropic agent can be reduced slowly as occurring during dialysis. 
Since the protein can adopt partially folded structures at medium denaturant concentrations, 
Introduction 
 48
this method is only applicable if the intermediate folding states are not prone to aggregation 
(De Bernadez Clark et al. 1999, Tsumoto et al. 2003). Otherwise the denatured protein can be 
folded by direct dilution of a concentrated, denatured protein solution in the folding buffer. 
Quick mixing results in a fast drop of the denaturant concentration and a collapse of the 
protein structure (Tsumoto et al. 2003), thus avoiding partially folded protein structures at 
intermediate denaturant concentrations. To keep aggregation low, even at higher protein 
concentrations, the protein is often added in several pulses or continuously (Vallejo and Rinas 
2004). Another in vitro folding method is the matrix-assisted folding, i.e. the protein is bound 
to a solid support under denaturing conditions, and is folded while still bound to the matrix 
(Li et al. 2004). This technique can be used with a variety of protein tag fusions resistant to 
chaotropic agents, thus combining folding with purification (Vallejo and Rinas 2004). 
However, protein binding to the matrix can also cause sterical hindrance of the folding 
reaction (Tsumoto et al. 2003).   
 
Folding of proteins in vivo is facilitated by chaperones (Deuerling and Bukau 2004), disulfide 
bridge isomerases (Frand et al. 2000) and small, polar molecules like sugars, salts and amino 
acids (Yancey et al. 1982). In vitro methods have been developed utilizing the same 
principles: chaperones or artificial chaperone systems supporting the folding process (Rozema 
1996, Daugherty et al. 1998, Walter and Buchner 2002), disulfide shuffling systems allowing 
for rapid disulfide bridge exchanges (Wetlaufer 1984) and the use of stabilizing and 
solubilizing reagents, respectively, for the improvement of folding yields (De Bernadez Clark 
et al. 1999, Lange and Rudolph 2005). 
 
For extracellular or membrane-anchored proteins the formation of correct disulfide bonds is 
often essential for proper folding. Oxidation of cysteine residues can be facilitated by air 
oxygen in the presence of Cu2+ ions (Menzella et al. 2002) or by a disulfide shuffling system, 
consisting of low molecular weight thiols such as glutathione or C in their reduced and 
oxidized state (Wetlaufer 1984, Vallejo and Rinas 2004).  
-
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S
-
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-
RSSR   RS
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RS-
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Fig. 4.1 Principle of disulfide bridge formation in a protein facilitated by a disulfide shuffling system 
containing low molecular weight thiols in the reduced (RS-) and oxidized state (RSSR). (Adapted 
scheme according to Jaenicke and Rudolph 1989) 
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At alkaline pH (pH > 8.0) the C residues of the protein can react with the disulfide shuffling 
system forming mixed disulfides and finally intramolecular cystines, which are supposed to 
be energetically favored, if the resulting protein structure is the native one (Fig. 4.1) (Lange 
and Rudolph 2005). 
 
Protein folding can be supported by addition of low molecular weight compounds, so called 
co-solutes, either enhancing intra- and intermolecular interactions (“folding enhancer”) or 
increasing the solubility of unfolded or partially folded protein structures (“aggregation 
suppressors”) (Tsumoto et al. 2003). Among the variety of substances successfully used as 
folding aids, the amino acid arginine (Arg) is the most common one (De Bernadez Clark et al. 
1999). Arginine is believed to reduce protein-protein interactions (Baynes et al. 2005, Reddy 
et al. 2005) possibly by preferential interactions with tyrosin residues (Tsumoto et al. 2004). 
However, the exact mechanism of action is not completely understood. 
Further co-solutes suppressing aggregation are polymers (Cleland et al. 1992), detergents 
(Krause et al. 2002) and chaotropic agents at low concentrations (Orsini and Goldberg 1978). 
Contrarily, co-solutes like sugars (Arakawa and Timasheff 1982), polyols and some salts 
(Hofmann et al. 1995, Lange and Rudolph 2005) enhance the formation of the compact, 
native protein structure (“folding enhancers”), but also favor aggregation. Since the effects of 
the folding aids depend on specific changes in the excluded volume of the co-solutes and 
interactions with the protein surface (Schellman 2003), the properties of the protein of interest 
determine the use of the folding agents.   
 
In vitro folding of an enzyme can be monitored easily in an appropriate activity assay. 
Therefore, in vitro folding of the human hyaluronidases expressed in E. coli (cf. Chapter 3) 
was performed with PH-20 and Hyal-1 due to the knowledge of the substrate and the 
availability of reliable activity assay systems (Gold 1982, Gmachl and Kreil 1993). In vitro 
folding of Hyal-2 and Hyal-4 was omitted due to the lack of information about the substrate 
and appropriate activity assays. Denatured bovine testicular hyaluronidase (BTH) was used as 
a reference to observe the refolding of a mammalian hyaluronidase. 
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4.2. Materials and Methods 
4.2.1. Chemicals 
Wet yeast extract was purchased from OHLY (Deutsche Hefewerke, Hamburg, Germany). 
Hyaluronic acid from Streptococcus zooepidemicus was purchased from Aqua Biochem 
GmbH, Dessau, Germany. Lysozyme was from Boehringer Mannheim GmbH, Mannheim, 
Germany, Benzonase from Merck, Darmstadt, Germany. BTH (Neopermease®, 50 000 
IU/mg, according to the supplier) was a gift from Sanabo, Vienna, Austria. BSA was 
purchased from Serva, Heidelberg, Germany, Cetyltrimethylammonium bromide (CTAB) and 
Tween 20 from Roth, Karlsruhe, Germany, and IPTG, p-dimethylaminobenzaldehyde 
(DMAB), GlcNAc and L-arginine · HCl (Arg) from Sigma, Munich, Germany. All other 
chemicals were from Merck, Darmstadt, Germany. 
4.2.2. Fermentation of E. coli BL21(DE3)RIL/pET15b/hyal-1/L 
6 L of sterile complete medium (50 g/L wet yeast extract, 5.0 g/L glucose, 11 g/L K2HPO4 · 2 
H2O, 0.5 g/L NH4Cl, 0.68 g/L MgSO4 · 7 H2O) containing 100 µg/mL of ampicillin were 
initiated by addition of 100 mL of E. coli BL21(DE3)RIL/pET15b/hyal-1/L overnight culture 
grown for 9 h in LB-medium with 100 µg/mL ampicillin. Fermentation was monitored by 
measuring cell density (OD600), pH, temperature, pressure and glucose concentration. The pH 
was controlled by automatic addition of 10 % (v/v) H3PO4 and 10 % (v/v) KOH, respectively. 
At the beginning of the fermentation process the pH was adjusted to 7.5 to ensure a strong 
growth of bacteria in the presence of glucose. At an OD600 of 22.2 (6 h after initiation) the 
glucose of the medium was depleted and the culture was fed for a further 1.5 h by addition of 
sterile feeding solution (30 % (w/v) wet yeast extract, 25 % (v/v) glycerol in water) at a flow 
rate of 2.5 mL/min. When feeding of the culture was started, the pH was adjusted to 6.5. 7.5 h 
after initiation of the culture, 1 mM IPTG (from a 1 M stock solution in water) was added to 
induce expression of Hyal-1/L. The bacteria were cultured for 4 h before the suspension was 
centrifuged (20 min, 6,000 g, 4 °C), and the pellets stored at -80 °C.    
4.2.3. Isolation and solubilization of inclusion bodies (IBs) 
A bacterial pellet of 1 g (wet weight) was resuspended in 5 mL of 100 mM Tris/HCl, 1 mM 
EDTA, pH 7.0. After addition of 7.5 mg of lysozyme the suspension was kept on ice for 30 
min. To support cell lysis the cells were sonicated on ice (microtip, power level 4 – 5, 40 – 50 
% Duty, 3 times 15 s continuous mode, Branson-Sonifier B15, G. Heinemann, Schwäbisch-
Gmünd, Germany). For pellets > 100 g a French press was used for cell lysis. Then 5 µL of 
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benzonase (25 U/mL) and 15 µL of 1 M MgCl2 were added and the suspension incubated at 
room temperature for 30 min. After addition of 2.5 mL of 3 x TEN buffer (60 mM EDTA, 6 
% Triton X-100, 1.5 M NaCl, pH 7.0), the mixture was incubated for 30 min on ice. Then the 
IBs were pelleted by centrifugation (15 min, 5,000 g, 4 °C) and washed twice with 15 mL of 
100 mM Tris/HCl, 20 mM EDTA, pH 7.0. Resuspension of the dense protein aggregates was 
facilitated by the use of an ultraturrax.   
After the last washing step the IB pellet was solubilized in denaturing buffer (8 M urea or 6 M 
GdmCl, 20 mM Tris/HCl, 1 mM EDTA, 50 mM DTT, pH 8.5) to gain a protein concentration 
of 5 – 10 mg/mL. Solubilization was supported by the use of an ultraturrax. The turbid 
reddish-brown solution was stirred overnight at room temperature and centrifuged (15 min, 
5,000 g, 25 °C) to pellet insoluble membrane fragments. The supernatant was then dialyzed at 
4 °C extensively against denaturing buffer without EDTA and DTT (MWCO 14,000).   
4.2.4. Purification of human hyaluronidases by IMAC under denaturing 
conditions 
Hyal-1/L was purified by ion metal affinity chromatography (IMAC) with a Ni2+ ion 
immobilized on nitrilotriacetic acid-agarose (NTA-agarose) (Quiagen, Hilden, Germany). The 
column was equilibrated with 20 mM Tris/HCl, 8 M urea, pH 8.5. After application of the 
sample the column was washed with 2 column volumes (CV) of 20 mM Tris/HCl, 8 M urea, 
pH 6.5. Elution was achieved by decreasing the pH of the buffer to 4.5. Fractions of 1 mL 
were collected and analyzed with respect to their protein concentration and by SDS-PAGE.  
While high concentrations of urea do not interfere with SDS-PAGE analysis, GdmCl forms 
insoluble aggregates with SDS. Therefore, GdmCl was removed from the samples by the 
following procedure: the sample (maximum 100 µL) was mixed with water to obtain a final 
volume of 1 mL. Then 100 µL of 1 % (w/v) sodium deoxycholate were added, the sample was 
vortexed and 200 µL of 50 % (w/v) TCA were added. The turbid solution was mixed again 
thoroughly. Protein aggregates were pelleted by centrifugation (15 min, 12,000 g), washed 
once with 1 mL of acetone, and the pellet was dried. Proteins were then resuspended in 20 – 
100 µL of SDS-sample buffer and prepared for SDS-PAGE (cf. Chapter 3). 
For protein folding experiments the fractions containing recombinant hyaluronidase were 
combined and concentrated in centrifugal devices (MWCO 30,000, Millipore, Eschborn, 
Germany) until a protein concentration of 3 – 10 mg/mL was reached.  
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4.2.5. In vitro protein folding 
Folding experiments were performed by direct dilution of a concentrated protein sample in 
the folding buffer. The concentrated protein solution was added dropwise under intensive 
stirring to a degassed folding buffer. Basically, the folding buffer contained 20 mM Tris/HCl, 
0.2 mg/mL BSA and 1 mM EDTA, pH 8.5. Further additives as well as variations in the basic 
buffer system are indicated for the respective experiments. The pH of the folding buffer was 
adjusted after addition of all additives. Aggregation could be observed immediately after 
dilution by measuring the optical density (OD) at 400 nm. Enzymatic activity assays (cf. 4.2.8 
and 4.2.9) were performed at different time periods after initiation of the folding reaction.     
Folding by air oxidation (Menzella et al. 2002) was tested by direct dilution of the protein 
solution in a buffer containing 100 mM Tris/HCl, 50 mM NaCl, 10 µM CuSO4, pH 10, under 
intensive stirring at room temperature for 24 h. 
As some folding additives were found to have a strong influence on the hyaluronidase activity 
assays, all samples underwent a buffer exchange into 100 mM Tris/HCl, 20 mM NaCl, pH 
7.0, (for BTH and PH-20) or into 20 mM Tris/HCl, pH 7.5, (for Hyal-1) either by dialysis or 
by gel filtration (Sephadex G-25 NAPTM columns, GE Healthcare Bio-sciences AB, Uppsala, 
Sweden).  
4.2.6. Determination of protein concentrations 
Protein concentrations were determined by the method of Bradford (Bradford 1976) using the 
Bio-Rad protein assay (Bio-Rad, Munich, Germany) with BSA as a standard substance. The 
assay was performed according to the supplier’s instructions.  
4.2.7. SDS-PAGE and Western blot 
SDS-PAGE was performed as described in Chapter 3. Western blotting was achieved in a 
Perfect-Blue “Semi-Dry” electro blot apparatus (Peqlab, Erlangen, Germany). As protein 
standard the peqGOLD Prestained Protein-Marker (Peqlab, Erlangen, Germany) was used. 
After electrophoresis the gel was equilibrated for 5 min in transfer buffer (25 mM Tris/HCl, 
pH 8.3, 192 mM glycine, 20 % (v/v) methanol), placed on top of a nitrocellulose membrane 
(0.2 µm, Peqlab, Erlangen, Germany) between 6 filter slides equilibrated in transfer buffer 
and blotted for 1.5 h at 10 mA/10 cm² of membrane.  
Then, the membrane was blocked by shaking for 1 h in 5 % (w/v) fat-free milk powder 
solubilized in PBS. The membrane was washed 3 x 5 min in washing buffer (0.05 % (v/v) 
Tween 20 in PBS) and then incubated for 2 h with primary antibody (mouse anti-His IgG, 
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Dianova, Hamburg, Germany) diluted 2000-fold in 10 mL of washing buffer. The primary 
antibody was washed away (see above) and the membrane was incubated for 1 h with 5 µL of 
secondary antibody (biotinylated anti-mouse/rabbit IgG, Vector Laboratories, Burlingame, 
USA) in 10 mL of washing buffer.  
After washing the membrane was incubated with a biotin/avidin/horseradish peroxidase 
(HRP) reaction kit (VECTASTAIN® ABC-kit Standard, Vector Laboratories, Burlingame, 
USA), which was prepared 30 min before use according to the manufacturer’s instructions. 
After a further washing step the membrane was stained with DAB (diaminobenzidine) 
staining solution as described by the supplier (DAB kit, Vector Laboratories, Burlingame, 
USA). Brown bands occurred after 2 – 15 min. Excessive substrate was washed away with 
water and the dry membrane was scanned with a DAB/HRP filter on a Bio-Rad gel detection 
system (GS-710 Imaging Densitometer) using Quantity One quantification software, version 
4.0.3. (Bio-Rad, Munich, Germany).  
4.2.8. Turbidimetric hyaluronidase activity assay 
The turbidimetric hyaluronidase activity assay was performed as described in Chapter 3. All 
measurements were correlated to internal negative controls containing the same incubation 
mixtures as the samples, but buffer solution instead of enzyme. The buffer was chosen 
according to the buffer solution used for the solubilization of the respective enzyme. The 
optical density values given in the results and discussion section are mean values ± SEM 
(standard error of means) of triplicates. 
For human PH-20 and BTH McIlvaine’s buffer, pH 5.0, was used as an incubation buffer, for 
human Hyal-1 either McIlvaine’s buffer, pH 4.0, or 0.1 M Na-formate, 0.1 M NaCl, pH 3.5, 
was used. McIlvaine’s buffer was prepared by mixing solution A (0.2 M NaH2PO4, 0.1 M 
NaCl) and solution B (0.1 M citric acid, 0.1 M NaCl) in appropriate portions to adjust the 
required pH. 
4.2.9. Colorimetric hyaluronidase activity assay (Morgan-Elson assay) 
The colorimetric assay based on the method described by Reissig et al. (Reissig et al. 1955) 
was performed according to Muckenschnabel et al. (Muckenschnabel et al. 1998). 
Degradation products of hyaluronic acid were quantified by the amount of GlcNAc formed at 
the reducing ends of the HA chains by measuring the absorbance of the Morgan-Elson 
reaction product at 585 nm (Muckenschnabel et al. 1998). Calibration curves were determined 
with GlcNAc under identical assay conditions.  
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According to the International Union of Biochemistry 1 unit (U) of hyaluronidase is defined 
as the enzymatic activity catalyzing the liberation of 1 µmol GlcNAc at the reducing ends of 
sugars per min under specified conditions, i. e. in a reaction mixture containing 50 µL of 
enzyme sample, 150 µL of H2O, 100 µL of BSA (0.2 mg/mL), 100 µL of buffer (0.2 M Na-
formate, 0.1 M NaCl, pH 3.68) and 50 µL of substrate (5 mg/mL of HA from rooster comb in 
H2O). 0.1 mU (0.1 nmol GlcNAc/min) are approximately equivalent to 1 international unit 
(IE) (Muckenschnabel et al. 1998). 
If buffer conditions varied from the conditions mentioned above, the enzymatic activity is 
given as µmol GlcNAc/min in the respective incubation mixture. During in vitro folding 
experiments the hyaluronidase activity was either referenced to the folding buffer volume 
(µmol GlcNAc·min-1·mL-1) or to the mass of protein present in the folding mixture (µmol 
GlcNAc·min-1·mg-1).  
All incubation mixtures were prepared with HA from S. zooepidemicus and with the volumes 
described above. As incubation buffers McIlvaine’s buffer at various pH and 0.1 M Na-
formate, 0.1 M NaCl, pH 3.5, respectively, were used. Incubation buffers are indicated for 
each experiment. 
 
4.3. Results and discussion 
4.3.1. Refolding of bovine testicular hyaluronidase (BTH) 
To get an idea about in vitro folding of mammalian hyaluronidases, control experiments were 
performed with a commercially available bovine testicular hyaluronidase (BTH) preparation, 
Neopermease®. As shown previously, BTH consists of three proteins fractions with the 58 
kDa fraction exhibiting the highest specific activity (Oettl et al. 2003). The specific activity of 
BTH was determined to be 2.5 µmol·min-1·mg-1, which is in accordance to the manufacturer’s 
declaration (Oettl 2000). The pH optimum as well as optimum ionic strength in the buffer 
system are well known from previous experiments (Hoechstetter 2005), thus enabling the 
determination of hyaluronidase activity during folding experiments under optimized 
incubation conditions. 
For refolding, BTH was treated identically to the IB material after the last washing step, i.e. 
BTH was completely reduced and denatured. Refolding was monitored by the regain of 
enzymatic activity in the turbidimetric hyaluronidase activity assay (Fig. 4.2).  
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Fig. 4.2 Refolding of 50 µg/mL BTH monitored by the regain of enzymatic activity in the 
turbidimetric activity assay after an incubation period of 1 h. The basic folding buffer was 
supplemented with a disulfide shuffling system (GSSG/GSH) and folding additives as indicated in the 
table. In the absence of enzymatic activity OD580 was determined to be 0.279 ± 0.007, indicated by the 
grey area in the chart.  
 
Though denaturation of BTH was only observed by the loss of enzymatic activity, the 
concentrations of denaturing and reducing agent (6 M GdmCl, 50 mM DTT) were assumed to 
result in a complete reduction of disulfide bridges as well as a complete destruction of tertiary 
structure (Jaenicke and Rudolph 1989).  
A partial regain of activity could be observed in all folding buffers after at least 24 h (Fig. 
4.2). The velocity of refolding was influenced more intensively by the stabilizing or 
solubilizing properties of the additives than by the GSSG/GSH ratio. BSA and Arg showed 
the best effects on the kinetics of refolding. Both additives support solubility and prevent 
aggregation and adhesion of proteins, respectively (Jaenicke and Rudolph 1989, Baynes et al. 
2005). Addition of NaSO4 exhibiting a “folding enhancer” effect (cf. 4.1) (Tsumoto et al. 
2003) decreased the yield of active BTH significantly probably due to increased aggregation 
of folding intermediates. The best folding system containing 0.2 mg/mL BSA and 1.0 M Arg 
yielded ca. 80 % of the original activity.  
As oxidation of disulfide bridges can be achieved by air oxygen with trace amounts of 
divalent cations catalyzing the process (Jaenicke and Rudolph 1989, Menzella et al. 2002), 
BTH was also assessed for refolding by air oxidation in the presence of Cu2+. Without any 
further additives a regain of the activity of only 5 – 6 % of the original activity was observed, 
but if the air oxidation buffer was supplemented with 0.5 M Arg or 0.16 mg/mL gelatine a 
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regain of enzymatic activity of 24 % and 80 %, respectively, was achieved. These results 
confirmed the importance of solubilizing agents during refolding of BTH. The choice of the 
oxidation system seemed to be of minor importance. 
 
4.3.2. In vitro folding experiments with PH-20/S and PH-20/L 
Inclusion bodies containing PH-20/S and PH-20/L were isolated from E. coli (cf. Chapter 3) 
and directly used for folding experiments. Folding was performed by direct dilution of a 
completely denatured and reduced protein solution containing 5 – 10 mg/mL PH-20/S and 
PH-20/L, respectively, in folding buffers supplemented with additives as used for BTH 
previously (De Bernadez Clark et al. 1999).  
At different time points after initiation of the folding reaction samples were probed for their 
catalytic activity in the turbidimetric hyaluronidase activity assay with incubation periods 
between 1 – 24 h. Though a variety of disulfide shuffling systems (GSSG/GSH = 1 mM/10 
mM to 10 mM/1 mM, air oxidation) and additives (Arg, BSA, gelatine, salts) was explored, 
no hyaluronidase activity could be observed for any of the PH-20 derivatives.  
 
4.3.3. Preliminary folding experiments with Hyal-1/S and Hyal-1/L 
A first screening of folding conditions for Hyal-1/S and Hyal-1/L was performed in analogy 
to the refolding of BTH as described in 4.3.1. Samples of the folding mixture were dialyzed 
and monitored for hyaluronidase activity in the turbidimetric assay (Fig. 4.3.b). In contrast to 
Hyal-1/L, which showed hyaluronidase activity in the presence of 1.0 M Arg in the folding 
buffer, the C-terminally truncated Hyal-1 derivative, Hyal-1/S, exhibited no enzymatic 
activity in any of the folding buffer systems (Fig. 4.3.a).  
Sequence analysis and comparison with the crystal structure of BVH (Markovic-Housley et 
al. 2000, Jedrzejas and Stern 2005) suggested an inferior role of the C-terminal domain in the 
catalytic action of the human hyaluronidases (cf. Chapter 1). Moreover, the short variant of 
the enzyme contains only four cysteine residues in contrast to ten cysteines in Hyal-1/L. If all 
cysteine residues are combined in a random fashion only three possible disulfide-linked 
protein isoforms exist theoretically for four cysteine residues (Hyal-1/S), while the ten 
cysteine residues present in Hyal-1/L provide 945 possible disulfide-bridged protein isoforms 
(Jaenicke and Rudolph 1989). Based on these preliminary considerations the truncated Hyal-1 
variant (Hyal-1/S) was assumed to be better suitable for in vitro folding than the full-length 
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protein (Hyal-1/L). However, the absence of any Hyal-1/S activity indicates a role of the C-
terminal domain in folding, stability or activity of the hyaluronidase. 
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Fig. 4.3 Variation of the GSSG/GSH ratio and Arg concentrations during folding experiments with 
Hyal-1/S (a) and Hyal-1/L (b). The folding mixtures contained 50 µg/mL of protein in folding buffer 
supplemented with the following additives: GSSG/GSH = 1 mM/10 mM (●); GSSG/GSH = 1 mM/3 
mM (○); GSSG/GSH = 1 mM/10 mM, 0.5 M Arg (Δ); GSSG/GSH = 1 mM/10 mM, 1.0 M Arg (■); 
GSSG/GSH = 1 mM/3 mM, 1.0 M Arg (□); GSSG/GSH = 10 mM/1 mM, 1.0 M Arg (▼). 
Turbidimetric activity assays were performed after dialysis of the samples with an incubation time of 
24 h. At zero enzymatic activity the OD580 was 0.281 ± 0.005 as indicated by the grey area in the 
graph.  
 
The folding reaction of Hyal-1/L was significantly influenced by the presence of Arg and the 
GSSG/GSH ratio of the disulfide shuffling system. The highest enzymatic activity was 
obtained in a buffer system containing 1.0 M Arg, 1 mM GSSG and 3 mM GSH. The same 
folding mixture did not enhance activity in the absence of Arg indicating the necessity of 
solubilizing agents for folding of hyaluronidases in accordance to the results obtained 
previously for BTH (cf. 4.3.1).  
 
4.3.4. Ni-IMAC purification of Hyal-1/L 
Further optimization of the folding conditions was performed with Hyal-1/L purified by Ni-
IMAC. Ni-IMAC is advantageous for the purification of IBs as it can be performed in the 
presence of high concentrations of denaturing agents (8 M urea or 6 M GdmCl). Completely 
denatured and reduced Hyal-1/L IB material was bound to a Ni-IMAC column and eluted by 
a decrease of pH (Fig. 4.4.a). Protonation of the His-tag at pH values below its pKA of 6.0 
released the recombinant protein from the Ni-complex binding. Hyal-1/L was eluted at pH 4.5 
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occurring as the major protein band on the SDS-PAGE with a molecular weight of 48 kDa 
(Fig. 4.4.b). 
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Fig. 4.4 a) Elution profile of Ni-IMAC (CV 5 mL) purification of Hyal-1/L from IB material as 
followed by the protein concentration (solid line). All purification steps were performed in 20 mM 
Tris, 6 M urea with pH values as indicated (dashed line). b) SDS-PAGE analysis of the isolation and 
purification of Hyal-1/L from E. coli BL21(DE3)RIL. A) total cell lysate before induction; B) cell 
lysate 5 h after induction with 1 mM IPTG; C) cytoplasmic fraction; D) insoluble fraction; E) eluate 
(pH 4.5) of the Ni-IMAC purification; F) Western blot of sample E with anti-His-IgG. 
 
The purification effect achieved by Ni-IMAC was rather low (Fig. 4.4.b), but the IBs already 
showed reasonable purity in SDS-PAGE analysis before purification. No major effects on the 
folding yield could be seen for Ni-IMAC purified protein in comparison to unpurified IB 
material. Hyal-1/L was purified either from normal bacterial cultures of from fermented 
bacteria. Generally, ca. 10 mg of Ni-IMAC purified protein were obtained per g bacterial 
pellet (wet weight). 
 
4.3.5. Influence of the denaturing agent on the aggregation of Hyal-1/L 
Solubilization of IBs was usually performed by addition of 8 M urea or 6 M GdmCl, 
respectively. Generally, GdmCl is preferred as denaturing agent due to its stronger denaturing 
properties compared to urea (De Bernadez Clark et al. 1999). Additionally, urea tends to 
decompose at high pH values into ammonium and cyanate, which can cause side chain 
modifications of the protein (Stark et al. 1960). 
However, if Hyal-1/L was denatured in GdmCl aggregation in the folding mixture was much 
more pronounced than when folding was performed with urea-denatured Hyal-1/L (Fig. 4.5). 
Surprisingly, the choice of urea instead of GdmCl as denaturing agent prevented aggregation 
almost completely even at higher protein concentrations, while the addition of 1 M Arg hardly 
influenced turbidity (Fig. 4.5).  
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Fig. 4.5 Aggregation during in vitro 
folding was followed by measuring the 
turbidity at 400 nm in the folding 
mixture during addition of Hyal-1/E. 
coli solubilized in 8 M urea (circles) or 
6 M GdmCl (triangles). Black symbols 
show dilution in a folding buffer 
supplemented with 1 M Arg, white 
symbols represent a folding mixture 
without Arg.   
Thus, the advantageous effect of Arg on hyaluronidase folding observed by enzymatic 
activity (cf. 4.3.3) could not be ascribed to the inhibition of aggregation, at least not at a 
macroscopic scale.  
 
4.3.6. Optimization of Hyal-1/L folding conditions  
Initial folding experiments (4.3.3) yielded best in vitro folding of Hyal-1/L in a folding buffer 
system containing 100 mM Tris/HCl, 1 mM EDTA, 0.2 mg/mL BSA, 1 M Arg, 1 mM GSSG 
and 3 mM GSH at pH 8.5. Based on the successful folding principle established in the initial 
experiments (Fig. 4.6) the folding buffer system as well as the “desalting” methods and 
buffers were optimized. 
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Fig. 4.6 Schematic presentation of purification and in vitro folding of Hyal-1/L expressed in E. coli. 
Folding was monitored by measurement of the hyaluronidase activity after “desalting” of the sample 
by gel filtration or dialysis.  
 
For further optimization the GSSG content of the folding buffer was increased while the Arg 
concentration was kept high (0.5 – 1.0 M). Fig.4.7 shows a strong dependency of the Hyal-
1/L folding reaction on the composition of the disulfide shuffling system as observed 
previously in the preliminary experiments (cf. 4.3.3). 
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Fig. 4.7 Folding kinetics monitored via 
the hyaluronidase activity over 120 h. 
At t = 0 Ni-IMAC purified, urea-
denatured Hyal-1/L was diluted 40-fold 
in basic folding buffers containing the 
following additives: GSSG/GSH = 1 
mM/3 mM, 0.5 M Arg (●); GSSG/GSH 
= 1 mM/3 mM, 1 M Arg (□); GSSG/ 
GSH = 1 mM/1 mM, 1 M Arg(▲); 
GSSG/GSH = 0.3 mM/3 mM, 1 M Arg 
(∇). The final Hyal-1/L concentration 
was 50 µg/mL.  Enzymatic activity was 
measured after buffer exchange in the 
colorimetric hyaluronidase assay using 
McIlvaine’s buffer, pH 4.0, as 
incubation buffer. Enzymatic activities 
are mean values ± SEM of three 
incubation mixtures. 
When the folding reaction was monitored over 120 h both, the velocity of the folding reaction 
and the maximum activity values, were obviously dependent on the GSSG/GSH ratio. The 
highest enzymatic activity was obtained already 24 h after initiation of the folding reaction in 
a buffer system containing a 1/1 ratio of GSSG/GSH and 1 M Arg.  
Disulfide shuffling is also depending on the degree of deprotonation of C residues in the 
protein of interest (cf. 4.1). As the pKa value of C residues in a protein depends on the close 
environment, a variation of pH values during the folding reaction can influence the amount of 
C residues available for disulfide bridge formation (Jaenicke and Rudolph 1989).  
Variation of the pH between 7.5 and 9.5 during the folding reaction did not influence the 
efficiency of folding of Hyal-1/L. However, EDTA and BSA were proven to be essential for 
efficient folding of Hyal-1/L (Fig. 4.8). The necessity of EDTA indicates either the presence 
of metalloproteases, which partially degrade Hyal-1/L during the folding reaction (24 h), or a 
high sensitivity of Hyal-1/L towards metal ions.  
BSA was added to the folding mixture to avoid adhesion of proteins to the surface of the 
reaction vessel and for stabilization (Jaenicke and Rudolph 1989). Hyaluronidases are known 
to have a tendency for surface adhesion and are therefore often used in combination with BSA 
(Gold 1982, Oettl 2000). 
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Fig. 4.8 Variation of the pH and the additives BSA and EDTA in the folding mixture of Hyal-1/L. 
Folding was performed by 20-fold dilution of a urea-denatured Hyal-1/L solution in 100 mM 
Tris/HCl, 1.0 M Arg with additives and pH as indicated. Enzymatic activity in the folding mixture was 
determined 24 h after initiation of the folding reaction as described in Fig.4.7. Enzymatic activities are 
mean values ± SEM of three incubation mixtures. 
 
However, the use of high concentrations of BSA with a molecular weight of 66 kDa during 
the folding reaction poses the problem of an additional protein impurity. BSA does not 
interfere with hyaluronidase activity assays, but disturbs biophysical characterization studies.  
Therefore, it was tried, if BSA can be excluded from the folding buffer at higher protein 
concentrations. As shown in Tab. 4.1 BSA is essential for activity at protein concentrations < 
100 µg/mL, but does not influence enzymatic activity at higher protein concentrations (≥ 200 
µg/mL) if urea is used as denaturing agent. 
 
Tab. 4.1 Enzymatic activity in the folding mixture in nmol GlcNAc · min-1 · mg-1 determined after 24 
h of renaturation in the colorimetric activity assay using McIlvaine’s buffer, pH 4.0. Folding was 
achieved by 40-fold dilution of completely denatured Hyal-1/L IBs in basic folding buffer 
supplemented with 1 mM GSH, 1 mM GSSG and 1.0 M Arg. The chaotropic agents indicate the 
denaturing reagents (6 M GdmCl and 8 M urea, respectively), the concentrations in µg/mL refer to the 
protein concentrations in the folding mixtures.  
Urea
GdmCl
4.00.050 µg/mL
5.04.9200 µg/mL
0.00.0> 100 µg/mL
3.00.050 µg/mL
+ BSA- BSAFolding conditions
enzymatic activity
[nmol·min-1·mL-1]
 
 
A comparison of the enzymatic activities obtained in Fig. 4.7 and in Fig. 4.8 revealed an 
almost 20-fold lower specific enzymatic activity (nmol GlcNAc · min-1 · mg-1) in the same 
buffer system (1 mM GSSG, 1 mM GSH, 1 M Arg in the basic folding buffer and a 
renaturation period of 24 h). This difference can be explained by a higher concentration of 
Results and discussion 
 62
urea in the folding buffer used in Fig. 4.8 due to a lower dilution factor of the denatured 
protein solution.  
 
4.3.7. Variation of the reducing conditions and pulse experiments 
As aggregation was observed during removal of DTT from the completely reduced and 
denatured Hyal-1/L by dialysis, folding of Hyal-1/L was determined in the presence of very 
low DTT concentrations (0.5 mM DTT instead of 50 mM). In this “low reductive system” 
Hyal-1/L was reduced by addition of 0.5 mM DTT during denaturation in 8 M urea. Residual 
DTT was not removed from the protein solution, but was oxidized in the folding reaction by 
addition of GSSG.  
To compare both systems, Hyal-1/L IB material was folded at various protein concentrations 
using a disulfide shuffling system of 1 mM GSSG/1 mM GSH in the standard system and 1.5 
mM GSSG/0.5 mM GSH in the low reductive system, respectively, while all other 
compounds of the folding buffer were kept constant (Fig. 4.9).  
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Fig. 4.9 Comparison of Hyal-1/L activity after folding in the standard system (50 mM DTT) and in the 
“low reductive (0.5 mM DTT) system” at increasing protein concentrations as determined in the 
turbidimetric activity assay. Samples were “desalted” after 24 h folding reaction by gel filtration and 
the enzymatic activity was determined in the turbidimetric assay using 0.1 M Na-formate, 0.1 M NaCl, 
pH 3.5, as incubation buffer.  a) Enzymatic activity is shown as ΔOD355, i.e. OD355 (zero activity) - 
OD355 (sample), measured after 24 h incubation in the activity assay. b) Enzymatic activity is shown as 
ΔOD355 after 24 h incubation time and per mg protein present in the folding mixture.  
 
While in the “low reductive system” (0.5 mM DTT) an increase in the total activity 
(ΔOD355/24 h) was observed with increasing protein concentrations, concentrations > 100 
µg/mL resulted in a lower activity in the standard folding system using 50 mM DTT (Fig. 
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4.9.a). However, when taking the yield of active protein per mg denatured protein used for 
folding (ΔOD355/(24h · mg protein)) into account, the best folding yield was obtained at a 
protein concentration of 100 µg/mL in both systems (Fig. 4.9.b).  
Since the “low reductive folding system” (0.5 mM DTT) seemed to be more effective at 
higher protein concentrations, pulse experiments were performed in this system using various 
protein concentrations (Fig. 4.10).  
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Fig. 4.10 Folding of Hyal-1/L in the “low reductive system (0.5 mM DTT)” with protein pulses set 
every 24 h. Each sample was pulsed 3 times with the same protein concentration: sample 1: 100 
µg/mL, sample 2: 200 µg/mL, sample 3: 300 µg/mL. Aliquots of 1 mL were taken after an incubation 
time of 24 h, “desalted” by gel filtration and the enzymatic activity determined in the turbidimetric 
assay using 0.1 M Na-formate, 0.1 M NaCl, pH 3.5, as incubation buffer. a) Enzymatic activity is 
shown as ΔOD355, i.e. OD355(zero activity)-OD355(sample), measured after 24 h incubation in the 
activity assay. b) Enzymatic activity is shown as ΔOD355 after 24 h incubation time and per mg protein 
present in the folding mixture.  
 
In the pulsed folding experiments the highest activity (ΔOD355/24 h) as well as the highest 
yield in activity per mg of protein (ΔOD355/(24h · mg protein)) was achieved with protein 
pulses of 200 µg/mL (Fig. 4.10). Interestingly, the activity (ΔOD355/24 h) measured after 
pulse 2 increased at all concentrations more than 2-fold compared to pulse 1, although the 
protein concentration was only twice as high as after pulse 1 (Fig. 4.10.a). Furthermore, the 
system pulsed three times with 100 µg/mL (sample 1/pulse 3) seemed to be much more 
efficient both in activity (ΔOD355/24 h) and in the yield of active protein (ΔOD355/(24 h · mg 
protein)) than the sample pulsed once with 300 µg/mL (sample 3/pulse 1), although both 
samples contained the same protein concentration. A similar effect can be observed when 
comparing sample 2/pulse 3 and sample 3/pulse 2, which both contained 600 µg/mL of 
protein, but differed significantly in the resulting activity (Fig. 4.10).  
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Since no BSA was present in these folding mixtures, the observed differences in activity 
could be due to adhesion of Hyal-1/L to surfaces of the reaction vessels at low protein 
concentrations, especially if no protein was present in the folding mixture before. However, at 
higher protein concentrations (300 µg/mL) aggregation limited protein folding resulting in 
lower yields of activity per mg of protein.  
In summary, the use of several pulses with low protein concentrations was found to be 
superior in both active protein yield and total activity compared to the addition of the same 
amount of protein in a single pulse. 
 
4.3.8. Theoretical considerations based on the Hyal-1 structure 
Proteins exhibiting a strong tendency for aggregation in aqueous buffer systems often contain 
hydrophobic patches. However, analysis of the hydrophobicity of Hyal-1/L by the algorithm 
of Kyte and Doolittle (Kyte and Doolittle 1982) revealed an even distribution of hydrophobic 
and hydrophilic amino acids within the primary sequence.  
Homology models of Hyal-1, e.g. Gl15147354 in MODBASE (Pieper et al. 2004), comprise 
merely the catalytic domain as they are based on the crystal structure of the BVH (Markovic-
Housley et al. 2000). In BVH charged amino acids (D, E, K, R) are distributed equally on the 
complete protein surface (Fig. 4.11.a and c). The Hyal-1 model based on the crystal structure 
of the BVH exhibits an equal distribution of charged residues on the side of the enzyme 
containing the large binding groove for the substrate (Fig. 4.11.b). However, at the 
“backside”, i.e. at the side not directly in contact with the substrate, the Hyal-1 model as well 
as the other human hyaluronidase models exhibits an area of hydrophobic amino acids 
exposed to the surface (Fehler! Verweisquelle konnte nicht gefunden werden..d). Jedrzejas 
and Stern (Jedrzejas and Stern 2005) postulated the existence of a flexible linker between the 
catalytic domain and the C-terminal domain, nevertheless, the C-terminal domain could be in 
contact with the catalytic domain covering the hydrophobic surface otherwise exposed to the 
aqueous environment.  
This hydrophobic surface area, albeit only based on the model structure, could explain the 
failure in the production of catalytically active, C-terminally truncated hyaluronidase Hyal-1 
(see above) and PH-20 derivatives (Gmachl and Kreil 1993, Arming et al. 1997) missing the 
complete C-terminal domain. 
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Fig. 4.11 Comparison of the crystal structure of BVH (1FCQ.pdb) and a model of Hyal-1 
(Gl15147354 from MODBASE (Pieper et al. 2004)) in respect of the distribution of charged (D, E, K, 
R shown in blue) and hydrophobic (F, L, I, V shown in red) amino acids exposed on the surface. a) 
HA binding side of BVH; b) HA binding side of the Hyal-1 model structure; c) “backside” of BVH; d) 
“backside” of Hyal-1. The putative position of the HA chain is highlighted in yellow, the C-terminal 
amino acid in green. Structures were visualized using Rasmol 2.6 (Massachusetts, USA).  
 
Further investigation of the primary sequence of Hyal-1/L revealed the presence of a high 
amount of charged residues (15 %). Uversky proposed a systematic explanation for the 
tendency of proteins to form stable intermediates during the unfolding process based on the 
ratio of the mean net charge (number of charged amino acids at pH 7 per total number of 
amino acids) to the mean hydrophobicity (sum of hydrophobicity values calculated by the 
Kyte and Doolittle algorithm per total number of amino acids) (Uversky 2002). In this model 
proteins with both low to medium net charge and low hydrophobicity tend to form stable 
intermediates, while proteins with a high overall hydrophobicity tend to unfold without any 
intermediates rather independent on their net charge (Fig.4.12). As the mean net charge of 
Hyal-1/L is extraordinarily high (0.15) compared to the proteins observed by Uversky Hyal-
1/L is positioned in a range with medium hydrophobicity (0.45) and a very high net charge, 
i.e. in a region of intermediate-forming proteins if the diagram is being extrapolated to higher 
mean net charge values. BVH, which was described in literature (Soldatova et al. 1998) to be 
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refolded in vitro at very low efficiencies, was found to have an even higher mean net charge 
at similar hydrophobicity values compared to Hyal-1/L.  
Hyal-1/L 
0.25 BVH
 
 
 
Fig. 4.12 Mean net charge plotted 
against the mean hydrophobicity of a 
protein. Open symbols represent 
proteins forming stable intermediates 
during unfolding, while the filled 
symbols show proteins forming no 
intermediates during unfolding. BVH 
and Hyal-1 are shown as stars. The 
scheme was modified from Uversky 
2002. 
  
The extremely high overall charge of hyaluronidases could provide an explanation for the 
influence of the kind of denaturing agent on the extent of aggregation occurring during in 
vitro folding (cf. 4.3.5). In contrast to urea, GdmCl is a charged molecule and electrostatic 
interactions with amino acids of the protein surface could cause GdmCl to stay in close 
proximity to Hyal-1/L. During subsequent in vitro folding by fast mixing with folding buffer 
urea could spread equally in the folding buffer, while GdmCl might remain partially bound to 
the highly charged protein and might thus stabilize intermediates prone to aggregation.  
Although the effects discussed above can explain the phenomena observed during in vitro 
folding of Hyal-1/L the theory is to be considered as speculative. One could imagine also 
other effects causing the different sensitivity of Hyal-1/L towards urea and GdmCl, e.g. the 
weaker denaturing ability of urea compared to GdmCl. 
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4.4. Summary and conclusions 
 
In vitro folding of hyaluronidases could be monitored by observation of the enzymatic 
activity, although not directly in the folding buffer. The samples had to undergo a buffer 
exchange to avoid interferences with enzymatic activity assays due to the presence of folding 
additives. 
 
In vitro folding experiments with PH-20 (PH-20/S and PH-20/L) yielded no active protein in 
contrast to Hyal-1/L. Possibly, folding of PH-20 is more complex than folding of Hyal-1 
because of the larger size of the C-terminal domain (8.4 kDa in Hyal-1, 17.4 kDa in PH-20), 
the existence of two additional C residues in the C-terminal domain and the presence of the 
propeptide in PH-20. Although the propeptide is known to be removed after anchorage of PH-
20 to the membrane via a GPI-anchor, its function during protein folding remains unclear. 
 
The C-terminally truncated variant of Hyal-1, Hyal-1/S, was expected to be folded more 
efficiently and more easily than the full-length enzyme, Hyal-1/L, due to the smaller size of 
the enzyme on the one hand and the presence of less C residues on the other hand. Usually, 
small proteins tend to fold faster than larger ones and the number of possible disulfide-
bridged protein isoforms increases significantly with the number of cysteine residues (3 
possibilities for 4 C, 945 for 10 C) (Jaenicke and Rudolph 1989).  
However, during in vitro folding experiments only Hyal-1/L was found to exhibit 
hyaluronidase activity. The failure to produce C-terminally truncated hyaluronidase 
derivatives might be explained by the close contact of the catalytic domain and the C-terminal 
domain in human hyaluronidases (cf. 4.3.8).  
Folding of Hyal-1/L was to a great extent dependent on the disulfide shuffling system 
indicating the necessity of the correct formation of disulfide bonds in the native protein. 
Control experiments using BTH showed a preference of hyaluronidases for solubilizing 
agents, especially Arg, and a negative effect of folding enhancers like ammonium sulfate. Arg 
is a common folding additive, however, its mechanism of folding support could not be 
elucidated up to now (Tsumoto et al. 2004, Baynes et al. 2005). Presumably, it facilitates 
solubilization of folding intermediates without the denaturing effect of chaotropic salts (Lilie 
et al. 1998, Mayer and Buchner 2004). In the case of Hyal-1/L Arg could not inhibit 
aggregation during folding of GdmCl-denatured Hyal-1/L. Folding of GdmCl-denatured 
Hyal-1/L yielded low quantities of active enzyme only at low protein concentrations 
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independent of the disulfide shuffling system and the presence of Arg. Contrarily, folding of 
urea-denatured Hyal-1/L resulted in less aggregates and allowed the use of higher protein 
concentrations.  
 
Taken together, in vitro folding of Hyal-1/L yielded enzymatically active protein, albeit with 
a low specific hyaluronidase activity (0.11 U/mg) and at low yields. A detailed comparison of 
the properties of in vitro folded Hyal-1/L and the same enzyme expressed in a eukaryotic 
expression system is given in the following chapter.  
Due to the insufficient results achieved with PH-20 and Hyal-1 folding experiments with 
Hyal-2 and Hyal-4 were omitted. In addition, for these hardly characterized hyaluronidases 
monitoring of folding poses a major problem since no appropriate and reliable activity assays 
exist. 
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Chapter 5 
Purification and characterization of human 
Hyal-1 expressed by DS-2 cells 
 
 
 
5.1. Introduction 
 
The major amount of hyaluronan in somatic tissues is assumed to be degraded by Hyal-1 in 
combination with Hyal-2, and, to a minor extent, PH-20 (Stern 2005). While Hyal-2 and PH-
20 are both linked to the cell-membrane by a glycosylphosphatidylinositol-(GPI-)anchor, 
Hyal-1 is a soluble, acid active lysosomal enzyme (Gold 1982). Acid active hyaluronidase has 
been isolated and purified from plasma, serum and liver, but characteristics as well as 
molecular sizes of the proteins isolated varied: 57 kDa for plasma hyaluronidase (Frost et al. 
1997), 72 kDa for serum hyaluronidase (Afify et al. 1993) and 76 kDa for human liver 
hyaluronidase (Gold 1982). Although only plasma hyaluronidase has been identified as a gene 
product of hyal-1 (Frost et al. 1997), the hyaluronidases isolated from serum and liver also 
show typical properties of Hyal-1. In urine an additional protein binding to Hyal-1 antibodies 
was described by Csoka et al. (Csoka et al. 1997) with a molecular mass of 45 kDa. This 
second, enzymatically active Hyal-1 isoform was supposed to be a truncated form of the 57 
kDa isoform with an interior part of the protein missing. However, function and mechanism 
of this truncation are unknown. 
Modulation of Hyal-1 expression has been observed in a genetic disorder, called 
mucopolysaccharidosis IX (Triggs-Raine et al. 1999), and in a number of malignant tumors. 
Based on the identification of the hyal-1 gene in a region of major deletions in tobacco-related 
bronchial carcinoma the gene was originally called LUCA-1 (lung cancer protein – 1) before 
the protein was correlated to its function as a hyaluronidase (Hosoe et al. 1994, Wei et al. 
1996). During the last years it became obvious that hyal-1 functions not only as a tumor 
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suppressor gene (TSG) as observed in lung cancer, but can also promote tumor growth and 
aggressiveness in prostate and bladder cancer (Lokeshwar et al. 2001, Franzmann et al. 2003). 
Hyal-1 in human urine has therefore been investigated for its potential as a marker protein for 
malignant urogenital cancers (Posey et al. 2003, Lokeshwar et al. 2005, Aboughalia 2006). 
However, information on the role of Hyal-1 in cancer progression remain controversial, 
possibly due to the fact that several different mechanisms control the activity of Hyal-1 in 
vivo, e.g. the control of hyal-1 expression on the DNA as well as on the RNA level 
(Lokeshwar et al. 2002, Stern 2005) and the existence of inhibitors of hyaluronidase activity 
(Mio and Stern 2002). 
Isolation of Hyal-1 from human sources has been hampered by the extremely low amounts of 
the enzyme present in the plasma and by the instability of the hyaluronidase during the 
purification process. As no in-depth characterization of the enzyme has been carried out only 
limited information on the enzymatic properties of Hyal-1 is available. 
 
Human Hyal-1 was expressed in prokaryotic expression systems as described in Chapter 3 
and 4. Although human Hyal-1 was refolded in vitro to an active conformation, the yield of 
active protein as well as the specific enzymatic activity were extremely low. Therefore, 
Drosophila Schneider-2 (DS-2) cells (Schneider 1972) were selected as an alternative 
eukaryotic expression system. As shown previously for bee venom hyaluronidase (BVH) 
(Soldatova et al. 1998), insect cells seem to be appropriate for the expression of 
hyaluronidases.  
DS-2 cells are immortalized, undifferentiated, embryonic Drosophila melanogaster cells with 
the ability to integrate up to 400 copies of an expression cassette into the genome (Deml and 
Wagner 1998). They are easy to cultivate and are especially suited for the expression of 
secreted proteins as they grow in serum-free medium.  
 
5.2. Materials and Methods 
5.2.1. Vectors, cells, enzymes and chemicals 
Drosophila Schneider-2 cells (DS-2 cells), pCoHygro and pMT/BiP/V5-HisA were kindly 
provided by V. Runza (Institute of Immunology, Faculty of Medicine, University of 
Regensburg, Germany). Materials for subcloning were described in Chapter 3. 
Hyaluronic acid from Streptococcus zooepidemicus was purchased from Aqua Biochem 
GmbH, Dessau, Germany. Chondroitin 4-sulfate (A) from bovine trachea, chondroitin 6-
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sulfate (C) from shark cartilage and chondroitin sulfate B from porcine intestinal mucosa 
were from Sigma, Munich, Germany. Chondroitinase ABC from Proteus vulgaris with an 
activity of 0.35 U/mg on chondroitin sulfate C was also purchased from Sigma, Munich, 
Germany. ChS A and ChS C contained impurities of the respective other GAG of up to 30 % 
as indicated by the supplier. 
Triton X-100 was from Roth, Karlsruhe, Germany. Hygromycin was from A.G. Scientific 
Inc., San Diego, USA. All other chemicals were of HPLC or analytical grade and were 
purchased from Merck, Darmstadt, Germany. 
5.2.2. Subcloning of hyal-1 cDNA in the insect cell expression vector pMT/Hygro 
By combination of pMT/BiP/V5-HisA and pCoHygro (both designed by Invitrogen, 
Karlsruhe, Germany) a new expression vector for DS-2 cells - pMT/Hygro - was generated. 
To obtain this vector, pMT/BiP/V5-HisA and pCoHygro were both cleaved with AccI and 
SapI, the respective fragments were purified by agarose gel electrophoresis and ligated after 
dephosphorylation of the 5’ ends of pMT/BiP/V5-HisA. Restriction digest was performed in a 
single step using 4 U of SapI and 10 U of AccI per µg of plasmid DNA in 1 x NEB4 buffer 
(New England Biolabs, Frankfurt a. M., Germany). The mixture was incubated for 2 h at 37 
°C.  
Human hyal-1 cDNA was amplified by PCR (Tab. 5.1 and Tab. 3.2) using the 
IRAKp961O1779Q2 plasmid (Tab. 3.1) as template, digested with SmaI and NotI and ligated 
into pMT/Hygro, which had been digested with the same enzymes and dephosphorylated at 
the 5’ ends.  
 
Tab. 5.1 PCR primers (5’-3’-direction) for cloning of hyal-1/S and hyal-1/L into SmaI and NotI 
restriction sites of pMT/Hygro. Underlined sequences indicate these restriction sites within the 
primers. MgSO4 refers to the final concentration in the PCR reaction mixture and Ta indicates the 
annealing temperature used for the PCR reaction. 
 
Hyaluronidase Forward primer Reverse primer MgSO4 Ta 
Hyal-1/S 
ATTATATCGCGGCCG
CCCGAGAAGGGCCCC
2.5 mM 80.0 °C
Hyal-1/L 
ATCTATTCCCGGGTT
TAGGGGCCCCTTGC ATTATATCGCGGCCG
CCACATGCTCTTCC 
1.5 mM 80.0 °C
 
The restriction digest was performed in two steps: SmaI digested the DNA in 1 x 
Y+/TANGOTM during 1 h incubation at 30 °C, then NotI was added, the buffer concentration 
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increased to 2 x Y+/TANGOTM and digestion continued for 2 h. A detailed description of all 
cloning steps is given in Chapter 3. 
5.2.3. DS-2 cell culture conditions and storage 
DS-2 cells were grown in serum-free Insect-XPRESSTM medium (Cambrex Bio Science, 
Copenhagen, Denmark) at 27 ± 1 °C in normal atmosphere. Adherent cultures were grown in 
25-cm² culture flasks (Nunc, Wiesbaden, Germany) for sub-culturing and small-scale 
expression experiments. For sub-culturing cells were serially passaged every 3 – 4 days. The 
semi-adherent, nearly confluent cells were removed from the bottom of the flask by tapping 
and the resulting suspension was diluted 5 – 6-fold with fresh medium. Suspension cultures 
were used for large-scale protein expression experiments, and were shaken at 135 rpm at 27 ± 
1 °C.  
For long term storage cells were grown to a density of 10 – 20 · 106 cells/mL, centrifuged (3 
min, 1,000 g, 4 °C), resuspended in the same volume of 1 x sterile PBS, centrifuged again and 
resuspended in the same volume of freezing medium (45 % fresh medium, 45 % conditioned 
medium containing 10 % DMSO). The cell suspension was split into aliquots of 1 mL and 
cooled down slowly for the storage in liquid nitrogen. For revival the DS-2 cells were quickly 
thawed and 1 mL of the cell suspension was diluted in 5 mL of fresh medium. After 2 – 4 h of 
incubation at normal growth conditions the medium was completely exchanged by fresh 
medium to remove residual DMSO. 
Cells were routinely monitored for mycoplasma contaminations by PCR using the 
VenorGEMTM mycoplasma detection kit (Minerva Biolab, Berlin, Germany). 
5.2.4. Transfection of DS-2 cells 
DS-2 wild type cells were transfected with pMT/Hygro/hyal-1 using LipofectaminTM 2000 
CD (Invitrogen, Karlsruhe, Germany) and FuGENE® 6 (Roche Applied Sciences, Mannheim, 
Germany) as transfection reagents. DS-2 cells were seeded in 6-well plates at a cell density of 
1 · 106 cells/mL one day before transfection. Transfections were performed according to the 
manufacturers’ instructions.  
5.2.5. Expression of Hyal-1/S and Hyal-1/L in transiently transfected DS-2 cells 
Transiently transfected cells were screened for heterologous protein expression by induction 
with 0.5 mM sterile CuSO4 (stock solution 100 mM) 24 h after transfection. At various time 
points after induction samples of the cell medium were analyzed by Western blotting and 
enzymatic activity assays, respectively. 
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5.2.6. Expression of Hyal-1/L in stably transfected DS-2 cells 
For selection of stably transfected DS-2/pMT/Hygro/hyal-1/L cells the medium was 
exchanged 24 h after transfection against fresh medium supplemented with 300 µg/mL 
hygromycin. The selection medium was subsequently changed every 3 – 4 days till the 
hygromycin resistant cells were confluent, then passaging was continued in the presence of 
hygromycin as described for the wild type cells.  
For induction of protein expression 0.5 mM sterile CuSO4 was added to a suspension culture 
at a cell density of 1.5 – 2.0 · 106 cells/mL. Ten days after induction the cells were harvested 
by centrifugation (1,500 g, 15 min, 4 °C) and the medium was used for isolation of Hyal-1/L. 
5.2.7. Purification of Hyal-1/L from DS-2 cell medium 
After addition of 1 mM EDTA and 0.1 % (v/v) Triton X-100 to the medium Hyal-1/L was 
precipitated by 30 % saturation of the medium with ammonium sulfate. The suspension was 
incubated on ice for 1 h before the precipitate was pelleted by centrifugation (20,000 g, 60 
min, 10 °C). The pellet was solubilized in 1/10 of the original medium volume of 50 mM Na-
phosphate, 0.1 % Triton X-100, pH 6.0. After stirring overnight at 4 °C insoluble protein 
aggregates were removed by centrifugation (20,000 g, 60 min, 4 °C), and the clear 
supernatant was loaded on CM (Carboxymethyl)-Sephadex C-50 (Amersham Biosciences, 
Uppsala, Sweden) packed in a 26/20 column (40 mL column volume (CV), Amersham 
Biosciences, Uppsala, Sweden) and equilibrated in 50 mM Na-phosphate, 0.1 % Triton X-
100, pH 6.0. The column was washed with 2 CV of equilibration buffer before Hyal-1/L was 
eluted by a linear gradient from 0 – 0.5 M NaCl increasing over 10 CV. After elution the 
column was washed with 2 CV of equilibration buffer supplemented with 1 M NaCl. Cation 
exchange chromatography was performed at a flow rate of 1 mL/min and a detector 
wavelength of 280 nm. Fractions of 8 mL were collected automatically. Protein purification 
was performed with an ÄKTA FPLC device and a Frac-950 fraction collector using 
UNICORNTM v5.10 software (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) for data 
analysis.  
The pH of the elute was carefully adjusted to 6.3 with 1 M NaOH and the fractions exhibiting 
hyaluronidase activity were pooled. The sample was then loaded on a HisTrapTM FF column 
(3 x 5 mL CV, GE Healthcare Bio-Sciences AB, Uppsala, Sweden) equilibrated in 50 mM 
Na-phosphate, 0.5 M NaCl, 0.1 % Triton X-100, pH 6.8. The column was washed with 2 CV 
of equilibration buffer and elution was achieved in three steps: firstly, the pH of the 
equilibration buffer was decreased to pH 4.5 (elute 1), secondly, the Ni2+ ions were eluted 
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together with Hyal-1/L by washing with 10 CV of 50 mM Na-phosphate, 0.5 M NaCl, 50 mM 
EDTA, pH 6.0 (elute 2). In the third step the residual Hyal-1/L was eluted by addition of 0.1 
% Triton X-100 to the elution buffer 2 (elute 3). Ni-IMAC was performed at a flow rate of 0.5 
mL/min. Fractions of 1 mL were collected manually and pooled after determination of their 
specific enzymatic activity. Pure samples were dialyzed against 50 mM Na-phosphate, 0.5 M 
NaCl, 1 mM EDTA, pH 6.0. Enzyme purity was confirmed by SDS-PAGE. 
All buffers used during the purification process were vacuum-degassed and filtrated through a 
0.45 µm filter (Millipore, Eschborn, Germany). 
5.2.8. SDS-PAGE and Western blot 
For SDS-PAGE and Western blotting the protocols described in Chapter 4 were followed. As 
primary antibody Anti-V5-IgG (Sigma, Munich, Germany) diluted 2000fold in 10 mL of 
washing buffer was used, the secondary antibody was identical to the one used in Chapter 4. 
5.2.9. Zymography 
Substrate gel electrophoresis was performed according to the method described by Cherr et al. 
(Cherr et al. 1996). In brief, SDS polyacrylamide gels were prepared as described in Chapter 
3 with the separating gel supplemented with 67 µg/mL hyaluronic acid. Generally protein 
samples were prepared by mixing with 0.25 volumes of 5 x SDS sample buffer (cf. 3.2.14) 
without DTT and were not boiled prior to electrophoresis.  
After electrophoresis SDS was removed from the gel by washing with a 2.5 % (v/v) Triton X-
100 solution for 30 min, a short incubation period in water and washing with incubation 
buffer (see below) for 30 min. Then, the gel was equilibrated with incubation buffer for 2 – 24 
h at 37 °C. The incubation buffer was chosen to achieve maximum enzymatic activity, i.e. in 
the case of Hyal-1/L 0.1 M Na-formate, 0.1 M NaCl, pH 3.5 were used. 
To visualize regions of hyaluronan digest the gels were stained in 0.5 % alcian blue in 7 % 
acetic acid for 1 h, destained in 7 % acetic acid and counterstained with Coomassie Brilliant 
Blue G-250 (Serva, Heidelberg, Germany). 
5.2.10. Detection of glycoproteins by PAS staining of gels 
For detection of glycoproteins SDS-PA gels were stained by the periodic acid – Schiff (PAS) 
technique with Schiff’s reagent purchased from Sigma, Munich, Germany, following the 
procedure described by Zacharius et al. (Zacharius et al. 1969).  
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5.2.11. Deglycosylation of Hyal-1/L expressed in DS-2 cells 
4 µg of partially purified Hyal-1/L (0.6 U/mg) were incubated with 0 – 2 U N-glycosidase F 
(Roche, Mannheim, Germany) for 4 h at 37 °C in 100 µL of 50 mM Na-phosphate, 10 mM 
EDTA, pH 6.0. 20 µL of each sample were used for Western blotting and 50 µL were 
analyzed in the colorimetric hyaluronidase activity assay.  
5.2.12. N-terminal sequencing of Hyal-1/L 
10 µg of purified Hyal-1/L were precipitated by methanol-chloroform-precipitation (Wessel 
and Flügge 1984) and solubilized in 300 µL of milli-Q water. After lyophilization the protein 
was N-terminally sequenced by Edman degradation (Edman and Begg 1967). Sequencing was 
performed at the laboratory of Prof. Dr. Deutzmann at the Institute of Biochemistry, 
Microbiology and Genetics, University of Regensburg, Germany, in a Procise® Protein 
Sequencing System 492 with phenylthiohydantoin amino acid analyzer (Applied Biosystems, 
Foster City, USA). 
5.2.13. Colorimetric hyaluronidase activity assay 
The assay was performed as described in Chapter 4. The following incubation mixtures were 
used: 
Incubation mixture A: 150 µL of water, 100 µL of BSA (0.2 mg/mL), 100 µL of 0.1 M formic 
acid/Na-formate, pH 3.5, 50 µL of HA (5 mg/mL), 50 µL of sample. 
Incubation mixture B: 150 µL of water, 100 µL of BSA (0.2 mg/mL), 100 µL of McIlvaine’s 
buffer, 50 µL of HA (5 mg/mL), 50 µL of sample. 
McIlvaine’s buffer was adjusted to the desired pH by mixing solution A (0.2 M Na2HPO4/0.1 
M NaCl, solution) and B (0.1 M citric acid/0.1 M NaCl).  
5.2.14. Turbidimetric hyaluronidase activity assay 
A detailed description of the turbidimetric activity assay is given in Chapter 3.  
Incubation mixture A: 31 µL of 0.1 M formic acid/Na-formate, pH 3.5, 8 µL of BSA (0.2 
mg/mL), 8 µL of HA (2 mg/mL), 13 µL of H2O, 10 µL of sample.  
Incubation mixture B: 15 µL of McIlvaine’s buffer (cf. 5.2.13), 15 µL of BSA (0.2 mg/mL), 8 
µL of HA (5 mg/mL), 22 µL of water, 10 µL of sample. 
If further additives were used in the assay, water was replaced by the additive solubilized in 
water.  
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5.2.15. Chondroitinase activity assays 
Chondroitinase activity was determined by the colorimetric and the turbidimetric method, 
respectively, (cf. 5.2.13 and 5.2.14) substituting HA by chondroitin sulfate A, B or C.   
Absorbance spectra of the Morgan-Elson reaction products were measured in a Cary 100 UV-
Vis Spectrophotometer (Varian, Darmstadt, Germany). 
5.2.16. Determination of protein concentrations 
Protein concentrations were determined by the bicinchoninic acid (BCA) assay (Smith et al. 
1985) using BSA as standard because of the presence of detergents in the protein samples. 
The assay was performed by mixing 70 µL of the BCA working solution described by Smith 
et al. (Smith et al. 1985) with 70 µL of sample. Absorbance was quantified after 1 h of 
incubation at 60 °C at 580 nm in a microplate reader (Tecan Deutschland GmbH, Crailsheim, 
Germany) applying 10 flashes per well. 
5.2.17. MALDI-TOF MS 
MALDI-TOF MS was carried out on a GSG/future linear MALDI-TOF mass spectrometer 
(GSG Mess- und Analysengeräte GmbH, Bruchsal, Germany). For sample preparation the 
GSG/SPA sample preparation system was used. 1 µL of pure Hyal-1 (1.3 µM in 0.5 mM Na-
phosphate, 5 mM NaCl, pH 6.0) was mixed with 1 µL of matrix solution (10 mg of 2,5-
dihydroxybenzoic acid dissolved in 1 mL of methanol/water (50 : 50)). 1 µL of the mixture 
was applied to the mesa and allowed to dry. Spectra were acquired in the positive ion mode 
over an m/z range of 400 – 100,000 Da. 
5.2.18. Biophysical characterization 
CD spectroscopy and analytical ultracentrifugation were performed by Dr. H. Lilie at the 
Institute of Biotechnology, Martin-Luther University Halle-Wittenberg, Germany. For the 
analysis a purified sample of Hyal-1 (10 U/mg, 0.5 mg/mL) solubilized in 50 mM Na-
phosphate, 0.5 M NaCl, 1 mM EDTA, pH 6.0 was used. CD spectra were measured in 0.1 
mm cuvettes on a Jasco 710 spectropolarimeter (Jasco, Gross-Umstadt, Germany) at a scan 
speed of 50 nm/min and a temperature of 20 °C. Spectra were measured 20 times, averaged 
and corrected for contributions of the buffer. Secondary structure elements were calculated by 
the program CDNN based on a neuronal network trained with 30 spectra of proteins with a 
known crystal structure (Böhm et al. 1992). 
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Analytical ultracentrifugation was performed in a Beckmann Optima XL-A centrifuge and a 
50Ti rotor. Sedimentation equilibrium measurements (absorption at 230 nm and 280 nm) 
were carried out at 10,000 rpm and 20 °C. After 60 h of centrifugation the apparent molecular 
mass was calculated using the software provided by Beckman Instruments (Palo Alto, USA). 
 
Crystallization was performed by B. Epler and Dr. M. Stubbs at the Institute of 
Biotechnology, Martin-Luther University Halle-Wittenberg, Germany. High-throughput 
screening of crystallization conditions was performed using 9.5 mg/mL purified Hyal-1 in the 
presence of 0.1 % (v/v) Triton X-100 and 6.9 mg/mL purified Hyal-1 in the absence of Triton 
X-100. Both enzymes were solubilized in 50 mM Na-phosphate, 0.5 M NaCl, 1 mM EDTA, 
pH 6.0. For screening of crystallization conditions the CrystalScreenTM kit 1 and 2 (Hampton 
Research, Aliso Viejo, USA) and the Basic Crystallization kit (Sigma, Munich, Germany) 
were used. 
 
5.3. Results and discussion 
5.3.1. Construction of pMT/Hygro 
Originally, the DS-2 cell system for the heterologous expression of proteins designed by 
Invitrogen (Karlsruhe, Germany) utilizes two cotransfected vectors for the selection of 
transfected cells, one carrying the foreign gene in a cloning/expression region (pMT/BiP/V5-
HisA) and one carrying the hygromycin resistance gene (pCoHygro). To avoid the necessity 
to transfect a cell with both vectors pMT/Hygro was designed as a combination of the 
hygromycin containing region from pCoHygro and the essential regions of pMT/BiP/V5-
HisA. The AccI and SapI cleavage sites were found to be positioned in both vectors in a 
fortunate way to enable the vector combination described above. Digestion of pMT/BiP/V5-
HisA with AccI and SapI resulted in the removal of only 0.3 kb from the 3.6 kb vector (Fig. 
5.1, lane A and B), while pCoHygro was cleaved into two fragments of similar length (2.1 
and 2.4 kb) (Fig. 5.1, lane C and D). Isolation of the 2.1 kb fragment carrying the hygromycin 
resistance was only possible after prolonged agarose gel electrophoresis. Prior to 
transformation of E. coli Top10 cells, the 3.3 kb pMT/BiP/V5-HisA fragment and the 2.1 kb 
pCoHygro fragment were isolated from the gel, ligated, and the resulting plasmids were 
screened for the correct construct. The identity of the plasmid pMT/Hygro was confirmed by 
sequencing. 
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Fig. 5.1 Agarose gel electrophoresis of pMT/BiP/V5-HisA and pCoHygro after restriction digest. A) 
pMT/BiP/V5-HisA linerarized with AccI. B) pMT/BiP/V5-HisA digested with AccI and SapI. C) 
pCoHygro linearized with AccI. D) pCoHygro digested with AccI and SapI. 
 
5.3.2. Construction of pMT/Hygro/hyal-1/S and pMT/Hygro/hyal-1/L 
A truncated (S) and a full-length (L) hyal-1 cDNA variant were cloned into pMT/Hygro by 
specific amplification of the respective fragments by PCR (Fig. 5.2), restriction digest using 
SmaI and NotI and ligation into pMT/Hygro digested with the same enzymes. 
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kb L       S
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Fig. 5.2 PCR products of hyal-1/S (S) and hyal-1/L 
(L) analyzed by agarose gel electrophoresis. Each 
lane contained 5 µL of the PCR mixture and 1 µl of 
10 x PCR loading buffer.  
Hyal-1/L and Hyal-1/S were expected to be targeted to the ER and the extracellular 
compartment due to an exchange of the mammalian signal sequence for an insect cell signal 
peptide (BiP). The full-length (L) as well as the truncated (S) variant of Hyal-1 were both 
fused C-terminally to a His-tag and a V5 epitope. Expression of the recombinant proteins was 
controlled by a metallothionein promotor (Pmetallothionein), a regulatory element originally 
inducing expression of proteins protecting the cell against heavy metal ion effects. A 
schematic view of the insect cell expression vector is given in Fig. 5.3. 
ampR
pUC ori
SV40 pA
Hygromycin SV40 pA
Pcopia
hyaluronidase cDNA
His-tag
V5 epitope
BiP signal sequence
Pmetallothionein
pMT/Hygro/
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Fig. 5.3 DS-2 cell expression vector 
pMT/Hygro with hyaluronidase cDNA 
(hyal) located in the multiple 
cloning/expression site. 
Chapter 5 Purification and characterization of human Hyal-1 expressed by DS-2 cells 
 83
5.3.3. Expression of Hyal-1/S and Hyal-1/L in DS-2 cells 
5.3.3.1. Transient expression of Hyal-1/S and Hyal-1/L in DS-2 cells 
To investigate if the hyaluronidases were expressed by the DS-2 cells in the expected way 
protein expression was induced directly after transfection of the DS-2 cells with the 
pMT/Hygro/hyal-1/S and pMT/Hygro/hyal-1/L, respectively. The presence of the 
recombinant enzymes in the medium was confirmed by Western blot analysis using an anti-
V5-antibody (Fig. 5.4).  
118.0
85.0
47.0
36.0
kDa          A      B      C  
 
Fig. 5.4 Western blot analysis of 30 µL of DS-
2 cell medium 6 d after induction of transient 
expression of Hyal-1/S (A) and Hyal-1/L (C). 
Lane B contained induced wild type DS-2 cell 
medium. Anti-V5-IgG was used as primary 
antibody and biotinylated anti-mouse-IgG as 
secondary antibody. Detection of the antibody 
binding was achieved by HRP/DAB staining.  
 
No cross reactivity with any wild type protein in the medium was observed (Fig. 5.4, lane B). 
Transfected DS-2 cells expressed a ca. 46 kDa protein (Hyal-1/S) and a ca. 51 kDa protein 
(Hyal-1/L), respectively, reacting with the primary antibody (Fig. 5.4, lane A and C). The 
molecular mass calculated from the amino acid sequence was 42.0 kDa (Hyal-1/S) and 50.5 
kDa (Hyal-1/L), respectively. Variations in the molecular mass of the heterologous proteins 
can be caused by post-translational modifications of the proteins in the eukaryotic expression 
system, but also by the inaccuracy of the pre-stained Western blot standard proteins. 
  
Hyaluronidase activity was subsequently determined for both Hyal-1/S and Hyal-1/L in the 
medium and in the complete cell lysate. However, neither the medium nor the complete cell 
lysate of DS-2 cells expressing Hyal-1/S contained any hyaluronidase activity. DS-2 cells 
transfected with pMT/Hygro/hyal-1/L exhibited 9 d after induction of expression a 
hyaluronidase activity of 0.6 nmol GlcNAc · min-1 · mL-1 cell suspension in the medium and 
an activity of 0.03 nmol GlcNAc · min-1 · mL-1 cell suspension in the complete cell lysate. The 
medium and complete cell lysate of wild-type DS-2 cells did not exhibit any hyaluronidase 
activity under identical assay conditions.  
The presence of hyaluronidase activity in the cell lysate of transfected cells might be due to 
the fact that Hyal-1 is a lysosomal enzyme (Gold 1982). Although no simple consensus 
sequence exists for the transport of proteins to lysosomes, a structural motif in the three-
dimensional structure of lysosomal proteins is supposed to be responsible for the sorting of 
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the majority of proteins to lysosomes via the mannose-6-phosphate receptor (Ni et al. 2006). 
Possibly, the human sequence motif for protein transport to lysosomes is, at least partially, 
recognized by insect cells, resulting in an accumulation of recombinant Hyal-1/L not only in 
the extracellular compartment, but also in lysosomes.  
The low hyaluronidase activity in the medium indicates that the transfection efficiency was 
rather low. After selection of hygromycin-resistant DS-2 cells and optimization of growth and 
expression conditions (see below) ca. 450 nmol GlcNAc · min-1 · mL-1 cell suspension could 
be achieved in the medium 10 d after induction. 
5.3.3.2. Stable expression of Hyal-1/L in DS-2 cells 
For production of Hyal-1/L in a larger scale (up to 6 L) some parameters of the DS-2 cell 
expression system were explored in order to improve the yields of recombinant protein.  
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Fig. 5.5 Hyal-1/L activity in the 
medium of stably transfected DS-2 cells 
depending on the time period after 
induction. Activity was determined by 
the colorimetric hyaluronidase activity 
assay (incubation mixture A) for cells 
grown in flasks (adherent culture, open 
circles) and for cells grown in 
suspension (filled circles). Cultures 
were initiated with 1.5 · 106 cells/mL 24 
h before induction. 
As it is inconvenient to grow large quantities of adherent cells, DS-2 cells were grown in 
suspension and the enzyme yields (measured via the enzymatic activity in the medium) were 
compared to cells grown adherently in culture flasks (Fig. 5.5). After 10 – 12 d of induction 
expression levels were very similar for both cultures. While the enzymatic activity in the 
medium increased further in the adherent culture, the activity in the suspension culture 
medium remained at a constant level. Therefore, for suspension cultures an induction period 
of 10 – 12 d was chosen.  
Furthermore, enzymatic activity depended on cell density (Fig. 5.6). Ten days after induction 
of expression the yield in recombinant hyaluronidase was similar, when initial cell densities 
were ≥ 2 · 106 cells/mL, but dropped significantly at lower initial cell densities. DS-2 cells are 
known to be density sensitive, but cell growth should not be impeded at cell densities 
exceeding 0.5 · 106 cells/mL (as declared by the supplier). However, for protein expression 
experiments it seemed to be advantageous to keep the initial cell density as high as possible 
(Fig. 5.6). 
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Fig. 5.6 Hyal-1/L activity in the 
medium of stably transfected DS-2 cells 
depending of the cell density at the time 
of initiation of the cell culture. 
Expression was induced 24 h after 
initiation. The cells were cultivated in 
suspension for 10 d before the activity 
in the medium was determined by the 
colorimetric hyaluronidase activity 
assay using incubation mixture A. 
 
During optimization experiments a range of different Hyal-1/L yields was observed in 
dependence on the sub-culturing stage of the transfected cells. This might be due to depletion 
of transfected DS-2 cells from the culture and deterioration of hygromycin solutions. Best 
expression yields with ca. 450 nmol GlcNAc · min-1 · mL-1 activity in the medium 
(colorimetric assay, incubation mixture A) were observed 10 - 12 d after induction of early 
passages of stably transfected DS-2 cells seeded at cell density of at least 2 · 106 cells/mL. 
Hygromycin in the expression culture influenced expression yields only to a minor extent 
(data not shown) and was thus excluded from larger suspension culture volumes. 
 
5.3.4. Purification of Hyal-1/L from DS-2 cell medium 
5.3.4.1. Ammonium sulfate precipitation 
In order to reduce the sample volume Hyal-1/L was in the first purification step precipitated 
in the DS-2 cell medium by ammonium sulfate.  
Ammonium sulfate precipitation was performed in the presence of 1 mM EDTA and 0.1 % 
Triton X-100. An initial precipitation experiment revealed that the main fraction of Hyal-1 
activity was found in the ammonium sulfate precipitate at 30 % saturation (Fig. 5.7). At 40 % 
saturation Hyal-1 activity was still found in the precipitate, however, at this concentration a 
strong increase in aggregation was observed in the medium indicating the co-precipitation of 
other proteins in the medium.  
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Fig. 5.7 Precipitation of Hyal-1/L at 
increasing ammonium sulfate concen-
trations. (NH4)2SO4 was added to DS-
2/pMT/Hygro/hyal-1/L medium 10 d 
after induction of expression. The 
solution was stirred for 15 min on ice, 
proteins were precipitated at 12,000 g 
(10 min) and the precipitate solubilized 
in 50 mM Na-phosphate, 0.5 M NaCl, 
0.1 % Triton X-100, pH 7.8 to yield a 
10-fold concentration of the sample. 
This precipitation step reduced the sample volume by a factor of 10. Precipitation of Hyal-1/L 
by ammonium sulfate was advantageous for concentration of the sample, but unfortunately 
resulted also in a loss of total Hyal-1/L due to incomplete solubility of the precipitated protein 
in solubilization buffer. 
5.3.4.2. Ion exchange chromatography 
As a primary step of the purification procedure Hyal-1/L (pI = 7.3, calculated from the amino 
acid sequence) was bound to a cation exchange chromatography column (CM-Sephadex) at 
pH 6.0. At pH values above pH 6.3 Hyal-1/L started to form aggregates due to approximation 
to the pI. 
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Fig. 5.8 Elution profile of Hyal-1/L bound to a CM-Sephadex cation exchange column (CV 37 mL). 
The absorbance (solid, blue line) was followed at 280 nm and the enzymatic activity (black circles) 
was measured in fractions of 8 mL in the colorimetric hyaluronidase activity assay using 0.1 M formic 
acid/Na-formate, 0.1 M NaCl, pH 3.5, as incubation buffer. Elution was achieved at increasing NaCl 
concentrations (dashed, red line). 
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At pH 6.0 91 % of the enzymatic activity of Hyal-1/L bound to the CM-Sephadex material. 
Elution was achieved by application of a linear NaCl gradient. Hyal-1/L eluted at NaCl 
concentrations of 0.3 – 0.4 M as a broad single peak (Fig. 5.8) yielding 83 % of the activity 
bound to the column.  
 
Alternatively, Hyal-1/L was assayed with respect to binding to an anion exchange 
chromatography column (Q-Sepharose) at pH 8.0. Though the protein bound with very high 
affinity (98 % binding of Hyal-1/L activity), the enzyme was neither eluted by increasing 
NaCl concentrations (up to 1.0 M) nor by a decrease in pH to pH 4.5. Elution was finally 
achieved by addition of 1.0 M arginine, possibly due to the solubilizing properties of this 
amino acid (cf. Chapter 4) (data not shown).  
As anion exchange chromatography seemed to pose more problems than the cation exchange 
chromatography, and additionally, Hyal-1/L is known to exhibit its activity at acid pH, 
purification by CM-Sephadex at pH 6.0 was favored. 
5.3.4.3. IMAC purification 
The fusion to a C-terminal His-tag allowed for the purification of Hyal-1/L via IMAC. In the 
course of the previous purification steps Cu2+ ions present in the medium of the insect cells 
were separated from the protein by addition of EDTA. Therefore, Hyal-1/L eluted from the 
cation exchange chromatography column was bound under slightly acidic conditions (pH 6.8) 
and after addition of 0.2 M NaCl to a Ni-IMAC. A strong tendency for aggregation of the 
Hyal-1/L sample was observed at pH values above pH 6.5, thus the pH of the sample was 
adjusted to 6.3 for binding, while the pH of the equilibration buffer was kept at pH 6.8 to 
allow for sufficient deprotonation of the His residues. This enabled a reasonable binding 
affinity of Hyal-1/L (70 % of the original activity) with minimum deficiencies during pH 
adjustment.  
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Fig. 5.9 Ni-IMAC purification (3 x 5 mL CV) of Hyal-1/L subsequent to ammonium sulfate 
precipitation and cation exchange chromatography. a) The elution profile of the Ni-IMAC shows the 
washing with equilibration buffer (pH 6.8), elution by a decrease of the pH (elute 1), elution by 
addition of EDTA at pH 6.0 (elute 2) and elution with EDTA in the presence of Triton X-100 (elute 
3). The protein concentration is represented by the blue squares, the enzymatic activity by black 
circles and the pH by the solid red line. b) SDS-PAGE analysis of the Hyal-1/L purification procedure. 
Each lane contained 30 µL of sample and 6 µL of 5 x SDS sample buffer. A) DS-2/pMT/Hygro/hyal-
1/L medium, 11 d after induction; B) ammonium sulfate precipitate after solubilization; C) Hyal-1/L 
after cation exchange chromatography; elute 1) – elute 3) refer to fractions of the Ni-IMAC marked 
with an arrow in a). The fractions were applied to the gel in the sequence of elution. 
 
A wide variety of binding buffers as well as elution methods was tested to gain sufficient 
purity of the protein in combination with high elution yields. Standard procedures, e.g. 
purification by the Protino® Ni-ion purification kit (Macherey-Nagel, Düren, Germany) and 
binding in the presence of low concentrations (10 – 20 mM imidazole) failed due to 
insufficient binding (maximum 30 % of the initial activity). Furthermore, binding of Hyal-1/L 
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in the CuSO4-supplemented medium directly to chelating Sepharose resulted in very weak 
binding of the enzyme.  
In the absence of imidazole in the binding buffer a high amount of impurities was bound to 
the Ni-IMAC column, but could be eluted by washing with binding buffer at pH 4.5 (Fig. 
5.9). Normally, a decrease in the pH to values below pH 6.0 is supposed to elute the His-
tagged protein as well. However, in the case of Hyal-1/L only a minor fraction of the His-
tagged protein was eluted at pH 4.5 and in the presence of high concentrations of imidazole 
(data not shown), while the main amount of Hyal-1/L could be gained only after elution of the 
Ni2+ ions with EDTA. As shown in Fig. 5.9.b Hyal-1/L eluted by EDTA occurred on the 
SDS-PAGE as a single band of 54 kDa with minimal impurities.  
In the absence of Triton X-100 in the elution buffer (elute 2 in Fig. 5.9.a) Hyal-1/L eluted 
extremely slowly from the column material even after elution of the Ni2+ ions. Addition of 
Triton X-100 enabled a faster and more concentrated elution of Hyal-1/L (elute 3 in Fig. 
5.9.a). During the whole purification procedure Triton X-100 had to be added to the buffers to 
avoid adhesion of Hyal-/L to column materials as well as to centrifugal devices. However, 
Triton X-100 can not be removed from the protein completely and disturbed photometric 
analyses of Hyal-1/L.  
 
Observations during optimization of the purification of Hyal-1/L suggest that the recombinant 
protein binds to the Ni-IMAC column via the His-tag, albeit not exclusively. The 
extraordinarily slow elution even in the absence of Ni2+ ions indicates a high affinity of the 
hyaluronidase itself to the column material, i.e. to Sepharose (cross-linked agarose) resulting 
in a retardation of Hyal-1/L in respect of the Ni2+ ions.  
Although protein purification column materials like Sepharose are designed to exhibit only 
minimum protein binding affinity, the special properties of the hyaluronidases strongly 
impede the protein purification methods. Possibly, the structural relationship of agarose to the 
natural substrate, hyaluronic acid, caused the unexpected binding affinity of Hyal-1/L to the 
Ni-IMAC column material. A similar, extraordinarily high binding affinity of Hyal-1/L was 
observed upon binding to Q-Sepharose (cf. 5.3.4.2), but not to CM-Sephadex. Presumably, 
Sephadex (cross-linked dextran) exhibits fewer interactions with the hyaluronidase than 
Sepharose. 
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5.3.5. Characteristics of Hyal-1/L, expressed by DS-2 cells, in comparison to Hyal-
1/L, expressed in E. coli 
In the following chapter Hyal-1/L, expressed in E. coli and refolded in vitro, is referred to as 
Hyal-1/E. coli and Hyal-1/L, expressed in DS-2 cells, as Hyal-1/DS-2. Due to missing 
enzymatic activity no characterization experiments were performed with Hyal-1/S. 
The schematic representation of the primary structures in Fig. 5.10 visualizes the differences 
between BVH, human Hyal-1, Hyal-1, expressed in E. coli (Hyal-1/E. coli), and Hyal-1, 
expressed in insect cells (Hyal-1/DS-2). 
Bee venom
hyaluronidase 
(BVH)
native human 
Hyal-1
Hyal-1/E. coli
Hyal-1/DS-2
H2N COOH
signal peptide catalytic domain C-terminal domain
H2N COOH
5xHis
H2N COOH
insect cell signal peptide V5  5xHis
H2N COOH
Disulfide bridges
 
Fig. 5.10 Diagrammatic representation of the primary structures of bee venom hyaluronidase (BVH), 
human Hyal-1 precursor, Hyal-1/E. coli and Hyal-1/DS-2. Domains are marked according to their 
function and C residues are shown as narrow black boxes. Disulfide bridge linkage is only known for 
BVH. The function of the C-terminal domain is unknown, but the sequence shows significant 
similarity to EGF domains. 
 
5.3.5.1. pH profiles 
The pH profile of a hyaluronidase is a characteristic feature differing for each of the 
hyaluronidase subtypes. Human Hyal-1 is known to be an acid active enzyme with maximum 
catalytic activity at pH 3.5 – 4.0 (Gold 1982, Afify et al. 1993, Csoka et al. 1997, Frost et al. 
1997). The pH profiles of Hyal-1/E. coli and Hyal-1/DS-2 resemble closely the profile of 
human plasma hyaluronidase reported by Muckenschnabel et al. (Muckenschnabel et al. 
1998), which was measured under comparable assay conditions (Fig. 5.11.a). The pH profile 
of Hyal-1/DS-2 was shifted slightly to higher pH values with an optimum at pH 4.0 instead of 
pH 3.5 possibly due to effects of the buffer present in the enzyme samples.  
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Fig. 5.11 pH profiles of in vitro folded Hyal-1/E. coli (red squares) and Hyal-1/DS-2 (blue triangles). 
Black circles indicate the pH profile of human plasma hyaluronidase as determined by 
Muckenschnabel et al. (Muckenschnabel et al. 1998). Activities were determined in the colorimetric 
activity assay (a) using incubation mixture B and the turbidimetric activity assay (b) using incubation 
mixture B. Maximum hyaluronidase activity was normalized to 100 % for each Hyal-1 derivative. 
Activity values are mean values ± SEM of three incubation mixtures. 
 
Hyaluronidase activity profiles were also measured in the turbidimetric activity assay to 
determine, if the pH optima of Hyal-1 were dependent on the type of assay as described 
previously for the pH profiles of BTH (Hoechstetter et al. 2001, Hoechstetter 2005). 
However, the turbidimetric and the colorimetric activity assay yielded nearly identical pH 
profiles for both recombinant enzymes, Hyal-1/E. coli and Hyal-1/DS-2, (Fig. 5.11.b), 
indicating the absence of pH dependent variations in the degradation mechanism (cf. Chapter 
8). 
5.3.5.2. NaCl sensitivity 
For human hyaluronidase isolated from liver and plasma an inhibitory effect of NaCl at 
concentrations exceeding 100 mM has been reported (Gold 1982, Afify et al. 1993). Indeed, 
colorimetric determination of Hyal-1 activity at pH 3.5 with increasing NaCl concentration (0 
- 1 M) revealed an inhibition of the hyaluronidase activity by NaCl (Fig. 5.12). However, 
Hyal-1/E. coli was already inhibited at concentrations > 50 mM, while Hyal-1/DS-2 showed 
an optimum of hyaluronidase activity at 100 mM NaCl with a fast drop in activity at 
concentrations > 100 mM. At 1 M NaCl the activity of both enzymes was completely 
inhibited. Without NaCl the activity of Hyal-1/DS-2 decreased by ca. 40 % compared to the 
optimum concentration of 100 mM, while the activity of Hyal-1/E. coli remained at its 
maximum even without any NaCl present. 
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Fig. 5.12 NaCl sensitivity of Hyal-1/E. 
coli (white squares) and Hyal-1/DS-2 
(black squares) determined in the 
colorimetric activity assay (incubation 
mixture A).  
The effects of ionic strength on hyaluronidase activity have often been ascribed to the ability 
of the substrate, hyaluronic acid, to interact with cations (Vercruysse et al. 1999, Oettl 2000). 
Alterations in the ionic strength could thus cause the formation or disruption of tertiary 
structures of hyaluronan, thereby influencing the contact regions available for the catabolizing 
enzymes. 
Apparently, the differences in the sensitivity towards NaCl of Hyal-1/E. coli and Hyal-1/DS-2 
can not merely be explained by the influence of the ionic strength on the hyaluronic acid as 
the catalytic site of the enzymes, and therefore, the mode of interaction with the substrate is 
supposed to be very similar for both enzymes. Since the inhibitory effects of NaCl were found 
to be reversible, one could imagine an influence of NaCl on the solubility of the enzymes in 
addition to the effects on the hyaluronic acid conformation. As solubility can be influenced by 
protein glycosylation this would provide a possible explanation for the differences in the 
NaCl sensitivities of the enzymes expressed in E. coli and in insect cells.  
5.3.5.3. Sensitivity towards denaturing agents 
During in vitro folding experiments with Hyal-1/E. coli a differential effect of GdmCl and 
urea on the solubility of the enzyme was observed (cf. Chapter 4, 4.2.). Therefore, the 
stability of Hyal-1/E. coli was determined in the presence of increasing concentrations of both 
denaturing agents by measuring the enzymatic activity (Fig. 5.13). Compared with urea as 
denaturing agent, a decrease in activity occurred at much lower GdmCl concentrations (50 % 
residual activity at 0.7 M GdmCl and 3 M urea, respectively). Even when taking the 1.5-fold 
stronger denaturing ability of GdmCl into consideration, the difference between the two 
denaturing agents is extraordinarily high. Hyal-1/DS-2 exhibited a similar behavior as Hyal-
1/E. coli but with a slightly higher stability in both denaturing agents. Interestingly, the 
activity of Hyal-1/E. coli increased at concentrations up to 1.5 M urea in the reaction mixture, 
possibly due to an increased solubility of the enzyme.  
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Fig. 5.13 Dependency of hyaluronidase 
activity on increasing concentrations of 
urea (squares) and GdmCl (circles). 
Curves represented with open symbols 
were measured using Hyal-1/DS-2, 
curves with black symbols were 
measured using Hyal-1/E. coli. Urea 
dependencies were determined in the 
colorimetric activity assay (incubation 
mixture A), GdmCl dependencies in the 
turbidimetric activity assay (incubation 
mixture A). Maximum hyaluronidase 
activity was normalized to 100 % for 
each curve separately. 
Activity curves were measured in the turbidimetric assay for GdmCl-dependence and in the 
colorimetric assay for urea-dependence due to disturbance of the alternative assay systems by 
the denaturing agents. References containing buffer instead of enzyme solution were 
subtracted for each concentration separately.  
5.3.5.4. Effect of metal ions on the activity of Hyal-1/DS-2 
Except for the influence of NaCl no other ionic effects have been described for human Hyal-1 
yet. Therefore, a variety of divalent cations known to occur either as cofactors (Ca2+, Mg2+, 
Zn2+) or as impurities in enzyme preparations (Fe2+, Ni2+, Cu2+) were tested for their influence 
on Hyal-1/DS-2 activity at two different concentrations (10 mM and 100 mM) (Fig. 5.14).  
The hyaluronidase activity was referenced to the activity in the presence of 100 mM of NaCl, 
the optimum NaCl concentration as determined in 5.3.5.2. To assure a minimum ionic 
strength of 100 mM the 10 mM mixtures were supplemented with 90 mM of NaCl. Although 
the ionic strength in the incubation mixtures was increased up to 4-fold compared to the 
reference ionic strength (100 mM), a maximum decrease of 10 – 15 % was expected as a 
result of the ionic strength (cf. 400 mM NaCl in Fig. 5.12).  
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Fig. 5.14 Influence of metal ions on the activity of Hyal-1/DS-2 as determined in the colorimetric 
activity assay (incubation mixture A) for 10 mM (black bars) and 100 mM (grey bars) of the salts 
indicated. Hyaluronidase activity at 100 mM NaCl was set as 100 %, incubation mixtures containing 
10 mM of salt additive were supplemented with 90 mM NaCl.  
a) Comparison to ionic strengths of 120 mM (10 mM salt additive, black) and 300 mM (100 mM salt 
additive, grey). b) Comparison to ionic strengths of 130 mM (10 mM salt additive, black) and 400 mM 
(100 mM salt additive, grey).  
 
Compared to the enzymatic activity in the presence of 100 mM NaCl (100 %) only NiSO4 and 
ZnCl2 at low concentrations (10 mM) revealed a minor stimulation (≤ 10 %) of the Hyal-
1/DS-2 activity. Strong inhibition (65 % - 98 %) was observed in the presence of 10 mM and 
100 mM FeSO4 and CuSO4. As Ni2+ from Ni-IMAC and Cu2+ ions from the induction of 
expression were present during the purification of Hyal-1/DS-2 the effects of these ions were 
of special interest. However, induction of Hyal-1 expression in DS-2 cells was achieved by 
very low concentrations of CuSO4 (0.5 mM). Ni2+ ions occurred only in trace amounts due to 
leakage from the Ni-IMAC. Obviously, Hyal-1/DS-2 does not depend on any metal ion as a 
cofactor, but is inhibited by mM concentrations of Cu2+ and Fe2+. 
5.3.5.5. Analysis of protein glycosylation 
To confirm the presence of glycosidic modifications purified Hyal-1/L from both expression 
systems was stained after SDS-PAGE using the periodic acid-Schiff (PAS) technique. As 
expected, Hyal-1/E. coli did not react with Schiff´s reagent, while Hyal-1/DS-2 formed a pink 
band on the gel indicating the presence of glycosidic residues (Fig. 5.15).  
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Fig. 5.15 Analysis of glycosylation of 
Hyal-1/E. coli and Hyal-1/DS-2 by 
SDS-PAGE and PAS staining. After 
scanning the gel was additionally 
stained with Coomassie. A) Hyal-1/E. 
coli purified from IBs. B) Hyal-1/DS-2 
purified from the medium of insect 
cells. 
The amino acid sequence of Hyal-1/DS-2 contains three potential N-glycosylation sites 
(consensus sequence N-X-T/S) and no O-glycosylation sites as determined by the ExPASy 
NetOGlyc 3.1 tool (Julenius et al. 2005). When Hyal-1/DS-2 was deglycosylated under native 
conditions by incubation with increasing amounts of N-glycosidase F (PNGase F) a second 
band was detected in the Western blot with a molecular mass reduced by ca. 3 - 4 kDa 
compared to the untreated control sample (0 units N-glycosidase F) (Fig. 5.16). Although 
deglycosylation could not be followed to completion, a 40 % reduction of enzymatic activity 
could be observed in the colorimetric activity assay when about half of the protein present on 
the western blot was deglycosylated.   
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Fig. 5.16 Partial deglycosylation of 
Hyal-1/DS-2 (4 µg, 0.6 U/mg) by 
incubation of the enzyme with 
increasing amounts of N-glycosidase F 
for 4 h at 37 °C in 50 mM Na-
phosphate, 10 mM EDTA, pH 6.0. A) 
Measurement of Hyal-1 activity in a 
colorimetric assay, using 0.1 Na-
formate, 0.1 NaCl, pH 3.5 as incubation 
buffer. B) Western Blot analysis of 
Hyal-1/DS-2 using anti-V5-IgG as 
primary antibody and HRP/DAB for 
subsequent staining. 
 
The molecular mass of 54.2 kDa of Hyal-1/DS-2 was additionally confirmed by MALDI-MS. 
Thus, the glycosidic residues attached to the protein comprise a molecular mass of 4 kDa 
since the molecular mass expected from the amino acid sequence was 50.5 kDa. 
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5.3.5.6. Analysis of the catalytically active enzyme fraction 
Hyal-1/DS-2 was analyzed for its catalytic activity on a zymography gel. Intriguingly, the 
activity of Hyal-1/DS-2 was hardly impeded by boiling for 5 min in the presence of reducing 
agents and 2 % SDS, indicating an extremely high stability of the recombinant enzyme (Fig. 
5.17). In the absence of DTT the enzymatic activity remained undisturbed even after 10 min 
of boiling with SDS.  
Surprisingly, the zymography showed two bands of ca. 53 and ca. 64 kDa as proteins 
exhibiting hyaluronidase activity at acid pH (Fig. 5.17). Since this observation is 
contradictory to the single protein band observed after purification of Hyal-1/DS-2 on the 
SDS-PAGE (Fig. 5.9), further experiments were performed to assure the existence of Hyal-
1/L as a homogenous protein species.  
66.2
45.0
35.0
25.0
116.0
- +     - +     - +      - + kDa    
0 min     3 min      5 min       10 min
 
 
 
Fig. 5.17 Zymography of Hyal-1/L 
expressed in DS-2 cells in the presence 
(+) and in the absence (-) of DTT. 
Samples contained 40 µl of DS-2 cells 
medium collected 10 d after induction 
of expression of Hyal-1/L. All samples 
were mixed with 10 µl of SDS sample 
buffer with or without DTT to achieve a 
final SDS concentration of 2 % and 
boiled for the times indicated above 
each pair of lanes. The gel was stained 
with Alcian blue and Coomassie. 
 
Considering previous reports on the existence of two human hyaluronidase Hyal-1 
isoenzymes of 45 kDa and 57 kDa in urine (Csoka et al. 1997), the question arose if Hyal-1 
expressed in DS-2 cells might also be cleaved endoproteolytically as suggested for the 
isoenzymes in urine. Therefore, purified Hyal-1/L was N-terminally sequenced by Edman 
degradation and the identity of Hyal-1/L was confirmed as a protein with a homogenous N-
terminal sequence. The N-terminus RSPWPGFRGPLLPNR is in accordance to the sequence 
expected from the amino acid sequence coded by pMT/Hygro/hyal-1/L after cleavage of the 
insect cell signal peptide (cf. Appendix 2). 
Analysis of the purified protein on an SDS-PAGE in the presence and in the absence of DTT 
revealed a significant change in the electrophoretic mobility of Hyal-1/DS-2, depending on 
the absence or presence of the reducing agents (Fig. 5.18). In the absence of DTT Hyal-1/DS-
2 was detected as a protein band with an apparent molecular weight of ca. 66 kDa, i.e. 
corresponding to one of the protein bands observed in the zymography. After reduction with 
DTT Hyal-1/DS-2 exhibited a molecular weight of ca. 54 kDa, which is in accordance with 
the molecular mass determined previously (5.3.4.3).  
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Fig. 5.18 SDS-PAGE of purified Hyal-1/DS-2 in the 
absence (- DTT) and in the presence of reducing agents 
(+ DTT). 20 µl of enzyme were mixed with 5 µl SDS 
sample buffer, with or without DTT, and boiled for 3 
min at 100 °C.  
Apparently, the detection of Hyal-1/DS-2 as two distinct protein bands on the zymography gel 
was due to partial reduction of the protein during electrophoresis pretending the presence of 
two different proteins with hyaluronidase activity. This effect was mainly observed in 
unpurified protein samples with a high enzymatic activity.  
 
5.3.6. Biophysical characterization of Hyal-1/DS-2 
5.3.6.1. CD spectroscopy 
To gain initial information on the structural elements of Hyal-1 CD spectra were recorded in 
the range between 195 and 260 nm (Fig. 5.19). Automatic analysis of the secondary structure 
elements revealed 36 % α-helix, 8 % antiparallel β-sheets, 8 % parallel β-sheets, 16 % beta-
turns and 31 % random coil.  
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Fig. 5.19 CD spectrum of 0.5 
mg/mL Hyal-1 solubilized in 50 mM 
Na-phosphate, 0.5 M NaCl, 1 mM 
EDTA, pH 6.0.  
The determined data are in good agreement with the (β/α)7 fold found in the crystal structure 
of BVH (1FCV.pdb). In BVH 32 % of the amino acid residues participate in α-helices, 13 % 
in β-sheets and 55 % are not assigned to any of the two secondary structure elements, i.e. they 
exhibit a random coil or turn structure (Botzki 2004).  
The human Hyal-1 model structure (Jedrzejas and Stern 2005) comprising both, the catalytic 
and the C-terminal domain, exhibits 41 % α-helices, 9 % β-sheets and 50 % turn and random 
coil structures. The model of human Hyal-1 is – except for the percentage in β-sheets – 
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roughly in accordance with the CD-spectrum of Hyal-1. Since the model of the C-terminal 
domain was predicted by an ab initio approach (Jedrzejas and Stern 2005), deviations 
between the model structure and experimental data could be due to changes in the secondary 
structure of the C-terminal domain. Furthermore, it should be noted that except for the 
percentage of α-helix the calculated percentage of the other secondary structures is rather 
imprecise (personal communication by Dr. H. Lilie). 
5.3.6.2. Analytical ultracentrifugation 
As mentioned previously (5.3.5.5) the molecular mass of Hyal-1/DS-2 determined by SDS-
PAGE and MALDI-MS was 54.2 kDa, with the protein component comprising 50.5 kDa and 
the glycosidic component comprising 3.7 kDa. 
The molecular mass of Hyal-1/DS-2 was calculated from the sedimentation equilibrium 
considering a partial specific volume of 0.726 cm³/g, which was calculated from the partial 
specific volume of the protein fraction (0.735 cm³/g) and the carbohydrate fraction (0.610 
cm³/g). Intriguingly, a molecular mass of 93.8 ± 1.3 kDa was determined from the 
sedimentation equilibrium at a protein concentration of 0.5 mg/mL (Fig. 5.20). 
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Fig. 5.20 Sedimentation equilibrium 
observed after 60 h of centrifugation for 
0.5 mg/mL Hyal-1/DS-2 solubilized in 
50 mM Na-phosphate, 0.5 M NaCl, 1 
mM EDTA, pH 6.0. The plot given at 
the bottom shows the difference 
between the experimental data and the 
calculated curve. 
The average molecular mass of 94 kDa indicates the existence of Hyal-1/DS-2 as a dimer. 
The difference between the expected molecular mass of a Hyal-1/DS-2 dimer (108 kDa) and 
the one determined by analytical ultracentrifugation might be a result of the presence of low 
concentrations of monomer in the solution (personal communication by Dr. H. Lilie).  
Unfortunately, the quantification of the average molecular mass in dependence of the protein 
concentration failed presumably due to the presence of low molecular weight compounds in 
the protein sample disturbing the baseline at lower protein concentrations. However, a shift in 
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the molecular weight towards a lower average molecular mass could be observed at 
decreasing protein concentrations indicating the existence of a monomer – dimer equilibrium. 
Determination of the molecular mass by analytical gel filtration was impossible because of 
interference of Hyal-1/DS-2 with the stationary phase resulting in a strongly asymmetric 
elution profile of the enzyme and a shift to longer retention times pretending a lower 
molecular mass (ca. 10 kDa) compared to the molecular weight standard proteins (data not 
shown).  
5.3.6.3. Crystallization experiments 
A variety of crystallization conditions was screened, but mainly resulted in the formation of 
Hyal-1/DS-2 aggregates. Few crystals were obtained, which either consisted merely of salt, 
were unstable during handling (Fig. 5.21.a) or too small for x-ray analysis (Fig. 5.21.b).  
 
Fig. 5.21 Crystals formed during crystallization experiments with Hyal-1/DS-2 in various buffers. 
(Photographed by B. Epler, Institute of Biotechnology, Martin-Luther University Halle-Wittenberg, 
Halle (Saale), Germany). 
 
No significant differences in the formation of crystals were observed for Hyal-1 solubilized in 
the absence and in the presence of Triton X-100. A tendency of crystal formation was found 
to occur under two major conditions: firstly, using 0.2 M calcium chloride hexahydrate, 0.1 M 
Tris, pH 8.5 and precipitating agent PEG 4000 and hexanediol, respectively; secondly using 
0.2 M zinc acetate, 0.1 M sodium cacodylate, pH 6.5 and precipitating agent PEG 8000 and 
PEG 4000, respectively (personal communication by B. Epler). 
Since crystals were inappropriate for x-ray analysis a fine screening of crystallization 
conditions is in progress. 
 
 
 
Results and discussion 
 100
5.3.7. Substrate specificity of Hyal-1/DS-2 
Like all other hyaluronidases known up to date the human hyaluronidases are expected to 
accept not only HA but also other glycosaminoglycans as substrates (Stern and Jedrzejas 
2006). Due to the availability of human hyaluronidases in very low quantities the degradation 
of alternative substrates has never been studied in detail.  
A common alternative substrate recognized by vertebrate hyaluronidases is chondroitin 
sulfate, a polysaccharide consisting of β1→4 linked disaccharide units of sulfated β-D-
GalNAc and β-D-GlcUAc residues linked by β1→3 glycosidic bonds (Fig. 5.22). Chondroitin 
sulfate B, also known as dermatan sulfate, additionally contains β-D-IdoAc instead of β-D-
GlcUAc. 
Chondroitin sulfates are important components of proteoglycans in the human body, e.g. of 
aggrecan, neurocan and brevican, and play an important role in inflammation (Taylor and 
Gallo 2006). They often occur together with HA and are thus accessible for hyaluronidases as 
well. In humans the hyaluronidase Hyal-4 is the only enzyme speculated to be a pure 
chondroitinase (cf. Chapter 1), while the other human hyaluronidases degrade ChS at a much 
slower rate than HA. 
Chondroitin sulfate (ChS) A and C Chondroitin sulfate B (ChS B)
OHOSO3HChS A
OSO3HOHChS C
R2R1
n n
 
Fig. 5.22 Structures of chondroitin sulfate A, B and C. 
 
5.3.7.1. Chondroitinase activity assays 
Due to the high structural similarity between ChS and HA the standard hyaluronidase activity 
assay systems used were tested for their ability to follow the degradation process of ChS. The 
turbidimetric assay is based on the precipitation of high molecular weight (> 6 – 8 kDa) 
hyaluronan fragments with quaternary ammonium salts. Degradation of hyaluronic acid 
results in a decrease in the turbidity (OD), which can be approximated by a linear fit for the 
initial degradation phase (Fig. 5.23). All chondroitin sulfates were found to precipitate with 
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CTAB in the turbidimetric assay, enabling the measurement of ChS degradation by this assay 
procedure.  
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Fig. 5.23 Degradation of ChS C by 
chondroitinase ABC from Proteus 
vulgaris followed in the turbidimetric 
activity assay at 355 nm (incubation 
mixture B, pH 7.0). Inset: degradation 
of hyaluronic acid by BTH followed in 
the turbidimetric activity assay at 580 
nm (incubation mixture B, pH 4.0).  
Yamagata et al. (Yamagata et al. 1968) detected the degradation products of bacterial 
chondroitinases by a colorimetric assay (Morgan-Elson assay). Since no reference substance 
was available for the quantification of the degradation products of ChS, the absorption spectra 
of the Morgan-Elson products originating from the degradation products of ChS A, ChS B 
and ChS C were compared to the spectrum of the Morgan-Elson reaction product formed with 
GlcNAc. 
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Fig. 5.24 Normalized absorption spectra 
of the Morgan-Elson reaction products. 
The following substances were used for 
the Morgan-Elson reaction: GlcNAc 
(black), ChS A degraded by 
chondroitinase ABC (blue), ChS B 
degraded by chondroitinase ABC 
(green) and ChS C degraded by 
chondroitinase ABC (red).  
Although the spectra of the Morgan-Elson products differ at shorter wavelengths (< 570 nm), 
the shape of the maximum at 585 nm, the quantification wavelength of the colorimetric 
activity assay, is nearly identical for all products (Fig. 5.24). Therefore, absorbance values 
determined in the Morgan-Elson assay with different substrates were compared to enable the 
determination of enzymatic activity relative to the activity on the natural substrate, HA, under 
optimum conditions (maximum enzymatic activity). 
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It should be noted, however, that the reaction catalyzed by chondroitinase ABC, the enzyme 
used for these reference measurements, is an elimination reaction creating Δ4,5-unsaturated 
disaccharide units (Yamagata et al. 1968). Human hyaluronidases catabolize HA in a 
hydrolysis reaction creating saturated disaccharide units and are expected to perform a similar 
reaction with the alternative substrates. 
5.3.7.2. pH-dependent degradation of ChS by Hyal-1 
Hyal-1, expressed by DS-2 cells, was tested for its ability to degrade ChS A, B and C at pH 
values 2.0 – 9.0 in the turbidimetric and in the colorimetric activity assay. Based on the 
considerations described above the results were converted into % of maximum enzymatic 
activity, i.e. the activity at the pH optimum of the HA degradation in the respective assay (cf. 
Fig. 5.11) was set as 100 %. 
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Fig. 5.25 pH-dependent degradation of ChS A, B and C by human Hyal-1 expressed in DS-2 cells. 
pH-profiles were measured in the colorimetric activity assay (Morgan-Elson assay, incubation mixture 
B) (a) and in the turbidimetric activity assay (incubation mixture B) (b). 100 % enzymatic activity was 
determined at pH 3.5 with HA used as a substrate. 
 
Both assays revealed the degradation of ChS A by Hyal-1/DS-2, but did not show any 
detectable activity of the enzyme on ChS B and C. Maximum activity on ChS A was 
measured at pH 4.0 with the pH profile closely resembling the pH dependent activity 
determined with HA as a substrate (Fig. 5.11 and Fig. 5.25).  
It should be noted that the relative activities (% of maximum enzymatic activity) in the 
colorimetric assay were significantly lower than the activities determined in the turbidimetric 
assay. This phenomenon was observed for other hyaluronidase derivatives as well and is 
discussed in Chapter 6.  
The recognition of ChS A as a substrate, but not of ChS C, revealed the tolerance of a 
charged, spacious group like the sulfate group in position 4 of the GlcNAc residue, but not in 
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position 6. Furthermore, a change of the position of the carboxylic group of GlcUAc into 
axial position in addition to the sulfate group in position 4 resulted in a complete loss of the 
recognition of the substance as a substrate for Hyal-1/DS-2. Interestingly, the 4-sulfated ChS 
(ChS A) is known to be a worse substrate for all other hyaluronidases than the 6-sulfated 
derivative (ChS C) (Stern and Jedrzejas 2006).  
 
5.4. Summary and conclusions 
In DS-2 cells the human hyaluronidase Hyal-1 was expressed as a long (Hyal-1/L) and short 
variant (Hyal-1/S) into the medium by the use of pMT/Hygro, a special expression vector 
constructed for the selection of cells and expression of recombinant proteins into the medium. 
 
Hyaluronidases have been described in the venoms of arthropods and insects, but in the 
extracellular matrix of D. melanogaster no hyaluronan has been found (Toyoda 2002). 
Furthermore, no sequences with any significant similarity to hyaluronidase genes were found 
in the genome of D. melanogaster. Drosophila Schneider-2 cells are undifferentiated, 
embryonic cells growing at high densities (up to 20 · 106 cells/mL) in serum-free medium 
(Schneider 1972, Deml and Wagner 1998). Both, the absence of endogenous hyaluronidases, 
and the continuous growth at high densities, was well suited for the expression of human 
hyaluronidases.  
While Hyal-1/L was identified as a homogenous, enzymatically active protein of 54 kDa in 
the medium of transiently and stably transfected DS-2 cells, Hyal-1/S with a molecular weight 
of 50 kDa exhibited no enzymatic activity at all. The expression of Hyal-1/L in stably 
transfected DS-2 cells was optimized in respect to the cell culture conditions during induction. 
The maximum activity gained in the cell medium was 450 nmol GlcNAc · min-1 · mL-1 cell 
medium. 
 
Purification of Hyal-1/L was optimized using various column materials and purification steps 
until finally highly pure enzyme (specific activity 8 - 10 U/mg) was obtained after a 
combination of ammonium sulfate precipitation, cation exchange chromatography and Ni-
IMAC. Purification was complicated by the binding of insect cell proteins to the Ni-IMAC 
and the tendency of Hyal-1/L to adhere to surfaces, e.g. column materials and filter 
membranes. Adhesion could be minimized by including a non-ionic detergent, Triton X-100, 
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in the buffer systems. Previous studies also described the necessity of detergents during the 
purification of human Hyal-1 (Frost et al. 1997).  
 
Comparison of Hyal-1, expressed in E. coli (cf. Chapter 4) and in a DS-2 cell system, clearly 
revealed the advantages and problems of each expression system. While the bacterial system 
is definitely the simplest and fastest one to achieve high amounts of protein, insect cells grow 
slower with much lower yields, but produce protein with a glycosylation pattern similar to 
mammalian proteins. Although both expression systems yielded enzymatically active Hyal-1, 
a comparison of yields as well as specific activities clearly shows the superiority of the insect 
cell system (Tab. 5.2).  
 
Tab. 5.2 Comparison of the characteristics of Hyal-1, expressed in a prokaryotic (E. coli) and in a 
eukaryotic (DS-2 cell) system.  
 
Expression system E. coli DS-2 cells 
Time of induction 3 – 4 h 10 – 12 d 
Molecular mass 48 kDa 54 kDa 
Glycosylation none N-glycosylation (4 kDa) 
Total protein yield 
10 mg / g bacterial pellet 
(5 g / 6 L culture volume) 
2.3 µg / mL medium 
(14 mg / 6 L culture volume) 
Active protein yield up to 1.0 mU/mL of folding buffer up to 450 mU/mL of  medium 
Specific activity 0.1 U/mg 8 - 10 U/mg 
 
HA was catabolized by both enzymes, Hyal-1/E. coli and Hyal-1/DS-2, with pH activity 
profiles similar to the one detected with human plasma hyaluronidase (pH optimum 3.5 – 
4.0). However, the absolute activity seems to be influenced by the glycosylation, which is 
only present in Hyal-1, expressed by DS-2 cells. The decrease in activity observed in the 
course of deglycosylation of Hyal-1/DS-2 can be explained either as a consequence of 
increased aggregation or surface adhesion of the enzyme or by a direct effect on the 
enzymatic activity. 
 
The sensitivity of Hyal-1 to NaCl concentrations > 100 mM has been reported previously 
(Gold 1982) and was observed for the recombinant enzymes as well. However, it remains 
unclear if NaCl influences the structure of the substrate, HA, or exerts a direct effect on the 
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enzyme. As the sensitivity of Hyal-1, expressed in E. coli and Hyal-1, expressed in DS-2 
cells, against NaCl differ, it can be assumed that in the relevant concentration range NaCl 
does not significantly affect the structure of HA. Among different metal ions only Cu2+, Fe2+ 
and Fe3+ show significant inhibition of the enzymatic activity of Hyal-1, expressed in DS-2 
cells. The necessity of any common metal ion as co-factor of the enzyme can thus be 
excluded. 
 
An additional feature of Hyal-1/L from both expression systems is its extraordinarily high 
sensitivity towards GdmCl as denaturing agent in contrast to a rather high stability in the 
presence of urea. This observation is in agreement with the phenomena observed during in 
vitro folding of Hyal-1 (cf. Chapter 4). 
Disulfide bridges were shown to influence the activity as well as the electrophoretic mobility 
of Hyal-1/DS-2 on the SDS-PAGE significantly. The appearance of two protein bands 
exhibiting activity against HA on zymography gels could be explained by partial reduction of 
the enzyme in the sample. The purified, recombinant enzyme was proven to contain a single 
N-terminal sequence in contrast to Hyal-1 isolated from urine (Csoka et al. 1997). 
 
Since no crystal structure has been obtained yet, the CD-spectroscopic data represent the first 
experimentally obtained structural information on the human hyaluronidase Hyal-1. The data 
are consistent with the predicted (β/α)7 barrel fold and the structural model reported in 
literature (Jedrzejas and Stern 2005). 
 
Hyal-1, expressed in DS-2 cells, exhibited low activity against ChS A, the 4-sulfated 
chondroitin sulfate derivative, but no activity against the 6-sulfated derivative (ChS C) and 
ChS B. Degradation of ChS A observed in a modified colorimetric and turbidimetric 
hyaluronidase activity assay revealed a similar pH dependency (pH optimum at pH 3.5 – 4.0) 
as detected previously for the degradation of HA.  
 
Taken together, Hyal-1, expressed in DS-2 cells, was found to be superior to Hyal-1, 
expressed in E. coli, and can be used for enzymological studies (cf. Chapter 8), crystallization 
and the development of specific inhibitors.  
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6. Purification and characterization of human PH-20 expressed 
by DS-2 cells 
Chapter 6 
Purification and characterization of human 
PH-20 expressed by DS-2 cells 
 
 
 
6.1. Introduction 
 
PH-20 (sperm adhesion molecule 1, SPAM1) was first described by its function as an egg’s 
zona pellucida binding protein of the sperm before its similarity to BVH revealed its function 
as a hyaluronidase (Gmachl and Kreil 1993).  
On the surface of the sperm head PH-20 is anchored in the membrane (Lathrop et al. 1990, 
Sabeur et al. 1997) and facilitates penetration of the egg through the cumulus extracellular 
matrix (ECM) (for review see Primakoff and Myles 2002). Upon contact with the zona 
pellucida the acrosome reaction is triggered, possibly supported by intracellular signaling, 
mediated by the HA binding region of PH-20 (Cherr et al. 2001). During the acrosome 
reaction PH-20 anchored in the inner acrosomal membrane (IAM) is released and acts as a 
soluble, acid active hyaluronidase (Fig. 6.1) (Hunnicutt et al. 1996, Yudin et al. 2001). 
 
Variations in the molecular weight and in the pH-dependent activity of PH-20 indicate several 
steps of modifications during maturation of the sperm and fertilization: a 2 – 3 kDa reduction 
in the molecular weight of PH-20 was described during maturation in the epididymis (Cherr et 
al. 2001), sperm surface PH-20 shows activity at both acid and neutral pH with maximum 
activity at pH 7.0 (Li et al. 1997, Sabeur et al. 1997), while IAM PH-20 was described to have 
a pH optimum at both neutral and acidic pH (Yudin et al. 2001). Membrane-anchored PH-20 
was described as a 64 kDa protein, which is reduced in its molecular weight by 9 kDa upon 
liberation from the membrane after the acrosome reaction. This soluble, low molecular weight 
form of PH-20 is probably generated by endoproteolytic cleavage of the high molecular 
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weight form, resulting in a shift of the pH optimum of the enzyme towards acid pH values 
(Cherr et al. 1996, Sabeur et al. 1997). The variety of pH optima is assumed to be due to the 
presence of two different regions involved in the catalytic activity of the enzyme (Cherr et al. 
2001).  
IAM PH-20
(acid active)
Nucleus
Sperm
Acrosome
Flagellum
Sperm head
Inner acrosomal
membrane (IAM)
Sperm
surface
PH-20
(neutral 
active)
Acrosome reaction:
release of soluble PH-20
from IAM PH-20
Oocyte
Cytoplasm
Cumulus
ECM
Extracellular matrix (ECM)
Hyaluronic 
acid
(HA)
Zona
pellucida  
Fig. 6.1 Role of PH-20 in fertilization. Membrane-anchored PH-20 is located on the surface of the 
sperm head, exhibiting activity at neutral pH, and in the inner acrosomal membrane (IAM). IAM-
anchored PH-20 is released as a soluble protein after the acrosome reaction was triggered by contact of 
the sperm head with the zona pellucida.  
 
PH-20 was found to be conserved in mouse, bull, macaque and human and was investigated 
in sperm and testicular preparations of different animals. Recently, an additional 
hyaluronidase, Hyal-5, was identified in mouse sperm acting in concert with PH-20 (Kim et 
al. 2005). As this hyaluronidase gene is not present in humans the results from animal studies 
should be interpreted carefully before transferring the results to human PH-20. 
 
Preparations of bovine testicular hyaluronidase (BTH), e.g. Hylase® „Dessau“, Neopermease® 
and Wydase®, were for many years therapeutically applied as spreading factors, degrading the 
glycosaminoglycans of the extracellular matrix (Baumgartner and Moritz 1988, Menzel and 
Farr 1998). A common field of application of BTH is its addition to local anesthetic agents for 
ophthalmic anesthesia, as it is known to improve the rapidity of onset, dispersion, depth and 
duration of the local anesthesia (Kallio et al. 2000). In the course of systemic oncological 
therapies with vinca alkaloids hyaluronidase is the only highly effective antidote to the 
extravasation of these antineoplastic agents, especially vinblastine, as it prevents local 
necrosis by improving the absorption of the paravasate (Albanell and Baselga 2000, Bertelli et 
al. 1994).  
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Replacement of the bovine PH-20 preparations by a recombinant human enzyme for 
therapeutical applications would be preferable in terms of the immune response, the 
homogeneity and the purity of the product. In 2006 the first recombinant human PH-20 
produced in CHO cells was suggested for the enhancement of the interstitial transport of 
therapeutics (Bookbinder et al. 2006) and for the use in in vitro fertilization (Taylor et al. 
2006).  
The following chapter describes the production of human PH-20 by Drosophila Schneider-2 
(DS-2) cells for enzymological studies and the development of specific inhibitors. The pH-
dependent activity of human PH-20 towards different GAGs was compared to BTH.  
 
6.2. Materials and Methods 
6.2.1. Materials and chemicals 
For subcloning all materials were purchased from the same suppliers as described in Chapter 
3. Drosophila Schneider-2 cells (DS-2 cells), pCoHygro and pMT/BiP/V5-HisA were kindly 
provided by V. Runza (Institute of Immunology, Faculty of Medicine, University of 
Regensburg, Germany). Hyaluronic acid from Streptococcus zooepidemicus was purchased 
from Aqua Biochem GmbH, Dessau, Germany. Chondroitin 4-sulfate (A) from bovine 
trachea, chondroitin 6-sulphate (C) from shark cartilage and chondroitin sulfate B from 
porcine intestinal mucosa were purchased from Sigma, Munich, Germany. ChS A and ChS C 
contained impurities of the respective other GAG of up to 30 % as indicated by the supplier. 
Triton X-100 was from Roth, Karlsruhe, Germany. Hygromycin was from A.G. Scientific 
Inc., San Diego, USA. All other chemicals were of HPLC or analytical grade and were 
purchased from Merck, Darmstadt, Germany.  
6.2.2. Construction of the expression vector pMT/Hygro/ph-20 
Human ph-20 cDNA was amplified by PCR from the I.M.A.G.E. clone vector 
IMAGp998N2310771 using 5’-ACGCCTAGATCTCTGAATTTCAG-3’ as forward primer 
generating an additional BglII cleavage site and 5’-TAAATTGGGCCCAGATAGTGTGGA-
3’ as reverse primer with an additional ApaI cleavage site. Amplification was achieved after 
30 cycles with an annealing temperature of 53 °C in the presence of 3.0 mM MgSO4. Both, 
the PCR product and the vector pMT/Hygro (cf. Chapter 5), were digested with ApaI and 
BglII. The insert restriction digest mixture contained 40 µl of purified PCR product, 2 µL of 
ApaI and 4.7 of µL TANGOTM buffer (Fermentas, St. Leon-Rot, Germany). After incubation 
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for 1 h at 37 °C, 5.2 µL of TANGOTM buffer and 1 µL of BglII were added, and the mixture 
was incubated for 3 h at 37 °C. For digestion of the vector 1 µL of pMT/Hygro (1 mg/mL) 
were incubated with 2 µL of ApaI, 2 µL of TANGOTM buffer and 15 µL of water for 1 h at 37 
°C. Then, 2.5 µL of TANGOTM buffer and 1 µL of BglII were added, and the mixture was 
incubated for 3 h at 37 °C. Additionally, the vector was dephosphorylated (cf. Chapter 3). 
Restriction enzymes and the phosphatase were inactivated by heating at 80 °C for 20 min. 
After ligation and transformation of pMT/Hygro/ph-20 into E. coli Top10 the insertion was 
confirmed by sequencing (Entelechon, Regensburg, Germany) using a T7 promoter primer 
and a BGH primer. If not otherwise indicated all cloning procedures were performed as 
described in Chapter 3.  
6.2.3. Expression of PH-20 by Drosophila Schneider-2 cells (DS-2 cells) 
DS-2 cells were cultured as described in Chapter 5. DS-2 wildtype cells were transfected with 
pMT/Hygro/ph-20 using Lipofectamin™ (Invitrogen, Karlsruhe, Germany) and FuGENE® 6 
(Roche Applied Sciences, Mannheim, Germany) as transfection reagents. Transient and stable 
expression of PH-20 was performed as described for Hyal-1 (Chapter 5). 
Aliquots of the medium were taken 3 and 10 d after induction, and the medium was directly 
used for determination of hyaluronidase activity.  
6.2.4. Purification of PH-20 from the medium of stably transfected DS-2 cells 
The cell-free medium was supplemented with 0.1 % (v/v) Triton X-100, and the pH was 
carefully adjusted to 6.7. Before loading the column, the sample was clarified completely by 
centrifugation (30 min, 8,000 g, 4 °C). PH-20 containing a C-terminal His-tag was bound via 
the Cu2+ ions present in the medium to a HiTrap® Chelating Column (CV 5 ml, GE 
Healthcare Bio-Sciences AB, Uppsala, Sweden) equilibrated in 50 mM Na-phosphate, 0.5 M 
NaCl, 0.1 % (v/v) Triton X-100, pH 6.5. After application of the sample the column was 
washed with 2 CV of equilibration buffer before PH-20 was eluted with 6 CV of 50 mM Na-
phosphate, 0.5 M NaCl, 0.1 % (v/v) Triton X-100, pH 4.5. Fractions of 1 mL were collected 
and analyzed for their protein content and their enzymatic activity.  
All buffers used during the purification process were vacuum-degassed and filtrated through a 
0.45 µm filter (Millipore, Eschborn, Germany).    
6.2.5. SDS-PAGE, Western blot and zymography 
SDS-PAGE, Western blot and zymography were performed as described in Chapter 3 and 
Chapter 5, respectively. For zymography McIlvaine’s buffer, pH 4.0, was used as an 
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incubation buffer. McIlvaine’s buffer was adjusted to the desired pH by mixing solution A 
(0.2 M Na2HPO4, 0.1 M NaCl) and solution B (0.1 M citric acid, 0.1 M NaCl).  
6.2.6. Detection of glycoproteins by PAS staining 
For detection of glycoproteins SDS-PA gels were stained by the periodic acid – Schiff (PAS) 
technique with Schiff’s reagent purchased from Sigma, Munich, Germany, following the 
procedure described by Zacharius et al. (Zacharius et al. 1969). Samples were prepared as 
described in Chapter 5. 
6.2.7. Colorimetric hyaluronidase activity assay (Morgan-Elson assay) 
The assay was performed as described in Chapter 4. The following incubation mixture was 
used: 150 µL of water, 100 µL of BSA solution (0.2 mg/mL), 100 µL of McIlvaine’s buffer of 
various pH (cf. 6.2.5), 50 µL of HA solution (5 mg/mL), 50 µL of sample. 
When chondroitin sulfate derivatives were used as substrates, HA was exchanged with an 
equal volume of chondroitin sulfate solution (5 mg/mL). 
6.2.8. Turbidimetric hyaluronidase activity assay 
The assay was performed as described in Chapter 3. The turbidity was detected at 355 nm. 
When chondroitin sulfate derivatives were used as substrates, HA was exchanged against an 
equal volume of a chondroitin sulfate solution (2 mg/mL). 
 
6.3. Results 
6.3.1. Construction of the expression vector pMT/Hygro/ph-20 
As PH-20 is primarily a membrane-anchored, extracellular protein it was truncated at its N- 
and C-terminus to yield a soluble protein, which is secreted by the insect cells into the culture 
medium.  
kb ph-20
3.0
2.0
1.5
1.2
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Fig. 6.2 Agarose gel electrophoresis of the PCR 
amplification product of ph-20 with the expected length of 
1.40 kb. The gel was loaded with 10 µl of PCR product and 
2 µl of 10 x PCR loading buffer.  
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At the N-terminus the human signal peptide was replaced with the BiP signal sequence 
encoded on pMT/Hygro. At the C-terminus the GPI-anchoring signal peptide comprising aa 
492-512 was excluded from the PCR amplification product (Fig. 6.2). Thus, pMT/Hygro/ph-
20 coded for a 502 aa precursor protein with a C-terminal V5 epitope and a His-tag (Fig. 6.3 
and Appendix 2).  
native PH-20
(512 aa)
PH-20/DS-2
(502 aa)
H2N COOH
signal peptide catalytic domain
H2N COOH
insect cell
signal peptide V5  5xHis
zona pellucida
binding domain
GPI-anchoring
signal
 
Fig. 6.3 Schematic view of the primary structure of native human PH-20 (above) and recombinant 
human PH-20 expressed by DS-2 cells (below). Black boxes indicate the presence of C residues 
presumably all linked by disulfide bridges. 
 
Due to the absence of activity in the truncated form of Hyal-1 (Hyal-1/S, cf. Chapter 5) PH-20 
was merely expressed as a full length protein including both the catalytic and the zona 
pellucida binding region. Previous experiments by Arming et al. with PH-20 expressed in 
HeLa cells had shown that a C-terminal truncation of 133 aa, i.e. the GPI-anchoring signal 
and the zona pellucida binding region, resulted in a complete loss of activity (Arming et al. 
1997). 
 
6.3.2. Expression of PH-20 in DS-2 cells 
DS-2 wildtype cells were transfected with pMT/Hygro/ph-20 using varying DNA/transfection 
reagent ratios. As observed previously for the transfection of DS-2 cells with 
pMT/Hygro/hyal-1, the activity in the medium after transient expression of PH-20 was much 
lower than after stable expression.  
Passaging of transfected DS-2 cells for several weeks in the presence of hygromycin resulted 
in the stable integration of the expression vector into the genome. Expression of PH-20 was 
confirmed after 3 and 10 d of growth in the absence and in the presence of the inducing agent 
CuSO4 by Western blot analysis (Fig. 6.4) and the detection of enzymatic activity in the 
culture medium (Fig. 6.5). 
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Fig. 6.4 Western blot analysis of DS-2 cell 
medium from wild type cells (Wt), DS-
2/pMT/Hygro/ph-20 cells in the absence (-CuSO4) 
and in the presence (+CuSO4) of CuSO4 as inducer. 
Each lane contained 30 µl of medium after 10 d of 
induction. Anti-V5-IgG was used as primary 
antibody, biotinylated anti-mouse-IgG as 
secondary antibody and detection of the antibody 
binding was achieved by HRP/DAB staining.  
Recombinant PH-20 was detected by the use of an anti-V5-antibody in the medium of both, 
induced and uninduced cells, as single band of ca. 60 kDa. However, a quantitative 
comparison of the expression rates and the exact calculation of the molecular weight were 
impossible in the Western blot. 
Therefore, the enzymatic activity of PH-20 was determined in a colorimetric hyaluronidase 
activity assay at acid and neutral pH (Fig. 6.5) revealing a superior hyaluronidase activity at 
acidic pH.  
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Fig. 6.5 Hyaluronidase activity in the medium of DS-2 cells, stably transfected with pMT/Hygro/ph-
20. DS-2 wildtype cells induced with CuSO4 were used as a control (Wt), the medium of transfected 
cells was analyzed in the presence (+CuSO4) and in the absence of CuSO4 (-CuSO4). Enzymatic 
activity was determined in the colorimetric activity assay at pH 4.0 (left panel) and pH 7.0 (right 
panel) 3 and 10 d after induction of expression.  
 
The expression of catalytically active PH-20 was found to increase significantly with 
prolongued cell growth. Induction of expression with CuSO4 caused a 1.7fold increase in the 
yield of enzymatic activity 10 d after induction, i.e. at the time of harvesting of the culture 
medium.    
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6.3.3. Purification of PH-20 by chelating IMAC 
Purification of recombinant human PH-20 from the medium of stably transfected DS-2 cells 
was achieved by chelating IMAC. The His-tagged, recombinant protein was bound to 
chelating column material employing the Cu2+ ions present in the medium for the induction of 
the metallothionein promoter. Elution was achieved by a decrease in pH to pH-value of 4.5 
for at least 6 CV due to a strong binding affinity of PH-20 to the column material (Fig. 6.6). 
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Fig. 6.6 Purification of PH-20 from the medium of stably transfected DS-2 cells 10 d after induction 
of expression with CuSO4. Chelating IMAC (a) was monitored by the absorbance at 280 nm (solid, 
blue line) and by the determination of hyaluronidase activity of the fractions in the colorimetric 
activity assay (black circles). The decrease in pH at the beginning of the elution of the protein is 
indicated by the red line. The SDS-PAGE (b) shows the culture medium before application to the 
column (A), the flow-through (B) and the concentrated elute comprising volume 45 – 53 mL (C).  
 
Measurement of the enzymatic activity at pH 4.0 showed that 91 % of the recombinant PH-20 
present in the medium were bound to the column. 127 % of the bound activity was eluted, 
indicating an increase in the enzymatic activity after purification. The specific enzymatic 
activity determined in the colorimetric activity assay after purification was 0.5 U/mg, which 
was 16-fold higher than in the medium. SDS-PAGE analysis after purification revealed a 56 
kDa protein as the major protein present in the chelating IMAC elute (Fig. 6.6.b), differing 
only marginally from the molecular weight calculated from the amino acid sequence of PH-20 
(55 kDa). Some impurities of lower molecular weight were detected, but zymography 
revealed the existence of only one catalytically active fraction (ca. 60 kDa) in the medium of 
DS-2 cells expressing PH-20 (6.3.5). The yield of PH-20 with a specific activity of 0.5 U/mg 
was ca. 2 µg/mL of culture medium.  
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Thus, the specific activity of recombinant human PH-20 was ca. 10-fold lower than the 
activity of BTH (Neopermease®: 50,000 IE/mg referring to 5 U/mg, according to the 
supplier). This discrepancy is probably due to a lower degree of purification of PH-20 
compared to BTH. Furthermore, the removal of the GPI-anchoring signal could cause a 
decrease in the enzymatic activity as described for the C-terminally truncated forms of PH-20 
by Arming et al. (Arming et al. 1997). 
 
6.3.4. Analysis of protein glycosylation 
As the calculated molecular weight of PH-20 expressed in DS-2 cells was very similar to the 
molecular weight determined experimentally (cf. 6.3.3), the protein was checked for the 
presence of glycosidic residues by PAS staining (Fig. 6.7). The amino acid sequence of PH-
20 contains seven potential N-glycosylation sites (cf. Chapter 1). 
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Fig. 6.7 Analysis of the glycosylation of 
BTH and human PH-20 by PAS staining 
(A) of a SDS-PA gel. For comparison the 
same samples were also stained with 
Coomassie to visualize the protein 
components (B). 
Out of the three catalytically active fractions of BTH (Hoechstetter 2005) only the 77 kDa and 
the 58 kDa fraction showed a reaction with PAS. The 33 kDa fraction is not glycosylated as 
described previously. Human PH-20, expressed by DS-2 cells, was found to be glycosylated, 
however, the glycosylation seems to have only minor influence on the molecular weight.  
 
6.3.5. Stability towards reducing agents 
To investigate the presence of disulfide bridges in PH-20 and the stability of the protein, the 
activity of PH-20 was determined by zymography under different conditions. Obviously, PH-
20 was expressed as a single protein exhibiting a molecular weight of ca. 60 kDa in the 
absence of DTT on the SDS-PA gel (Fig. 6.8).  
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Fig. 6.8 Zymography of human PH-20 
expressed by DS-2 cells in the presence (+) 
and in the absence of reducing agents (-). 
Samples contained the culture medium of 
DS-2 cells collected 10 d after the induction 
of PH-20 expression. All samples were 
mixed with SDS sample buffer with or 
without DTT to achieve a final SDS 
concentration of 2 % and boiled for the time 
periods indicated on top of each lane. The 
gel was stained with Alcian blue and 
Coomassie. 
 
The presence of disulfide bridges seems to be essential for the activity of PH-20 since the 
catalytic activity was lost even without boiling of the sample. When the disulfide bridges 
were present in the protein, PH-20 regained enzymatic activity even after boiling for 20 min 
with 2 % SDS (Fig. 6.8).  
 
6.3.6. pH-dependent hyaluronidase activity of PH-20 in comparison to BTH 
Previous experiments in our laboratory had revealed a difference in the pH activity profiles of 
BTH in dependence on the type of activity assay (Hoechstetter 2005) (Fig. 6.9.a). Therefore, 
it was of interest to investigate the pH profiles of recombinant human PH-20. As shown in 
Fig. 6.9.b the pH dependent degradation of HA by human PH-20 exhibited a maximum 
located at neutral pH (pH 5.5) in the turbidimetric assay, while this maximum was shifted to 
acidic pH (pH 4.5) in the colorimetric assay. Thus, the resulting pH profiles of human PH-20 
were similar to the profiles of bovine PH-20 (BTH) with respect to the inverse shape of the 
profiles and the location of the maxima.  
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Fig. 6.9 pH activity profiles of BTH (a) and human PH-20 expressed by DS-2 cells (b) determined in 
the colorimetric activity assay (white squares) and in the turbidimetric activity assay (black circles).  
* The pH profile of BTH was adopted from Hoechstetter 2005. 
Chapter 6 Purification and characterization of human PH-20 expressed by DS-2 cells 
 119
The difference between the activity maxima in the turbidimetric and in the colorimetric assay 
was more pronounced for BTH than for human PH-20 (Tab. 6.1). A possible explanation 
could be the presence of three different active species in BTH with different activity profiles 
(Oettl et al. 2003, Hoechstetter 2005), while human PH-20 expressed in DS-2 cells was 
merely a single active species in the zymographic analysis (Fig. 6.8). 
 
Tab. 6.1 pH of maximum activity of bovine and human PH-20, determined in the colorimetric and in 
the turbidimetric hyaluronidase activity assay. 
 
 Bovine PH-20 (BTH) Human PH-20/DS-2 
Colorimetric assay pH 3.5 pH 4.5 
Turbidimetric assay pH 5.5 – 6.0 pH 5.5 
 
The phenomenon of the inverse pH profiles was discussed in detail by Hoechstetter 
(Hoechstetter 2005). The existence of inverse pH profiles for human PH-20 indicates 
variations in the catalytic process with respect to high and low molecular weight HA 
fragments at acidic and neutral pH. A thorough discussion of the differences between the 
enzymatic reactions at acidic and neutral pH is given in Chapter 8. 
 
6.3.7. pH-dependent degradation of ChS by PH-20 and BTH 
As described in Chapter 5 the colorimetric and the turbidimetric hyaluronidase activity assays 
were both found to be suitable for the determination of chondroitin sulfate degradation. To 
investigate the substrate specificities of the enzyme preparations the pH-dependent activities 
of BTH and human PH-20 on chondroitin sulfate derivatives were measured in both assay 
systems.  
BTH degraded ChS A and ChS C at a pH range from pH 3.5 to 7.0 with a maximum in 
enzymatic activity at pH 5.5 for ChS C degradation and at pH 4.0 – 5.0 for ChS A 
degradation. ChS B was not degraded by BTH (Fig. 6.10). Both assay systems showed very 
similar results concerning the pH dependency of the degradation, but the relative enzymatic 
activity determined at each pH value varied significantly: in the turbidimetric assay the 
relative enzymatic activity was generally about twice as high as in the colorimetric assay. 
This phenomenon was also observed for the degradation of ChS degradation by Hyal-1 
(Chapter 5) and human PH-20 (see below).  
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Fig. 6.10 pH-dependent degradation of chondroitin sulfates by BTH determined in the colorimetric (a) 
and in the turbidimetric activity assay (b). 100 % enzymatic activity was determined with HA as 
substrate at pH 3.5 in the colorimetric assay and at pH 5.5 in the turbidimetric assay, respectively. 
 
Recombinant human PH-20 was compared to BTH with respect to its pH-dependent 
degradation of ChS A and ChS C (Fig. 6.11). ChS B was excluded from the experiments with 
PH-20 due to the absence of any catalytic activity of BTH towards this chondroitin sulfate 
derivative. ChS B, also known as dermatan sulfate, differs from ChS A merely in the 
exchange of GlcUAc against IdoUAc. This change in the position of the carboxyl group 
(equatorial in GlcUAc, axial in IdoUAc) seems to disturb the recognition of the substrate 
essentially, i.e. no degradation occurs.  
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Fig. 6.11 pH-dependent degradation of chondroitin sulfates by recombinant human PH-20 determined 
in the colorimetric (a) and in the turbidimetric activity assay (b). 100 % enzymatic activity was 
determined with HA as a substrate at pH 4.5 in the colorimetric assay and at pH 5.5 in the 
turbidimetric assay, respectively. 
 
In contrast to the substrate specificity of BTH, ChS A was a better substrate for recombinant 
human PH-20 than ChS C. The pH-optima were generally narrower than those measured with 
Chapter 6 Purification and characterization of human PH-20 expressed by DS-2 cells 
 121
BTH. However, the pH-optima were also in the range between pH 5.0 and 6.0. A 2-fold 
increase in the relative enzymatic activity values determined in the turbidimetric assay 
compared to the values calculated from the colorimetric assay was also found for PH-20. 
This difference in the two assay systems was independent of the type of hyaluronidase and of 
the type of substrate used (cf. Chapter 5), indicating a general phenomenon in the degradation 
of these alternative substrates. 
The main difference between the colorimetric and the turbidimetric assay is the fact, that in 
the turbidimetric assay only the degradation of high molecular weight substrate molecules (> 
8 kDa) is detected, while the colorimetric assay is independent of fragment size. Thus, if the 
turbidimetric assay yields higher relative enzymatic activities than the colorimetric assay, this 
is indicative for a faster degradation of high molecular weight substrates compared to smaller 
substrate molecules with molecular weights, which are not precipitated in the turbidimetric 
assay. 
 
6.4. Summary and conclusions 
Human PH-20 was expressed by DS-2 cells as a soluble protein with a molecular weight of 56 
kDa. The protein was glycosylated, however, the molecular weight differed only by about 1 
kDa from the molecular weight calculated from the amino acid sequence.  
Although human PH-20, expressed on the surface of HeLa cells, was reported to be 
glycosylated to a higher higher degree (65 kDa) (Arming et al. 1997), PH-20, expressed by 
DS-2 cells, was catalytically active. Thus, the presence of glycosidic modifications seems to 
be essential to gain enzymatically active PH-20 (cf. Chapter 4), but the exact pattern of 
glycosylation seems to be of minor importance. Similar results were previously obtained with 
Hyal-1 (cf. Chapter 5), indicating a role of N-linked glycans in the stability or solubility of 
human hyaluronidases.  
In accordance with the data on macaque sperm PH-20 reported in literature (Li et al. 1997), 
the activity of recombinant human PH-20 was completely eliminated after reduction of the 
disulfide bridges. Otherwise, the protein exhibited a high stability even after extended periods 
of boiling. 
 
A comparison of PH-20, expressed in DS-2 cells, to BTH revealed a similar pH-dependent 
degradation of HA with the typically inverse pH profiles in the colorimetric and in the 
turbidimetric hyaluronidase activity assay (Hoechstetter 2005). The alternative substrates ChS 
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A and ChS C were degraded to a much lower extent by BTH and recombinant human PH-20 
than HA with a pH optimum at pH 5.0 – 6.0. Surprisingly, PH-20, expressed by DS-2 cells, 
showed a higher activity towards ChS A, while BTH degraded ChS C more efficiently than 
ChS A. As the sequence identity of human and bovine PH-20 is rather high (65 %), a possible 
explanation for the differing behavior towards ChS A and ChS C might be the presence of 
three catalytically active protein fractions in BTH, each exhibiting an unknown activity 
against the chondroitin sulfates.  
Furthermore, the determination of the pH-dependent activity against chondroitin sulfates 
indicated a preferential degradation of higher molecular weight chondroitin sulfates.  
 
Taken together, recombinant human PH-20 exhibited a similar catalytic behavior against HA, 
but differed in its activity against alternative substrates compared to BTH. PH-20, expressed 
in DS-2 cells, was not purified to homogeneity, but the achieved purity was sufficient for the 
development of specific inhibitors and the characterization of catalytic properties (cf. Chapter 
8). 
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7. Characterization of human Hyal-2 expressed by DS-2 cells 
 
Chapter 7 
Characterization of human hyaluronidase 
Hyal-2 expressed by DS-2 cells 
 
 
 
7.1. Introduction 
 
Hyal-2, formerly termed LUCA-2 (Wei et al. 1996), was first described by Lepperdinger et al. 
(Lepperdinger et al. 1998) as an acid-active, lysosomal hyaluronidase present in all tissues 
except brain. However, since then, the few publications on the localization and catalytic 
activity of Hyal-2 have been rather inconsistent.  
 
Hyal-2 was found as a GPI-anchored protein on the surface of some cultured cells (Rai et al. 
2001, Müllegger and Lepperdinger 2002b, Miller 2003), but was also located intracellularly 
in lysosomes (Lepperdinger et al. 1998, Chow et al. 2006a, Chow et al. 2006b). It was 
identified as the cell surface receptor for Jaagsiekte sheep retrovirus (JSRV) (Miller 2003) 
and was suggested to be responsible for the strong oncogenic potential of the retrovirus, 
which, itself, contains no oncogenes (Rai et al. 2001, Liu et al. 2003). While Lepperdinger et 
al. speculated that Hyal-2 might be targeted to lysosomes by re-uptake of formerly 
membrane-anchored Hyal-2 (Lepperdinger et al. 2001), Chow et al. suggested the localization 
of Hyal-2 primarily in lysosomes with a fraction of the expressed protein being transferred to 
a membrane-anchor and occurring at the cell surface (Chow et al. 2006b).  
 
Data about the catalytic activity of Hyal-2 are even more contradictory. Hyal-2 was described 
to degrade high molecular weight HA from different sources to fragments of ca. 20 kDa 
(Lepperdinger et al. 1998, Lepperdinger et al. 2001), but also to low molecular weight HA 
fragments, albeit at a much slower rate (Vigdorovich et al. 2005). The detected hyaluronidase 
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activity was considerably lower than the activity of other hyaluronidases (PH-20, Hyal-1), and 
some authors could not detect any hyaluronidase activity at all (Rai et al. 2001). Degradation 
of HA by Hyal-2 was observed at pH 3.5 – 4.0 (Lepperdinger et al. 1998, Chow et al. 2006a), 
but was also described at nearly neutral pH (Müllegger and Lepperdinger 2002a, Vigdorovich 
et al. 2005).  
The variety of properties described for Hyal-2 possibly results from interferences with 
intrinsic hyaluronidases present in many cell types (Lepperdinger et al. 1998, Rai et al. 2001). 
Detection of the extremely low Hyal-2 activity might therefore be a problem in transfected 
cells. Moreover, the detected activity of Hyal-2 seems to be species as well as tissue specific 
due to a differential distribution of Hyal-2 (intracellular and membrane-anchored).  
 
Due to the absence of hyaluronan (Toyoda 2002) and hyaluronidase-like genes in Drosophila 
melanogaster, DS-2 cells present a suitable system for the production of Hyal-2. Hyal-2 was 
expressed as a soluble protein in the medium of DS-2 cells by analogy with PH-20 (cf. 
Chapter 6) since the aim of this study was the characterization of the catalytic properties of 
Hyal-2 and the supply of the enzyme for inhibitor assays.  
 
A variety of hyaluronidase assays has been developed over the years ranging from the 
classical methods (Meyer and Rapport 1952) to electrophoretic (Guntenhoner et al. 1992, Mio 
et al. 2001), chromatographic (Cramer et al. 1994, Vercruysse et al. 1994), fluorescent (Krupa 
et al. 2003, Nagata et al. 2004) and ELISA-like assays (Stern and Stern 1992, Nawy et al. 
2001). The classical methods comprise biological techniques like the observation of the 
“spreading effect” of a dye in the tissue of animals (Meyer and Rapport 1952), chemical 
methods including the colorimetric activity assay (Morgan-Elson assay) (Reissig et al. 1955, 
Takahashi et al. 2003) and physicochemical methods. Viscosimetric (Vercruysse 1995) and 
turbidimetric activity assays (Di Ferrante 1956) utilize changes in the physicochemical 
properties of HA dependent on the chain length for the detection of hyaluronidase activity.  
Since the detection of Hyal-2 activity is complicated by its unusual substrate specificity 
described in literature (Lepperdinger et al. 2001), a range of activity assays (colorimetric, 
turbidimetric, viscosimetric assays, electrophoretic techniques) was applied to detect the 
activity of Hyal-2 expressed in DS-2 cells. 
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7.2. Materials and Methods 
7.2.1. Vectors, cells, enzymes and chemicals 
Drosophila Schneider-2 cells (DS-2 cells), pCoHygro and pMT/BiP/V5-HisA were kindly 
provided by V. Runza (Institute of Immunology, Faculty of Medicine, University of 
Regensburg, Germany). Materials for subcloning were described in Chapter 3, materials used 
for DS-2 cell culture, protein expression and purification were identical to those described in 
Chapter 5. 
Hyaluronic acid from S. zooepidemicus was purchased from Aqua Biochem GmbH, Dessau, 
Germany, HA from umbilical cord from Serva, Heidelberg, Germany. BTH (Neopermease®) 
was a gift from Sanabo, Vienna, Austria. Chondroitin 4-sulfate (A) from bovine trachea and 
chondroitin 6-sulfate (C) from shark cartilage were from Sigma, Munich, Germany. All other 
chemicals were from Merck, Darmstadt, Germany. 
7.2.2. Construction of the expression vector pMT/Hygro/hyal-2 
Human hyal-2 cDNA was amplified by PCR from the IMAGE clone vector 
IMAGp958H01139Q2 using 5’-TACTACCCGGGATGGAGCTCAAGCCCAC-3’ as 
forward primer generating an additional SmaI cleavage site and 5’- 
TTAACTAAGCGGCCGCCCTCCAGCTGCC-3’ as reverse primer with an additional NotI 
cleavage site. Amplification was achieved after 30 cycles and an annealing temperature of 77 
°C in the presence of 2.5 mM MgSO4. Both, the PCR product and the vector pMT/Hygro (cf. 
Chapter 5), were cleaved sequentially with SmaI and NotI. The insert restriction digest 
mixture contained 40 µL of purified PCR product, 1 µL of SmaI and 4.5 µL of TANGOTM 
buffer (Fermentas, St. Leon-Rot, Germany). After an incubation time of 2 h at 30 °C 5.2 µL 
of TANGOTM buffer and 2 µL of NotI were added and the mixture was incubated for 2 h at 37 
°C. For digestion of the vector 1 µL of pMT/Hygro (1.0 mg/mL) was incubated with 1 µL of 
SmaI, 2 µL of TANGOTM buffer and 16 µL of water for 1 h at 30 °C. Then 2.5 µL of 
TANGOTM buffer and 2 µL of NotI were added and the mixture was incubated for 1 h at 37 
°C. The vector was additionally dephosphorylated (cf. Chapter 3). Restriction enzymes and 
the phosphatase were inactivated by heating at 80 °C for 20 min. After ligation and 
transformation of pMT/Hygro/hyal-2 into E. coli Top10 the insertion was confirmed by 
sequencing using a T7 promoter primer and a BGH primer. 
If not indicated otherwise all cloning procedures were performed as described in Chapter 3.  
Materials and Methods 
 128
7.2.3. Tranfection of DS-2 cells with pMT/Hygro/hyal-2 and expression of Hyal-2 
DS-2 cells were cultivated and transfected with pMT/Hygro/hyal-2 as described previously 
for Hyal-1 (Chapter 5) using LipofectaminTM 2000 CD (Invitrogen, Karlsruhe, Germany) as 
transfection reagent. Hyal-2 was expressed in DS-2 cells according to the protocol for Hyal-1 
expression described in Chapter 5. 
7.2.4. Western blot 
Principally, the protocol described in Chapter 4 was followed for the preparation of Western 
blots. Anti-V5-IgG (Sigma-Aldrich, Munich, Germany) diluted 2000-fold in 10 mL washing 
buffer was used as primary antibody and the secondary antibody was identical to the one used 
in Chapter 4. 
For analysis of HA binding properties native PA-gels were prepared by analogy with the 
procedure for the preparation of SDS-PA gels, but without SDS. To achieve gel retardation 
the gels were supplemented with 67 µg/mL of HA. All gels were used for Western blotting 
after electrophoresis. DS-2 cell medium samples were mixed with 0.2 volumes of 5 x SDS 
sample buffer without DTT (cf. Chapter 3). Some samples were mixed with 5 x SDS sample 
buffer without SDS and DTT.   
7.2.5. Purification of Hyal-2 by Ni-IMAC 
DS-2/pMT/Hygro/hyal-2 cells were incubated for 10 d at 27 ± 1 °C and 135 rpm with an 
initial cell density of 1.5 · 106 cells/mL. The cell-free medium was supplemented with 0.1 % 
(v/v) Triton X-100, 20 mM imidazole and the pH was carefully adjusted to pH 7.8. Before 
application to the column the sample was clarified completely by centrifugation (30 min, 4 
°C, 8,000 g). Hyal-2 containing a C-terminal His-tag was bound to a Ni-IMAC Column (CV 5 
mL, GE Healthcare Bio-sciences AB, Uppsala, Sweden) equilibrated in 50 mM Na-
phosphate, 0.5 M NaCl, 0.1 % (v/v) Triton X-100, pH 7.8. After loading the column was 
washed with 2 CV equilibration buffer before Hyal-2 was eluted with 1 CV of 50 mM Na-
phosphate, 0.5 M NaCl, 0.1 % (v/v) Triton X-100, pH 4.5 and with 1 CV of 50 mM Na-
phosphate, 0.5 M NaCl, 0.1 % (v/v) Triton X-100, pH 3.5. Fractions of 1 mL were collected 
and analyzed for their protein content (Bradford assays, cf. Chapter 4) and their enzymatic 
activity.  
All buffers used during the purification process were vacuum-degassed and filtrated through a 
0.45 µm filter (Millipore, Eschborn, Germany).    
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7.2.6. Turbidimetric and colorimetric hyaluronidase activity assay 
The turbidimetric and colorimetric hyaluronidase activity assays were described in detail in 
Chapter 3 and 4, respectively. For determination of BTH activity McIlvaine’s buffer, pH 4.0, 
was used as an incubation buffer, for examination of Hyal-2 activities McIlvaine’s buffer, pH 
4.0 – 7.0, and 0.1 M Na-formate/formic acid, 0.1 M NaCl, pH 3.5, were used. If indicated the 
buffers were also used in absence of NaCl.  
7.2.7. Agarose gel electrophoresis of hyaluronic acid (HA) 
HA digestion mixtures were analyzed by agarose gel electrophoresis as described previously 
(Rai et al. 2001, Vigdorovich et al. 2005). In brief, incubation mixtures were prepared 
consisting of 25 µL of HA solution (5 mg/mL), 10 µL of BSA (0.2 mg/mL), 10 µL of 
incubation buffer and 10 µL of sample. After incubation for 24 h and 5 d, respectively, at 37 
°C the samples were mixed with 10 µL of HA loading buffer (40 mM Tris/HOAc, 1 mM 
EDTA, pH 8.0, 85 % (v/v) glycerol). 30 µL of these samples were immediately loaded on a 
0.5 % agarose gel (for preparation cf. Chapter 3). Electrophoresis was performed with ca. 20 
mA for 4 h. Then the gel was stained for 1 – 2 h in 0.5 % (w/v) Alcian blue in 7 % HOAc, pH 
2.5, and subsequently destained by incubation with 7 % HOAc until bands of hyaluronic acid 
became visible.  
Gels were analyzed with a Bio-Rad gel detection system (GS-710 Imaging Densitometer) 
using a “Stains All” filter set and Quantity One quantification software, version 4.0.3. 
(Biorad, Munich, Germany). GeneRulerTM DNA Ladder Mix (Fermentas, St. Leon-Rot, 
Germany) was used as molecular weight marker and was visualized after incubation of the 
agarose gel slice containing the marker in 1 x TBE (cf. Chapter 3) supplemented with 1 
µg/mL ethidium bromide. DNA bands were detected as described in Chapter 3. The number 
of base pairs of the DNA marker was converted into Da (1 bp = 660 Da). 
7.2.8. Pulsed field gel electrophoresis (PFGE) 
Pulsed field gel electrophoresis (PFGE) was performed in a Bio-Rad electrophoresis chamber 
(Bio-Rad, Munich, Germany) using 0.5 x TBE buffer (cf. Chapter 3) and a 0.5 % (w/v) 
agarose gel. Samples were prepared in twice the volume described in 7.2.7 and 90 µl of each 
sample were applied to the gel. As DNA standards a mixture of phage lambda DNA and 
GeneRulerTM DNA Ladder Mix (Fermentas, St. Leon-Rot, Germany) was used. 
Electrophoresis was performed by a clamped-homogeneous-electric-field technique for 10.5 h 
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at 4 °C and 6 V/cm with an automatic program adapted for DNA fragments of 2 – 100 kb. 
The initial switch time was 0.1 s and the final switch time 21.8 s at a switching angle of 120 °.  
7.2.9. Viscosimetric detection of HA degradation 
Based on the official method for standardization of hyaluronidase preparations (European 
Pharmacopoeia, 2002) the hyaluronidase activity was measured as described by Hoechstetter 
(Hoechstetter 2005) in an Ubbelohde capillary viscosimeter (Schott-Geräte, Mainz, 
Germany). A micro-Ubbelohde viscosimeter (Ref. No. 53713, capillary diameter 0.53 mm) 
was clamped into an AVS measurement tripod connected to an AVS automated measuring 
device. The viscosimeter was immersed in a waterbath with a tripod at 37 °C.  
Incubation mixtures containing 1 mL of incubation buffer, 1 mL of BSA (0.2 mg/mL), 1.5 
mL of HA solution (5 mg/mL), 0.5 mL of H2O and 0.5 mL of enzyme solution were 
incubated at 37 °C for 24 h and 5 d, respectively, and filled into the viscosimeter. Due to the 
long incubation periods the outflow time during measurement of the viscosity was neglected 
for the calculation of incubation times. 
The relative viscosity ηrel was calculated according to the following equations: 
HCref
HCM
refref
rel tt
tt
tK
tK
−
−=⋅
⋅== ν
νη     Eq. 7.1 
with ν being the kinetic viscosity of the sample and νref of the reference substance. K is the 
viscosimeter constant (0.03082 mm²/s²). The outflow times tM, measured for the sample and 
tref for the reference substance, were both corrected by the Hagen-Couette correction time 
(tHC) according to the manufacturer’s recommendation. 
References were prepared by replacement of HA by H2O in the incubation mixtures. 
Incubation buffers were identical to those specified in 7.2.6. Enzyme samples were prepared 
from the medium of DS-2 cells expressing Hyal-2 (10 d after induction of expression) by 
dialysis (MWCO 14,000, 4 °C) against PBS supplemented with 1 mM EDTA. As negative 
control DS-2 wild type cells were treated in an identical way as DS-2 cells transfected with 
pMT/Hygro/hyal-2. 
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7.3. Results 
7.3.1. Construction of the expression vector pMT/Hygro/hyal-2 
Hyal-2 is presumably a membrane-anchored, extracellular protein similar to PH-20. 
Therefore, the hyal-2 cDNA was truncated during subcloning into pMT/Hygro (Fig. 7.1) at its 
N- and C-terminus to yield a soluble protein transported into the medium of the insect cells 
(cf. Chapter 6).  
3.0
2.0
1.5
1.2
hyal-2  kb
1.0
 
 
Fig. 7.1 Agarose gel electrophoresis of the PCR 
amplification product hyal-2, showing the expected 
length of 1.3 kb. The lane contained a mixture of 5 µl of 
PCR product and 1 µl of 10 x PCR loading buffer.  
At the N-terminus the human signal peptide was replaced by the BiP signal sequence encoded 
on pMT/Hygro and at the C-terminus the GPI-anchoring signal peptide comprising aa 449-
473 was excluded from the PCR amplification product. Thus, pMT/Hygro/hyal-2 coded for a 
485 aa precursor protein with a C-terminal V5 epitope and His-tag (Appendix 2).  
 
7.3.2. Stable expression of Hyal-2 in DS-2 cells 
DS-2 cells were transfected with pMT/Hygro/hyal-2 and selected for the presence of 
hygromycin resistance. These stably transfected cells were found to express a ca. 54 kDa 
protein reacting specifically with anti-V5-IgG into the medium (Fig. 7.2). In the Western blot 
analysis no significant difference could be found in the Hyal-2 expression rate of induced and 
non-induced cells.  
A     B     C       kDa
118.0
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Fig. 7.2 Western blot analysis of 30 µl of cell medium 
10 d after induction of stable expression. Lane A 
contained induced wild type DS-2 cell medium, lane B 
uninduced DS-2/pMT/Hygro/hyal-2 cell medium and 
lane C induced DS-2/pMT/Hygro/hyal-2 cell medium. 
Anti-V5-IgG was used as primary antibody, biotinylated 
anti-mouse-IgG as secondary antibody and detection of 
the antibody binding was achieved by HRP/DAB 
staining.  
 
The molecular mass of Hyal-2 expressed in DS-2 cells was consistent with the mass 
calculated from the amino acid sequence (53.7 kDa) indicating a low level of glycosylation.  
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7.3.3. Purification of Hyal-2 by Ni-IMAC 
Since the expression of Hyal-2 in the medium of DS-2 cells did not reveal a significant 
difference between induced and non-induced cell medium (7.3.2) purification of Hyal-2 was 
performed using non-induced DS-2/pMT/Hygro/hyal-2 cell medium to avoid interferences of 
CuSO4 with the purification procedure (Fig. 7.3).  
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Fig. 7.3 Ni-IMAC purification of Hyal-2 from DS-2 cell medium after 10 d of incubation.  
a) Elution profile detected by the protein concentration; b) SDS-PAGE of the Hyal-2 purification 
process: A) DS-2/pMT/Hygro/hyal-2 cell medium, B) flow-through, C) – E) elution fractions at pH 
4.5. 
 
At pH 4.5 a 54 kDa protein was eluted from the Ni-IMAC column, which was identified as 
Hyal-2 by Western blot analysis. Although the elute contained protein impurities further 
purification was abandoned due to the absence of any enzymatic activity (see below). 
 
7.3.4. Colorimetric and turbidimetric activity assays 
The standard hyaluronidase activity assays used for detection of the catalytic activity of BTH, 
Hyal-1 and PH-20 (cf. Chapter 5 and 6) failed to detect any hyaluronidase activity for Hyal-2 
purified from the medium of stably transfected DS-2 cells. Although a range of pH values (pH 
3.5 – 7.0), different substrate molecules (HA from S. zooepidemicus, HA from umbilical cord, 
chondroitin sulfate A and C) and extended incubation times (24 h – 7 d) were used, no 
activity could be detected in the colorimetric and the turbidimetric hyaluronidase activity 
assay, respectively. Therefore, alternative hyaluronidase activity assays were explored for 
their ability to detect the degradation of HA through the action of Hyal-2. 
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7.3.5. Agarose electrophoresis of HA digestion mixtures 
Hyal-2 activity was in most cases detected by the increase in the electrophoretic mobility of 
HA fragments of lower size in an agarose gel (Lepperdinger et al. 1998, Rai et al. 2001, 
Vigdorovich et al. 2005). As the colorimetric and the turbidimetric activity assays failed to 
detect HA degradation by Hyal-2 expressed by DS-2 cells HA degradation mixtures were 
separated on an agarose gel to visualize decreases in the size of high-molecular weight HA 
fragments.  
 
Fig. 7.4 Agarose gel electrophoresis of HA digestion mixtures (24 h) with HA from human umbilical 
cord (a) and HA from S. zooepidemicus (b). M) standard DNA molecular weight marker, A) cell-free 
medium, B) induced wild type cell medium, C) uninduced DS-2/pMT/Hygro/hyal-2 medium, D) 
induced DS-2/pMT/Hygro/hyal-2 medium. Samples A) – D) were incubated using 0.1 M Na-
formate/formic acid, pH 3.5, samples A’) – D’) containing the analogous samples were incubated with 
McIlvaine’s buffer without NaCl, pH 5.5. Sample E) was a control using BTH as sample and 
McIlvaine’s buffer, pH 4.5. 
 
As shown in Fig. 7.4 HA fragments were not distinctly separated by electrophoresis, but 
formed a broad band consistent with the polydisperse nature of HA in the incubation 
mixtures. This observation confirms the previously described results of this assay 
(Lepperdinger et al. 1998, Rai et al. 2001).  
The increased propagation of umbilical cord HA compared to HA from S. zooepidemicus 
indicates a lower molecular weight of HA from umbilical cord. According to the suppliers’ 
declarations the molecular weight of HA from S. zooepidemicus is 1 – 2 MDa and 200 – 
800,000 Da for HA from umbilical cord. However, a comparison of the molecular weight 
given by the suppliers with the molecular weight observed on the agarose gel reveals a large 
discrepancy, probably due to the different electrophoretic mobilities of DNA and HA. 
If HA was degraded during the incubation period a shift of the HA band towards lower 
molecular masses should occur. The positive control (lane E in Fig. 7.4) contained no visible 
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HA fragments due to complete degradation of HA to low molecular weight fragments by the 
action of BTH. The residual incubation mixtures revealed no changes in the size of the HA 
fragments compared to the negative controls containing cell-free medium. Neither after 24 h 
(Fig. 7.4) nor after 5 d (data not shown) of incubation any hyaluronidase activity was 
observed for the Hyal-2 samples in the agarose gel electrophoresis. 
 
7.3.6. Pulsed field gel electrophoresis (PFGE) 
To improve the separation of HA fragments in the agarose gel electrophoresis PFGE was 
performed. PFGE is generally used for the separation of macromolecular DNA fragments 
with up to 5 Mb (Lottspeich and Zorbas 1998). However, the high molecular weight HA 
fragments present in the incubation mixtures were not separated distinctly by this technique 
(Fig. 7.5). 
 
 
Fig. 7.5 Pulsed field gel electrophoresis (PFGE) of 
HA from S. zooepidemicus. A) HA solubilized in 
water, B) HA, sonicated for 3 min, C) HA, sonicated 
for 5 min, D) incubation mixture (24 h) with purified 
Hyal-2 and 0.1 M Na-formate/formic acid, pH 3.5, 
as incubation buffer, E) incubation mixture (24 h) 
with purified, heat-inactivated Hyal-2 and 0.1 M Na-
formate/formic acid, pH 3.5, as incubation buffer,  
F) incubation mixture (24 h) with BTH and 
McIlvaine’s buffer, pH 4.5 as incubation buffer,  
M) DNA ladders with bp transformed into MDa.  
Although a reduction in the molecular weight of HA was observed upon ultrasonication (lane 
B and C in Fig. 7.5) no changes in the HA fragment sizes were observed in the incubation 
mixtures containing purified Hyal-2 (lane D and E in Fig. 7.5).  
 
7.3.7. Viscosimetric determination of HA degradation 
7.3.7.1. Principle of hyaluronidase detection by viscosimetry 
The degradation of high molecular weight HA through the action of hyaluronidases can be 
followed by the decrease in the viscosity of the incubation mixture. The kinetic viscosity ν 
can be determined by the volume (V) passing a capillary with an inner radius R during the 
time t as follows: 
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Kt
LV
ghRt m ⋅=⋅=
8
4πν        Eq. 7.2 
The geometric parameters of the capillary (R, hm, L, V) can be summarized in the 
viscosimeter constant K. Due to loss of pressure at the ends of a capillary the real flow time tM 
is increased compared to the ideal flow time t, thus a correction time tHC (Hagen-Couette-
correction time) has to be substracted from tM: 
HCM ttt −=         Eq. 7.3 
The difference between the real and the ideal flow time decreases with increasing tM. The tHC 
values can be inferred from instrument specific calibration tables (Wilke et al.). Thus, the 
relative viscosity ηrel of a HA degradation mixture was determined as given in Eq. 7.1 using a 
solution without HA as reference. Maximum relative viscosities were determined at zero 
enzymatic activity in the presence of HA. 
7.3.7.2. Sensitivity of viscosimetry compared to the colorimetric and turbidimetric 
hyaluronidase activity assays 
To allow for a comparison of the different hyaluronidase activity assays the change in the 
detected parameter, i.e. relative viscosity, A585 or OD355, was observed in dependence of the 
enzymatic activity of BTH in the stock solution (IE/mL) after an incubation period of 24 h ( 
Fig. 7.6 and Fig. 7.7). 
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Fig. 7.6 Decrease in the relative viscosity of 
HA digestion mixtures through the action of 
BTH. The digestion mixtures were prepared 
with McIlvaine’s buffer, pH 4.0, as 
incubation buffer and were incubated for 24 
h at 37 °C. The viscosity of each sample was 
determined three times. The relative viscosity 
values are mean values ± SEM. 
Enzymatic activities of ca. 0.1 IE/mL were already detected by a decrease in the viscosity of 
the incubation mixture, while the formation of Morgan-Elson products in the colorimetric 
assay was observed at activities > 2 IE/mL (Fig.7.7.a). The turbidimetric assay performed in 
microtiter-plates was found to be slightly less sensitive than the colorimetric assay with ca. 5 
IE/mL being the minimum hyaluronidase activity detected after 24 h of incubation time 
(Fig.7.7.b). 
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Fig. 7.7 Sensitivity of the colorimetric (a) and turbidimetric activity assay (b) for the degradation of 
HA through the action of BTH after 24 h of incubation in McIlvaine’s buffer, pH 4.0.  
 
When all assays were performed according to the standard procedures the decrease in 
viscosity was the most sensitive method to determine degradation of HA by the action of 
hyaluronidases. Compared to the colorimetric and turbidimetric assay viscosimetry was ca. 
10-fold more sensitive. 
7.3.7.3. Viscosimetric analysis of Hyal-2 in DS-2 cell medium 
Incubation mixtures containing HA from S. zooepidemicus and the dialyzed medium of wild 
type DS-2 cells or of DS-2 cells expressing Hyal-2 were incubated for 24 h and 5 d, 
respectively, at acidic and nearly neutral pH. Strikingly, the viscosity determined at pH 3.5 
was significantly higher than the viscosity determined at pH 5.5, as shown in Fig.7.7. 
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Fig. 7.8 Viscosimetry of HA digestion 
mixtures incubated at 37 °C for 24 h 
(black bars) and 5 d (grey bars) at pH 
3.5 (a) and pH 5.5 (b), respectively. The 
HA was of microbiological origin (S. 
zooepidemicus). Incubation mixtures 
contained the induced medium of DS-2 
wild type (Wt) cells or of DS-2 cells 
expressing Hyal-2 (Hyal-2). The refer-
ence lines (dashed) indicate the 
maximum relative viscosity measured 
with PBS at the beginning of the 
incubation period. 
Furthermore, a decrease in viscosity was observed in all incubation mixtures incubated at 37 
°C for ≥ 24 h in comparison to the reference with maximum viscosity (t = 0) (Fig. 7.8). 
However, the incubation mixtures containing the medium from DS-2 cells expressing Hyal-2 
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did not differ in the reduction of viscosity compared to the DS-2 wild type cell medium, 
neither after 24 h nor after 5 d.  
The activity of Hyal-2 described in literature was often determined with HA from human 
umbilical cord (Rai et al. 2001). Therefore, the viscosity was also measured after incubation 
of HA from human umbilical cord to assure that the absence of hyaluronidase activity was not 
dependent on the source of HA used in the assay. 
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Fig. 7.9 Viscosimetry of HA digestion 
mixtures incubated at 37 °C for 24 h 
(black bars) and 5 d (grey bars) at pH 
3.5 (a) and pH 5.5 (b), respectively. 
The HA was a preparation from human 
umbilical cord. Incubation mixtures 
contained the induced medium of DS-2 
wild type (Wt) cells or of DS-2 cells 
expressing Hyal-2 (Hyal-2). The 
reference lines indicate the relative 
viscosity measured with PBS at the 
beginning of the incubation period (t = 
0). 
As already described previously (Hoechstetter 2005), the viscosity of human umbilical cord 
HA was significantly lower than that of HA derived from S. zooepidemicus (Fig. 7.8 and Fig. 
7.9) due to a reduced HA chain length of umbilical cord HA. Additionally, the difference 
between the viscosity at acid and nearly neutral pH was much more significant for HA from 
S. zooepidemicus than for HA from umbilical cord. Possibly, the pH-dependent differences in 
viscosity originate from the formation of HA secondary or tertiary structures occurring 
through interactions of high molecular weight HA chains at higher pH values. An increased 
chain length as present in HA from S. zooepidemicus might facilitate the formation of these 
interactions in contrast to the lower molecular weight chains in HA from umbilical cord. 
 
7.3.8. HA binding properties of Hyal-2 
As no hyaluronidase activity of Hyal-2 expressed in DS-2 cells could be detected, the 
question arose if Hyal-2 might merely be a receptor for HA, i.e. if Hyal-2 could bind 
hyaluronan without catabolizing it.  
Therefore, the primary sequences of human Hyal-1, Hyal-2, Hyal-4, PH-20 and BVH were 
analyzed for the presence of HA binding motifs (Yang et al. 1994). The HA binding motif 
B(X)7B, with B being a basic amino acid and X being any amino acid except an acid one, was 
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found 1 – 3 times in all hyaluronidases. In Hyal-2 the motif was found twice, but not in close 
proximity to the active site. RR, another sequence motif causing binding of HA in peptides 
(Amemiya et al. 2005), was also identified a few times in the human hyaluronidases. 
However, Hyal-2 did not exhibit any extraordinary sequence motifs compared to the other 
hyaluronidases. A BLAST search (Altschul et al. 1990) of human Hyal-2 revealed only Hyal-
2 from other species, other human hyaluronidases and hypothetical proteins without any 
identified function as proteins with any reasonable sequence similarity (BLAST score > 300). 
The sequence identity of Hyal-2 with the other human hyaluronidases comprises ca. 35 – 40 
%. 
 
Although the sequence of Hyal-2 did not reveal any extraordinarily high number of HA 
binding motifs compared to other human hyaluronidases, Hyal-2 was tested for its ability to 
bind HA. Previous studies on HA binding proteins revealed a retardation of these proteins on 
SDS-PA gels containing HA (Hrkal et al. 1996). To test for HA binding properties of Hyal-2 
the electrophoretic mobility of unpurified Hyal-2 was observed in the absence and in the 
presence of HA integrated in a PA-gel and visualized by Western blotting (Fig. 7.10). The use 
of SDS-PA gels did not alter the running behavior of Hyal-2 on the Western blot (data not 
shown). 
a) Native PAGE b) Native PAGE + HA
A       B      C       D     kDaA       B       C      D     kDa
85.0
47.0
85.0
47.0
 
Fig. 7.10 Western blot analysis of Hyal-2 on a native PAGE (a) and a native PAGE supplemented 
with HA (b). DS-2 cell medium 10 d after induction of expression was mixed with sample buffer with 
or without SDS, the gels were blotted after electrophoresis and the antibody reaction was achieved 
with Anti-V5-IgG as primary antibody, biotinylated anti-mouse-IgG as secondary antibody and 
subsequent HRP/DAB staining. A) DS-2/pMT/Hygro/hyal-2 medium without SDS, B) DS-
2/pMT/Hygro/hyal-2 medium with SDS, C) DS-2 wild type medium without SDS, D) DS-2 wild type 
medium with SDS. 
 
Since the HA binding properties had to be retained during electrophoresis PA-gels without 
SDS were used for the Western blot analysis. However, the electrophoretic mobility of Hyal-2 
was not decreased in the presence of HA in the PA-gel (Fig. 7.10) indicating the absence of 
strong HA binding properties. Addition of SDS to the sample buffer did not influence the 
electrophoretic mobility of Hyal-2.  
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7.4. Summary and conclusions 
 
By analogy with the human hyaluronidases Hyal-1 and PH-20 (cf. Chapter 5 and 6) Hyal-2 
was expressed into the medium of stably transfected DS-2 cells and partially purified by Ni-
IMAC. The presence of Hyal-2 was proven by Western blot analysis, but the detection of 
hyaluronidase activity failed. Since Hyal-2 is known to degrade mainly high molecular weight 
HA to fragments of ca. 20 kDa (50 disaccharide units), a variety of assays was evaluated for 
the detection of HA degradation through the action of Hyal-2.  
Absence of Hyal-2 activity in the colorimetric hyaluronidase activity assay was reported 
previously (Lepperdinger et al. 1998). Furthermore, the suitability of the turbidimetric activity 
assay for the detection of HA degradation products of ca. 20 kDa must be put into question. 
Nevertheless, both assays were tested for the detection of Hyal-2 activity, but failed to give 
positive results. To investigate if insufficient sensitivity of these standard hyaluronidase 
activity assays was the reason for the absence of Hyal-2 activity, degradation of HA was 
analyzed by agarose gel electrophoresis of HA and by viscosimetry. Agarose gel 
electrophoresis assays, although often employed for the detection of Hyal-2 degradation 
products, did not reveal any decrease in the molecular weight of HA even after extended 
incubation periods (up to 5 d) with Hyal-2. As the agarose gel electrophoresis exhibited some 
disadvantages in handling, e.g. high background staining of the agarose with Alcian blue, 
viscosimetry was used to detect the activity of Hyal-2. The significant decrease in HA 
viscosity, particularly at the beginning of the degradation reaction (Hoechstetter 2005), favors 
viscosimetry for the detection of Hyal-2 activity. As the viscosity of mixtures incubated for 
up to 5 d did not decrease compared to the negative control (DS-2 wildtype cells), Hyal-2 
expressed in DS-2 cells was considered as a protein without any hyaluronidase activity.  
 
Heterologous expression of proteins can cause a loss of protein function due to wrong or 
missing post-translational modifications or the combination with sequence tags. However, 
Vigdorovich et al. (Vigdorovich et al. 2005) expressed human Hyal-2 as a soluble protein 
linked to a C-terminal His-tag in a baculovirus system. In this insect cell system, Hyal-2, 
lacking the GPI-anchor signal peptide, was excreted into the culture medium of Sf9 cells. 
Thus, the resulting recombinant Hyal-2 was very similar to Hyal-2 expressed in DS-2 cells. 
Vigdorovich et al. observed Hyal-2 activity over a broad pH range (Vigdorovich et al. 2005), 
but revised their observations due to an intrinsic hyaluronidase activity of the Sf9 cells 
(Vigdorovich et al. 2007). Very recently, recombinant Hyal-2 was described as an acid-active 
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enzyme with very weak hyaluronidase activity (Vigdorovich et al. 2007). However, in 
consideration of the extremely weak activity it seems problematic to discriminate between 
endogenous hyaluronidase and Hyal-2. 
No matter if the activity of Hyal-2 is extremely low or not detectable at all, the biological 
function of Hyal-2 as a hyaluronidase has to be questioned. Up to now it could not be proven 
that Hyal-2 binds hyaluronic acid, although this could explain the function of Hyal-2 as a HA 
receptor as postulated by Csoka et al. (Csoka et al. 2001). For Hyal-2 expressed in DS-2 cells 
there was no retardation of the protein in a PA-gel as a consequence of HA binding. However, 
HA binding can not be completely excluded based on this assay and further investigations are 
necessary to confirm the results.  
 
In summary, the recombinant expression of Hyal-2 in DS-2 cells showed that the 
hyaluronidase activity of Hyal-2 described in literature has to be evaluated very carefully with 
respect to impurities affecting hyaluronidase activity and concerning the assay systems used 
for the detection of HA degradation products. Hemopexin, a serum-heme binding protein, 
provides an example for a protein, first described as a hyaluronidase (Zhu et al. 1994), while 
further investigations revealed only HA binding properties and no catalytic activity (Hrkal et 
al. 1996). Serum hyaluronidase impurities within the hemopexin samples had feigned the 
existence of hyaluronidase activity. If Hyal-2 is only an extremely weak or no hyaluronidase 
at all, the biological function of the enzyme has to be reviewed as well.  
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8. Isozyme-specific differences in the degradation of HA and 
HA oligosaccharides 
Chapter 8 
Isozyme-specific differences in the 
degradation of HA and HA oligosaccharides 
by BTH, human PH-20 and human Hyal-1 
 
 
 
8.1. Introduction 
 
Bovine testicular hyaluronidase (BTH) has been extensively studied with respect to its 
catalytic behavior at various pH values, dependency on salt concentrations and the formation 
of reaction products (Gorham et al. 1975, Takagaki et al. 1994, Oettl 2000, Hoechstetter 
2005). In contrast to BTH, the HA degradation products of human Hyal-1 and human PH-20 
have not been studied in detail yet. Due to the availability of the human enzymes in very low 
quantities up to now information on their enzymatic properties has been restricted to a few 
elementary properties, such as the pH profiles and the nature of the reaction products (Gold 
1982, Afify et al. 1993, Gmachl et al. 1993, Frost et al. 1997, Sabeur et al. 1997). The 
production of pure, recombinant human Hyal-1 (cf. Chapter 5) and partially purified, 
recombinant human PH-20 (cf. Chapter 6) enabled the detailed investigation of Hyal-1 and 
PH-20 in comparison to BTH.  
 
Bovine testicular hyaluronidase (BTH) and, presumably, all mammalian hyaluronidases 
catalyze the hydrolysis as well as the transglycosylation of hyaluronan fragments (Weissmann 
1955) (cf. Chapter 1). For BTH hydrolysis is favored at acidic pH values, while 
transglycosylation occurs preferentially at neutral pH values and at low NaCl concentrations 
(Gorham et al. 1975, Saitoh et al. 1995).  
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The complex reactions catalyzed by hyaluronate hydrolases and the polymeric structure of the 
substrate severely complicate the analysis of enzymological characteristics by means of 
Michaelis-Menten kinetics. Although KM and vmax values for hyaluronidase-catalyzed 
degradation of the high molecular weight substrate HA can be found in literature (Cramer et 
al. 1994, Vercruysse et al. 1995, Asteriou et al. 2006), the determination of exact Michaelis-
Menten kinetics is impeded by the steady increase in the substrate concentration during the 
cleavage of the HA chains. Therefore, small oligosaccharides have been employed enabling 
an exact analysis of the reactions catalyzed by BTH (Cramer et al. 1994).  
 
Due to the negatively charged groups present in GAG oligosaccharides capillary zone 
electrophoresis (CZE) is often applied in the analysis of GAGs in biological or 
biopharmaceutical preparations (Mao et al. 2002). CZE has been used for the separation of 
HA digestion products from various biological samples, e.g. for vitreous humor HA 
(Grimshaw et al. 1994), synovial fluid HA (Grimshaw et al. 1996) and for the analysis of HA 
fragments produced by venom hyaluronidases (Pattanaargson and Roboz 1996). A wide 
variety of CZE conditions is described in literature for the separation of HA fragments, e.g. 
migration with normal polarity (Grimshaw et al. 1994, Pattanaargson and Roboz 1996), 
migration with reverse polarity (Hayase et al. 1997), the use of ion-pairing reagents (Payan et 
al. 1998) and polymers (Kakehi et al. 1999) to improve the separation of high molecular 
weight HA fragments. 
The analysis of unmodified HA degradation products in biological samples is hampered by 
the absence of a suitable chromophore in the HA degradation products of hydrolases. If 
detection is performed by absorbance at low wavelengths (200 – 210 nm) buffer substances as 
well as protein impurities interfere with the GAG detection. Grimshaw et al. (1994) employed 
a capillary zone electrophoresis method with an alkaline phosphate-borate buffer and SDS for 
the separation of protein impurities from the HA fragments. As described in the following 
chapter this method was optimized for the qualitative and quantitative analysis of hydrolase 
digestion products formed by the catalysis of pure enzyme samples.  
 
The CZE method was utilized to analyze the formation of degradation products of high 
molecular weight HA and of hyaluronan oligosaccharides produced through the action of 
BTH, recombinant, human PH-20 and recombinant, human Hyal-1. The hyaluronan 
hexasaccharide (n3) is known to be the minimum substrate for BTH (Highsmith et al. 1975, 
Cramer et al. 1994), and is supposed to be the minimum substrate of the human 
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hyaluronidases as well (Stern and Jedrzejas 2006). BTH was shown to exhibit differences in 
its catalytic activity at acidic and neutral pH (Hoechstetter 2005). Therefore, the 
investigations performed with BTH were focused on the comparison of the HA fragments 
produced at acidic and around neutral pH.  
While the degradation kinetics of high molecular weight HA was followed qualitatively in a 
colorimetric hyaluronidase activity assay and by CZE, the degradation kinetics of n3 and n4 at 
different substrate concentrations was quantified in the CZE.  
 
8.2. Materials and Methods 
8.2.1. Chemicals 
Hyaluronic acid (HA) from S. zooepidemicus was purchased from Aqua Biochem GmbH, 
Dessau, Germany. Neopermease® was a gift from Sanabo, Vienna, Austria, Hyal-1 and PH-20 
were produced by DS-2 cells and purified as described in Chapter 5 and 6. BSA was 
purchased from Serva, Heidelberg, Germany, cetyltrimethylammonium bromide (CTAB) 
from Roth, Karlsruhe, Germany, p-Dimethylaminobenzaldehyde (DMAB) from Sigma, 
Munich, Germany. All other chemicals were from Merck, Darmstadt, Germany. Water was 
purified by a Milli-Q system (Millipore, Eschborn, Germany). 
8.2.2. Preparation of HA oligosaccharides 
High molecular weight HA was exhaustively digested by BTH (Neopermease®) for 48 h at 37 
°C. One mL of BTH (50,000 IE/mL, according to the supplier, dissolved in BSA solution (0.2 
mg/mL)) was added to an incubation mixture containing 50 mL of incubation buffer (0.1 M 
HOAc/NaOAc, 0.1 M NaCl, pH 4.0), 50 mL of HA solution (5 mg/mL), 25 mL of BSA 
solution (0.2 mg/mL) and 74 mL of water. At the end of the incubation period the solution 
was boiled for 10 min and centrifuged for 20 min at 5,000 g. The supernatant was lyophilized, 
and the residual oligosaccharides dissolved in Milli-Q water to gain a concentration of 40 
mg/mL. The oligosaccharides were filtered (GH Polypro membrane disc filter, 0.45 µm, Pall 
Life Sciences, Dreieich, Germany) and separated on a SuperdexTM Peptide 10/300 GL (GE-
Healthcare Bio-sciences AB, Uppsala, Sweden) at a flow rate of 0.5 mg/mL, using 0.1 M 
NH4OAc as mobile phase. The maximum sample volume was 200 µL. 
For large-scale preparation of HA oligosaccharides a HiLoad 16/60 SuperdexTM 30 prep grade 
(GE-Healthcare Bio-Sciences AB, Uppsala, Sweden, formerly Pharmacia Biotech) was used 
at a flow rate of 1 mL/min with a maximum sample volume of 1.5 mL. Both columns were 
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operated by a Millipore® Waters solvent delivery module, Model 590, connected to a Merck 
Hitachi L-4000 UV detector. Detection was carried out at 210 nm, and fractions were 
collected manually. Di- and tetrasaccharides were sufficiently pure after one separation step, 
while hexa- and octasaccharides had to be purified twice on the Superdex 30 column. 
Fractions were pooled, lyophilized and dissolved in Milli-Q water. Purity and identity of the 
fractions was determined by mass spectrometry and capillary zone electrophoresis, 
respectively. Oligosaccharide solutions were stored at -20 °C. 
All buffers used during the preparation process were vacuum-degassed and filtrated through a 
0.45 µm filter (Millipore, Eschborn, Germany).   
8.2.3. ESI-MS 
HA oligosaccharides were analyzed by ESI-MS on a ThermoQuest Finnigan TSQ 7000 
spectrometer (Thermo Electron GmbH, Dreieich, Germany). Lyophilized oligosaccharide 
samples were dissolved in a 1:10 mixture of water and methanol containing 10 mM NH4OAc, 
and were manually injected into the ion source. Analysis was performed in the negative ion 
mode with a spray voltage of 3 kV and a capillary temperature of 200 °C.  
8.2.4. Capillary zone electrophoresis (CZE) 
8.2.4.1. Qualitative analysis of high molecular weight HA degradation products 
High molecular weight HA was incubated for different time periods in the following 
incubation mixtures: 
BTH, pH 4.5: 100 µL of BSA solution (0.2 mg/mL), 100 µL of incubation buffer (0.1 M 
HOAc/NaOAc, 0.1 M NaCl, pH 4.5), 50 µL of HA solution (5 mg/mL), 10 µL 
of BTH (2,000 IE/mL, according to the supplier). Water was added to reach a 
total volume of 450 µL. 
BTH, pH 5.5:  analogous to BTH, pH 4.5, but using 0.1 M HOAc/NaOAc, 0.1 M NaCl, pH 
5.5 as incubation buffer and 23 µL of BTH (2,000 IE/mL, according to the 
supplier). 
PH-20, pH 4.5: analogous to BTH, pH 4.5, but using 40 µL of PH-20 instead of BTH (20 
IE/mL, as determined by the Morgan-Elson assay at pH 5.0). 
PH-20, pH 5.5: analogous to BTH, pH 5.5, but using 40 µL of PH-20 instead of BTH (20 
IE/mL, as determined by the Morgan-Elson assay at pH 5.0). 
Hyal-1:  analogous to BTH, pH 4.5, but using 0.1 M formic acid/Na-formate, pH 3.5 as 
incubation buffer and 10 µL of Hyal-1 instead of BTH (6,300 IE/mL, as 
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determined by the Morgan-Elson assay at pH 3.5). Additionally, the mixture 
was supplemented with 5 µL of NaCl solution (1 M). 
After incubation at 37 °C for various time periods the enzymatic reaction was stopped by 
addition of 900 µL of cold acetonitrile. The samples were dried in the Speed Vac (Savant 
speed-vac Plus SC110A, Divebid, Cambridge, USA), dissolved in 225 µL of 10-fold diluted 
CZE operating buffer (cf. 8.2.4.4) and centrifuged for 10 min at 12,000 g. The supernatant 
was used for CZE analysis. 
8.2.4.2. Quantitative analysis of oligosaccharide degradation products 
Various concentrations of HA hexasaccharides (n3) and octasaccharides (n4), isolated as 
described in 8.2.2, were incubated with BTH, Hyal-1 and PH-20. Incubation mixtures 
containing the following components were used: 
BTH, pH 4.0:  44 µg/mL BSA, 22 mM HOAc/NaOAc, pH 4.0, 22 mM NaCl, 61 IE/mL BTH 
(as determined by the Morgan-Elson reaction at pH 4.0; 100 IE/mL according 
to the supplier). 
BTH, pH 6.0:  analogous to BTH, pH 4.0, but using 22 mM HOAc/NaOAc, pH 6.0, and 122 
IE/mL BTH (as determined by the Morgan-Elson reaction at pH 4.0; 200 
IE/mL according to the supplier). 
Hyal-1:  analogous to BTH, pH 4.0, but using 22 mM formic acid/Na-formate, pH 3.5, 
and 100 IE/mL Hyal-1 instead of BTH (as determined by the Morgan-Elson 
reaction at pH 3.5). 
PH-20:  analogous to BTH, pH 4.0, but using 60 IE/mL PH-20 instead of BTH (as 
determined by the Morgan-Elson reaction at pH 4.0). 
For calculation of the NaCl concentration in the incubation mixture it was considered that 
Hyal-1 and PH-20 were both dissolved in 50 mM Na-phosphate, 0.5 M NaCl, 0.1 % Triton X-
100, pH 4.5. Hyaluronidase activity was determined directly before the kinetic measurement 
in the Morgan-Elson assay using incubation mixtures analogous to the CZE mixtures.  
For each oligosaccharide concentration an incubation mixture was pre-incubated for 5 min at 
37 °C, then the enzyme was added and samples of 25 – 100 µL were taken at defined time 
points (0 – 60 min). The enzymatic reaction was stopped by mixing the sample with twice the 
volume of ice-cold acetonitrile. All samples were then dried in the SpeedVac at low drying 
rate and re-dissolved in 100 µL of 10-fold diluted CZE operating buffer (cf. 8.2.4.4). After 
centrifugation for 10 min at 12,000 g the supernatant was analyzed by CZE. 
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8.2.4.3. CZE calibration curves 
After determination of the concentration by the Morgan-Elson assay, n1, n2, n3 and, if 
necessary, n4 were mixed in the respective buffer system, used for the particular kinetic 
measurement (cf. 8.2.4.2). The calibration mixtures were treated in an identical way as the 
samples, i.e. they were mixed with twice the volume of acetonitrile, dried in a Speed Vac and 
solubilized in 10-fold diluted CZE operating buffer (cf. 8.2.4.4).  
8.2.4.4. CZE conditions 
All CZE experiments were carried out with a Biofocus 3000 capillary electrophoresis system 
(Biorad, Munich, Germany) equipped with an uncoated fused silica capillary (75 cm x 50 µm, 
Chrompack). Buffer conditions were adapted from Grimshaw et al. (Grimshaw et al. 1994). 
The CZE operating buffer contained 50 mM Na2HPO4, 20 mM Na2B4O7, pH 9. Samples were 
dissolved in 10-fold diluted CZE operating buffer in Milli-Q water. The sample was injected 
by pressure (20 psi · s), and electrophoresis was performed in the normal polarity mode at a 
capillary temperature of 15 °C with a run voltage of 15 kV. HA fragments were detected by 
their absorption at 200 nm. The capillary was washed after each run with 0.1 M NaOH (200 
s), Milli-Q water (200 s) and the operating buffer (300 s).  
8.2.5. Morgan-Elson assay (colorimetric hyaluronidase activity assay) 
The Morgan Elson assay, also termed colorimetric hyaluronidase activity assay (cf. Chapter 
3), was used for the quantification of HA oligosaccharides as well as for the detection of time-
dependent HA degradation by Hyal-1, PH-20 and BTH.   
For quantification of HA oligosaccharides 0.05 – 0.1 µmol of GlcNAc were dissolved in 450 
µL of water to obtain a calibration curve. Unknown oligosaccharide concentrations were 
determined in triplicate.  
When HA was enzymatically degraded to completion by BTH, PH-20 or Hyal-1, the 
incubation mixtures were identical to those used for the investigation of the HA degradation 
products by CZE (8.2.4). The enzymatic reaction was stopped after different incubation 
periods by addition of alkaline borate solution (cf. Chapter 3), and the samples were stored at 
4 °C until analysis. The detection of reducing GlcNAc ends was performed as described in 
Chapter 3. 
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8.2.6. Theoretical calculation of HA fragment patterns 
Calculation was performed by a C-program (“bth.c”) written by Dr. H.-J. Wittmann, Faculty 
of Chemistry and Pharmacy, University of Regensburg, Germany. Hydrolysis and 
transglycosylation were defined for a HA fragment containing n disaccharide units as follows: 
 
Hydrolysis:   ni → nj + nk   with i = j + k   Eq. 8.1 
Transglycosylation:  ni + nj → nk + nm  with i + j = k + m  Eq. 8.2 
 
All fragments were assumed to be converted at random, i.e. cleavage was allowed to occur at 
any site with the same probability, independent of the size of the fragment and the position of 
the cleavage site within the fragment. Di- (n1) and tetrasaccharides (n2) were excluded from 
further hydrolysis reactions due to the low binding affinity observed for these fragments with 
respect to the binding site of BTH (Highsmith et al. 1975). The smallest fragment allowed to 
be transferred during transglycosylation was one disaccharide unit (n1).  
8.2.7. Calculation of Michaelis-Menten kinetics 
Initial degradation velocity was obtained by plotting the substrate concentration determined in 
the CZE against incubation time and fitting the initial part of each degradation curve to a 
linear equation. For determination of the maximum velocity (vmax) and the Michaelis-Menten 
constant (KM) the initial degradation velocity (v) was plotted against the substrate 
concentration ([S]). Curves were fit to the data points according to the Michaelis-Menten 
equation (Eq. 8.3.) using SigmaPlot 9.0 (Systat Software Inc., San Jose, USA). 
  
][
][max
SK
Sv
v
M +
⋅=         Eq. 8.3 
The turnover-number (kcat) was determined by deviding the maximum velocity (vmax) by the 
number of enzyme molecules present in the sample.  
 
8.3. Results 
8.3.1. Determination of enzyme kinetics by CZE: optimization of the parameters 
For the quantification of BTH activity McIlvaine’s buffer (McIlvaine 1921) was routinely 
used (Oettl 2000, Hoechstetter 2005). However, for CZE a volatile incubation buffer was 
necessary to avoid interference with the CZE buffer system. As Gorham et al. reported an 
inhibitory effect of acetate on the enzymatic activity of BTH (Gorham et al. 1975), 
hyaluronidase activity was measured in HOAc/NaOAc and formic acid/Na-formate buffer. In 
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a standard Morgan-Elson assay the volatile buffer systems showed no inhibition of the 
activity of BTH in comparison to the enzymatic activity in McIlvaine’s buffer (Fig. 8.1.a).  
To assure a fast and complete stop of the enzymatic reaction after a defined period of 
incubation the addition of acetonitrile to the incubation mixture was investigated as an 
alternative to boiling, which is often used to stop hyaluronidase reactions (Holmbeck and 
Lerner 1993, Mahoney et al. 2001, Tawada et al. 2002). Stopping of the enzymatic reaction 
by addition of acetonitrile was shown to be more efficient than boiling, due to the faster 
denaturation of the protein by the organic solvent compared to inactivation by heat (Fig. 
8.1.b). 
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Fig. 8.1 Choice of a buffer system (a) and evaluation of the denaturing conditions for CZE analysis 
(b). Morgan-Elson incubation mixtures with 5 IE (black) and 20 IE (grey) of BTH (as declared by the 
supplier) were incubated for one hour. a) BTH was incubated at pH 4.0 with McIlvaine’s buffer (0.2 
M Na2HPO4/0.1 M citric acid) (A), 0.1 M NaOAc/HOAc (B) and 0.1 M Na-formate/formic acid (C). 
All buffers were supplemented with 0.1 M NaCl. b) Stopping of the reaction was investigated by 
incubation of BTH with buffer B. The samples were not stopped at all, boiled for 10 min or stopped by 
addition of twice the sample volume of acetonitrile. Then, the samples were incubated overnight at 37 
°C, dried in the SpeedVac, re-dissolved in the original sample volume of water. GlcNAc at the 
reducing ends was determined by the Morgan-Elson reaction. 
 
8.3.2. Degradation of high molecular weight HA 
8.3.2.1. Degradation of high molecular weight HA by BTH at pH 4.5 
The formation of GlcNAc residues from high molecular weight HA through the activity of a 
hyaluronidase is assumed to increase linearly with time, providing the basis for the 
determination of hyaluronidase activity in the Morgan-Elson assay (colorimetric 
hyaluronidase activity assay). The increase in absorbance at the absorption maximum (585 
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nm) of the Morgan-Elson reaction product per time is used for the definition of hyaluronidase 
activity units (U).  
However, the observed increase in absorbance in the Morgan-Elson assay over extended 
incubation periods revealed a non-linear proportionality for the formation of GlcNAc at the 
reducing ends during digestion of HA by BTH at pH 4.5 (Fig. 8.2).  
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Fig. 8.2 Formation of GlcNAc residues 
at the reducing ends during digestion of 
HA with BTH (44 IE/mL, as declared 
by the supplier) at pH 4.5 followed over 
an incubation period of 1,000 min by 
the Morgan-Elson assay. Data were fit 
to an exponential equation with 4 
parameters (A585 = a (1-e-bt)+c(1-e-dt)). 
The dashed line shows the fit to a 
mono-exponential equation (A585 = a (1-
e-bt)), the linear range is used for the 
determination of hyaluronidase activity. 
Grey data points were additionally 
obtained by CZE (Fig. 8.3). 
Obviously, reducing GlcNAc end groups were liberated with the highest velocity at the 
beginning of the reaction, i.e. high molecular weight HA was degraded with the highest 
efficiency. Thus, high molecular weight HA seems to be hydrolyzed faster than lower 
molecular weight HA with a steady decrease in the cleavage velocity with decreasing chain 
length. Consequently, the range between 0.1 and 0.4 A585 was used for the quantification of 
enzymatic activities, which can be approximated by a linear equation (Fig. 8.2). 
The description of the time-dependent formation of GlcNAc end groups by a double-
exponential model is consistent with the results obtained by Vincent et al. (Vincent et al. 
2003), who speculated about an effect of the HA chain length on the mode of hyaluronidase 
action. 
 
To gain a more detailed insight into the time-dependent degradation processes, the HA 
digestion products were analyzed by CZE in parallel with the determination of reducing 
GlcNAc end groups with the Morgan-Elson reaction. High molecular weight HA forms a 
single peak in CZE (Grimshaw et al. 1994) due to the low difference in the charge to mass 
ratio between the polydisperse HA. As shown in Fig. 8.3 high molecular weight HA (n2500 – 
n5000, 1 – 2 · 106 Da, according to the supplier) was degraded at pH 4.5 continuously into 
smaller fragments of di- (n1) to octasaccharides (n4) accumulating as final products.  
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Fig. 8.3 CZE analysis of different stages of HA digestion by BTH (44 IE/mL, according to the 
supplier) at pH 4.5. The enzymatic reactions were stopped after 0, 10, 40, 90 min and 17 h by mixing 
with acetonitrile. Each sample was additionally analyzed by the Morgan-Elson reaction (A585) as 
shown in Fig. 8.2. Exhaustive digestion products n1 – n5 were identified by mean differences in 
migration times (Tab. 8.2). 
 
8.3.2.2. Degradation of HA by BTH at pH 5.5 
Previous investigations by Hoechstetter (Hoechstetter 2005) indicated a change in the kinetics 
of HA degradation by BTH dependent on the pH. These observations were mainly based on 
differences in the pH profiles measured in the turbidimetric and the colorimetric 
hyaluronidase activity assay (Hoechstetter et al. 2001) and on the detection of HA degradation 
products by HPLC (Hoechstetter 2005). In the HPLC experiments HA digestion products 
were separated from the protein by filtration, thus excluding high molecular weight HA (MW 
> 10 kDa) from the HPLC analysis. The CZE procedure developed for the analysis of HA 
digestion products enables the analysis of HA digests without separation of reaction products 
and avoids possible modifications of the HA fragments as observed, e.g. during boiling. 
Therefore, BTH degradation products formed at pH 5.5 were analyzed by CZE by analogy 
with the measurements at pH 4.5 described above. 
As observed at pH 4.5, the increase in reducing GlcNAc residues during digestion of HA at 
pH 5.5 showed an exponential rise to a maximum value of ca. 1.2 A585 (Fig. 8.4). The time-
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dependent increase in reducing GlcNAc residues at pH 5.5 could be described by a double- 
exponential equation as shown in Fig. 8.2 for the degradation at pH 4.5.  
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Fig. 8.4 Formation of GlcNAc residues 
during digestion of HA with BTH (102 
IE/mL, as declared by the supplier) at 
pH 5.5 followed over an incubation 
period of 1500 min by the Morgan-
Elson assay. Data were fit to an 
exponential equation with 4 parameters 
(A585 = a (1-e-bt) + c(1-e-dt)), the linear 
range is used for the determination of 
hyaluronidase activity. Grey data points 
were additionally analyzed by CZE 
(Fig. 8.5).  
However, CZE analysis of the HA fragments produced at pH 5.5 revealed a different size 
distribution of HA degradation products than observed at pH 4.5: high molecular weight HA 
was degraded to small oligosaccharides (n1 – n4), but with higher molecular weight fragments 
remaining in the incubation mixture (marked with an arrow in Fig. 8.5). The exact size of the 
higher molecular weight HA fragments could not be determined since no separation of the 
fragments was achieved at these charge to mass ratios. A very small fraction of the higher 
molecular weight HA fragments could also be observed during degradation of HA by BTH at 
pH 4.5 (Fig. 8.3). 
It should be noted that the peaks of the HA degradation products, especially of the HA 
oligosaccharides, at pH 5.5, were broadened compared to the digestion products at pH 4.5. 
Hoechstetter (Hoechstetter 2005) previously observed the formation of odd-numbered HA 
oligosaccharides at pH 5.0 – 6.0 carrying GlcUAc at both ends. Due to the different 
separation principles of CZE and HPLC HA fragments, carrying the same charge, but a 
slightly reduced molecular mass, might result in a broadening of peaks in CZE, while anion 
exchange HPLC was capable of separating even- and odd-numbered HA fragments. 
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Fig. 8.5 CZE analysis at different stages of HA digestion by BTH (102 IE/mL, according to the 
supplier) at pH 5.5. Enzymatic reactions were stopped after 0, 10, 40, 90 min and 16 h by mixing with 
acetonitrile. Each sample was additionally analyzed with the Morgan-Elson assay (A585) as shown in 
Fig. 8.4. Exhaustive digestion products n1 – n4 were identified by mean differences in migration times 
(Tab. 8.2). 
 
8.3.2.3. Degradation of HA by recombinant, human PH-20 
Partially purified human PH-20 expressed in DS-2 cells exhibited a shift in the pH-dependent 
activity in the colorimetric and turbidimetric assay similar to BTH. Maximum enzymatic 
activity was found at pH 4.5 in the colorimetric assay and at pH 5.5 in the turbidimetric assay 
(cf. Chapter 6).  
Due to instability problems during storage the enzymatic activity of PH-20 available for the 
CZE experiments was significantly lower than the activity used for the degradation of HA by 
BTH and Hyal-1. The low activity was compensated by extended incubation periods in order 
to gain similar amounts of reducing GlcNAc groups for each of the time points analyzed with 
CZE (Fig. 8.6). The formation of reducing GlcNAc residues by PH-20 exhibited a similar 
time-dependent curve as observed for BTH (Fig. 8.2 and Fig. 8.4) with a continuous decrease 
in the velocity of the liberation of reducing GlcNAc ends (data not shown).  
The reaction products formed at both pH optima were analyzed by CZE after varying periods 
of incubation. As shown in Fig. 8.6 the degradation products formed at pH 4.5 and at pH 5.5 
were nearly identical. The formation of small oligosaccharides in the presence of higher 
molecular weight HA fragments, as observed with BTH at pH 5.5 (Fig. 8.5), was detected at 
both pH values, but with a significantly smaller fraction of higher molecular weight HA 
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fragments remaining in the mixture than observed with BTH at pH 5.5 (indicated by arrows in 
Fig. 8.6). The fraction of residual high molecular weight HA seemed to be only slightly 
increased at pH 5.5 compared to pH 4.5.  
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Fig. 8.6 CZE analysis at different stages of HA digestion by recombinant, human PH-20 (2 IE/mL, as 
determined by the Morgan-Elson assay at pH 4.5) at pH 4.5 (a) and pH 5.5 (b). Enzyme reactions were 
stopped after 0, 2, 4, 6 and 27 h by mixing with acetonitrile. Each sample was additionally analyzed in 
the Morgan-Elson reaction (A585). Digestion products n1 – n4 were identified by the mean differences 
in migration times (Tab. 8.2). 
 
However, the enzymatic activity of PH-20 was insufficient to follow the degradation process 
to completion, i.e. the reaction products observed after 27 h represent not the final 
oligosaccharides. Nevertheless, the smallest oligosaccharides produced by human PH-20 at 
both pH values, pH 4.5 and 5.5, were identified as HA disaccharides (n1) and tetrasaccharides 
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(n2). A significant broadening of the peak shape at pH 5.5, as seen with BTH, was not 
observed. Thus, the formation of odd-numbered oligosaccharides described for BTH around 
neutral pH might be a phenomenon specific for BTH. 
8.3.2.4. Degradation of HA by recombinant human Hyal-1  
As described above for BTH and PH-20, the degradation process of high molecular weight 
HA through the action of Hyal-1 was followed in parallel with the Morgan-Elson assay (Fig. 
8.7) and by means of CZE (Fig. 8.8).  
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Fig. 8.7 Formation of reducing GlcNAc 
residues during digestion of HA with 
Hyal-1 (35 IE/mL) at pH 3.5 followed 
over an incubation period of 1,100 min 
by the Morgan-Elson assay. Data were 
fit to a mono-exponential equation with 
2 parameters (A585 = a (1 - e-bt)). The 
linear range was used for the 
determination of hyaluronidase activity. 
Grey data points were additionally 
analyzed by CZE (Fig. 8.8). 
In contrast to BTH and PH-20, the formation of reducing GlcNAc end groups caused by the 
action of Hyal-1 exhibited a mono-exponential time-dependency (Fig. 8.7). The initial part of 
the curve showed an extended linear range (0.1 – 0.8 A585) suitable for the determination of 
Hyal-1 activity. Intriguingly, the degradation kinetics of BTH (Fig.8.2, Fig.8.4) could only be 
described sufficiently by a double-exponential equation.   
 
The time-dependent formation of GlcNAc end groups through the action of a hyaluronidase 
following a mono-exponential process can be explained by the following model proposed by 
Vincent et al. (Vincent et al. 2003): 
The degradation of HA chains can be considered as a reaction with each possible cleavage site 
…- GlcNAc - GlcUAc -… present in the incubation mixture being a substrate moiety: 
............ 1 −+−⎯→⎯−−− GlcUAcGlcNAcGlcUAcGlcNAc k  Eq. 8.4 
The time-dependent degradation of n cleavage sites can thus be assumed as a first-order 
reaction. The concentration of n cleavage sites at any time t is given by the following 
equation:  
  [ ] [ ] tkenn 10 −⋅=        Eq. 8.5 
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Thus, the formation of reducing GlcNAc end groups (…-GlcNAc) measured with the 
Morgan-Elson reaction via the absorbance at 585 nm is described by a function of exponential 
growth to a maximum value A0: 
  [ ] )1(... 10 tkeAGlcNAc −−=−       Eq. 8.6  
The existence of a single velocity constant k1 for the degradation process thus indicates a 
constant catalytic activity of Hyal-1 towards all HA fragments, independent of the chain 
length. CZE analysis of the degradation products confirmed this assumption as a continuous 
decrease in the molecular weight of the HA chains (Fig. 8.8). As final reaction products tetra- 
(n2), hexa- (n3) and octasaccharides (n4) with traces of disaccharide (n1) accumulated. 
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Fig. 8.8 CZE analysis of different stages of HA digestion by Hyal-1 (35 IE/mL, as determined in the 
Morgan-Elson reaction at pH 3.5) at pH 3.5. Enzymatic reactions were stopped after 0, 10, 20, 60 min 
and 23 h by mixing with acetonitrile. Each sample was additionally analyzed in the Morgan-Elson 
reaction as shown in Fig. 8.7. Exhaustive digestion products n1 – n4 were identified by the mean 
differences in migration times (Tab. 8.2). 
 
8.3.2.5. Theoretical calculation of the size distribution of HA fragment produced by 
hydrolysis and transglycosylation 
The existence of both, high and low molecular weight HA fragments after digestion of HA by 
BTH and PH-20, gave rise to the idea that this unusual distribution of HA fragments might be 
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a result of the transglycosylation activity of these enzymes. Therefore, the distribution of HA 
fragment sizes was calculated, allowing hydrolysis as well as transglycosylation reactions.  
In order to keep the calculation time within a reasonable limit, the HA chain length had to be 
chosen far below the actual size of high molecular weight HA. Additionally, the number of 
degradation steps accessible by calculation was limited, especially when considering 
transglycosylation reactions.  
The absorbance at 200 nm can be estimated to be directly proportional to the number of 
disaccharide units n of a HA fragment. Therefore, a comparison of the calculated relative 
concentrations to the fragment patterns observed in the CZE was enabled by multiplying the 
relative concentration of the oligosaccharide fragments by the chain length (n): 
 
 relative absorbance = relative concentration · n    Eq. 8.7 
 
After 5 cleavage steps of a HA chain comprising 20 disaccharide units the relative 
concentration of fragments produced by hydrolysis only, decreased steadily with increasing 
chain length (Fig. 8.9.a). Di- (n1) and tetrasaccharides (n2) were excluded from further 
reactions and accumulated as the major products. The highest relative absorbance was 
observed for the tetrasaccharide (n2). When the calculation was continued, the concentration 
of longer HA chains decreased further with an accumulation of n1 and n2.  
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Fig. 8.9 Calculation of the relative occurrence of HA fragments (black) and the relative absorbances 
(grey) after 5 conversion steps. The initial HA chain contained 20 disaccharide units with a relative 
concentration of 1. The following reaction probabilities (P) were chosen for the calculation: a) 
P(hydrolysis) = 0.6,  P(transglycosylation) = 0. b) P(hydrolysis) = 0.3, P(transglycosylation) = 0.3.  
 
In a second approach hydrolysis and transglycosylation reactions were allowed to occur with 
equal probabilities (Fig. 8.9.b). When transglycosylation was allowed to occur at random with 
fragments of every size, HA fragments of both, higher and lower molecular weight compared 
to the initial HA fragment, were formed. Thus, a fragment pattern containing much longer HA 
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fragments than the initial chain length (n20) was observed. After 5 steps of conversion the 
pattern of the relative concentrations of fragments was similar to the one observed after mere 
hydrolysis, with n1 and n2 accumulating as the final products. However, the relative 
absorbances revealed the occurrence of a fraction of fragments in the range between n10 and 
n15 with an increased relative absorbance compared to shorter HA fragments (marked with an 
arrow in Fig. 8.9.b). Additionally, n1 and n2 accumulated as the major reaction products, 
exhibiting also the highest relative absorbance values. 
 
Although the calculation was restricted to very few elementary parameters and the initial 
chain length did not approximate the real situation, the fragment patterns calculated were 
comparable to the situation experimentally observed during degradation of high molecular 
weight HA by the action of hyaluronidases.  
When only hydrolysis was allowed in the calculation, the fragment pattern resembled roughly 
the situation observed during degradation of HA by BTH at pH 4.0 and by Hyal-1. The 
accumulation of hexasaccharides (n3) in addition to tetrasaccharides (n2) as the main 
fragments in the CZE analysis might indicate that the hexasaccharide (n3) might be a worse 
substrate than the higher molecular weight HA fragments. Changes in the affinity of very low 
molecular weight HA chains towards the binding site were not considered in the calculations 
except for the di- (n1) and tetrasaccharide (n2), but probably contribute to the fragment pattern 
observed in the real degradation reactions (Highsmith et al. 1975). 
The fragment pattern, observed when transglycosylation and hydrolysis were allowed to occur 
with equal probabilities, showed the characteristic bulk of higher molecular weight HA 
fragments remaining in the reaction mixture in addition to the low molecular weight 
oligosaccharides. A similar fragment pattern, but with much larger overall fragment sizes, 
was observed during degradation of HA by BTH at nearly neutral pH and by PH-20 (Fig. 8.5 
and Fig. 8.6).  
Although only very few restrictions were introduced in the calculation, the allowance of 
transglycosylation and hydrolysis reactions could provide a fragment pattern approximating 
the situation observed in the CZE.  
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8.3.3. Preparation and quantification of HA oligosaccharides 
8.3.3.1. Separation of HA oligosaccharides by size exclusion chromatography (SEC) 
After exhaustive digestion at acid pH, high molecular weight HA is degraded by BTH to 
even-numbered oligosaccharides with tetra- (n2) and hexasaccharides (n3) forming the main 
reaction products (Hoechstetter 2005). A volatile incubation buffer system (NH4OAc) was 
chosen to allow for the lyophilization and concentration of the degradation products after 
digestion.  
Fig. 8.10 shows the elution profile of an exhaustive HA digest separated by size exclusion 
chromatography (SEC) on a SuperdexPeptide 10/300 GL. The HA fragments were detected at 
210 nm due to the lack of a chromophore absorbing at higher wavelength. Detection at this 
wavelength resulted in a high absorbance of the buffer leading to a low sensitivity in 
detection.  
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Fig. 8.10 Elution profile of HA 
digestion products separated by SEC 
(Superdex Peptide 10/300 GL). 150 µL 
of HA digested by BTH for 48 h were 
applied to the column in a concentration 
of 30 mg/mL. Separation was 
performed at 0.5 mL/min in 0.1 M 
NH4OAc and monitored by detection of 
the absorbance at 210 nm. The 
oligosaccharide peaks were identified 
by ESI-MS. 
HA fragments were exclusively separated by their size, i.e. large fragments were eluted first, 
followed by oligosaccharides of decreasing size. Since the relative differences in molecular 
weight increase with decreasing size of the HA fragments, the separation improved with 
decreasing chain length. Fractions containing di- (n1) to octasaccharides (n4) contained pure 
oligosaccharides as determined by ESI-MS and CZE (8.3.3.2).  
Higher quantities of HA oligosaccharides were separated on a Superdex 30 column with a 
sample volume of up to 1.5 mL, but the separation of the HA oligosaccharides deteriorated 
(Fig. 8.11). Peaks containing hexa- (n3) and octasaccharide (n4) were not sufficiently pure 
after the first separation and were therefore pooled, concentrated by lyophilization and 
separated in a second run on the same column. 
Comparison of the mass of the oligosaccharides to the mass of high molecular weight HA 
used for digestion revealed a yield of < 4 % for n1, 8 % for n2, 44 % for n3 and 12 % for n4. 
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The overall yield in pure HA oligosaccharides was ca. 68 % of the digested high molecular 
weight HA. Deficits resulted mainly from intermediate fractions containing mixtures of 
oligosaccharides, which were not collected. Additionally, higher molecular weight fragments 
were still present in the incubation mixture, but were not collected.  
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Fig. 8.11 Elution profile of HA 
digestion products separated by SEC 
(Superdex 30). 1.5 mL of HA digested 
by BTH for 48 h were applied to the 
column in a concentration of 40 mg/mL. 
Separation was performed at 1.0 
mL/min in 0.1 M NH4OAc monitored 
by detection of the absorbance at 210 
nm. The oligosaccharides were 
identified by ESI-MS. 
However, when the concentration of the oligosaccharides was determined by the Morgan-
Elson reaction (Fig. 8.12), it turned out that the yield calculated using the molecular masses 
depicted in Tab. 8.1 was much lower than the one calculated from the mass after 
lyophilization. For n1 a yield of 2 % was determined, for n2 4 % and for n3 8 %. 
Probably, this discrepancy between oligosaccharide masses determined by direct and indirect 
measurement via the Morgan-Elson assay was a result of the strong hygroscopicity of HA. 
While water molecules associated to HA as well as to oligosaccharides were implied during 
direct weighing, those were not determined by the Morgan-Elson reaction resulting in these 
extreme discrepancies. 
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Fig. 8.12. Calibration curve for the 
quantification of HA oligosaccharides 
by the Morgan-Elson assay. GlcNAc 
diluted in water was quantified by the 
absorbance of the Morgan-Elson 
product at 585 nm. Water was used as a 
reference. 
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8.3.3.2. Analysis of HA oligosaccharides by ESI-MS and CZE 
After separation by SEC the components of the lyophilized fractions were identified by ESI-
MS. In Tab. 8.1 the molecular masses of the monoisotopic oligosaccharides are given. 
The purity of oligosaccharides identified by ESI-MS was confirmed by CZE. As the elution 
times in the CZE vary from one experiment to another, an identification of SEC fractions by 
CZE was impossible. However, during separation of HA digestion mixtures (cf. 8.3.2) n1, n2, 
n3 and n4 were identified by mean differences between the migration times of specific HA 
oligosaccharides (Tab. 8.2). 
 
Tab. 8.1. Calculated molecular masses of the monoisotopic oligosaccharides. 
 
HA oligosaccharide Molecular formula Molecular mass (Da) 
disaccharide (n1) C14H23NO12 397.33 
tetrasaccharide (n2) C26H44N2O23 776.23 
hexasaccharide (n3) C42H65N3O34 1155.34 
octasaccharide (n4) C56H86N4O45 1534.46 
 
Tab. 8.2 Mean differences in the migration times of HA oligosaccharides in the electropherograms. 
Distances were calculated from 14 independent experiments using mixtures of pure di- (n1), tetra- (n2), 
hexa- (n3) and octasaccharides (n4). STD indicates the standard deviations.  
 
Oligosaccharides Mean difference ± STD 
n1 – n2 3.01 ± 0.40 min 
n2 – n3 1.82 ± 0.25 min 
n3 – n4 0.87 ± 0.24 min 
 
Although the standard deviations (STD) of the mean differences were high (up to 27 %) an 
unambiguous identification of n1 – n4 was possible for fragments occurring in combination 
with the neighboring HA fragments. 
8.3.3.3. Quantitative analysis of di-, tetra- and hexasaccharides by CZE 
The concentration of pure HA oligosaccharides was quantified by the amount of reducing 
GlcNAc ends by the Morgan-Elson assay and the molecular mass of the respective 
compound. In the CZE the area/time (A/t) ratio of n1, n2 and n3 correlated linearly to the 
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concentration of the respective oligosaccharide in a concentration range between 25 µM and 
ca. 2.0 mM (Fig. 8.13).  
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Fig. 8.13 Calibration curve of di- (n1) (black triangles), tetra- (n2) (grey circles) and hexasaccharides 
(n3) (open squares) measured by CZE. A/t values are mean values ± SEMs (standard error of means) 
of 3 injections. The inset shows a magnified view of the concentration range 0 – 500 µM.    
 
Peaks at concentrations > 2 mM showed flattened peak tops, thus concentrations above 2.0 
mM were not used for the quantitative analysis. Triple injection of the same sample 
confirmed a constant sample volume injected automatically by pressure (SEMs ≤ 5 %) (Fig. 
8.13). Therefore, variations of the injection volume were neglected in the following 
experiments and all samples were injected only once. 
 
8.3.4. Time-dependent degradation of hyaluronan oligosaccharides 
8.3.4.1. Time-dependent degradation of n3 by BTH at pH 4.0 
To investigate, if the pH influences BTH with respect to its degradation kinetics as well as its 
mechanism of HA degradation HA hexasaccharide (n3) was used as a substrate at pH 4.0 and 
pH 6.0. The conversion of the HA hexasaccharide (n3), the well-known minimum substrate of 
BTH (Cramer et al. 1994), was monitored over a concentration range (25 µM – 2 mM) to gain 
information about the catalytic behavior of the hyaluronidase under Michaelis-Menten 
conditions.  
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CZE analysis of the conversion of n3 revealed the formation of n2 as the major reaction 
product, while all other products, n1, n4, n5 and n6, occurred at very low concentrations. 
Especially, the formation of the transglycosylation products, n4 and n5, was extremely low. 
Fig. 8.14 shows as an example the electropherograms after the conversion of 100 µM n3 into 
n1, n2 and n4 through the action of BTH at pH 4.0.  
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Fig. 8.14 CZE analysis of the degradation of 100 µM HA hexasaccharide (n3) by BTH (100 IE/mL 
according to the supplier; 60 IE/mL measured in the Morgan-Elson assay at pH 4.0) at pH 4.0. 
Samples were incubated for 0 and 60 min, respectively. 
 
Considering n5 as the largest reaction product and omitting hydrolysis reactions of HA 
fragments larger than n3, the following reactions can be assumed to occur at the initial stage 
of n3 degradation at pH 4.0: 
Hydrolysis:  n3  →  n1 + n2       Eq. 8.8 
Transglycosylation: 2 n3  →  n2 + n4      Eq. 8.9 
n4 + n3  →  n2 + n5      Eq. 8.10 
Previous data (Highsmith et al. 1975) indicate that n1 and n2 are too small to bind to the active 
site. Removal of n1 was not allowed with the exception of Eq. 8.8, which obviously occurred 
due to the high concentrations of n3 present in the reaction mixture (Fig. 8.14). 
Intriguingly, the degradation of n3 slowed down at concentrations > 300 µM and came to a 
complete halt at concentrations > 500 µM, indicating substrate inhibition of the enzyme at 
higher concentrations (Fig. 8.15). It should be noted that n3 is under physiological conditions 
the degradation product of high molecular weight HA rather than the substrate. Thus, the 
inhibition can be described as both, substrate and product inhibition.  
Results 
 166
0 10 20 30 40 50 60 70
0
4000
8000
12000
16000
20000
50 µM
A
/t
incubation time [min]
0 10 20 30 40 50 60 70
0
2e+4
4e+4
6e+4
8e+4
1e+5
250 µM
A
/t
incubation time [min]
µ
time (min)
0 10 20 30 40 50 60 70
0
5000
10000
15000
20000
25000
30000
35000
100 µM
incubation time [min]
A
/t
time (min)
0 5 10 15 20 25 30 35
0
1e+5
2e+5
3e+5
4e+5
5e+5 1 mM
incuba on time [min]
A
/t
 
Fig. 8.15 Time-dependent degradation of different concentrations of n3 followed by the area/time (A/t) 
ratio of the oligosaccharide in the CZE with n1 represented as filled triangles, n2 as open circles, n3 as 
filled circles, n4 as open triangles and n5 as filled squares. Digestions were performed by BTH (100 
IE/mL according to the supplier; 60 IE/mL as determined by the Morgan-Elson reaction at pH 4.0) at 
pH 4.0.    
  
Octa- (n4) and decasaccharides (n5) produced by transglycosylation at the initial stage of the 
reaction were observed to be degraded preferentially in the course of the incubation time even 
in the presence of a great excess of hexasaccharide (n3) (e.g. 100 µM in Fig. 8.15). 
The initial linear part of the degradation curve of the hexasaccharide at various concentrations 
enabled the calculation of initial degradation velocities in dependence on the substrate 
concentration. The calculation of characteristic enzymatic constants based on the observation 
of the time-dependent degradation of HA hexa- (n3) and octasaccharides (n4) is summarized in 
8.3.4.5. 
8.3.4.2. Time-dependent degradation of n3 by BTH at pH 6.0 
Experiments with high molecular weight HA had shown a difference in the degradation mode 
of BTH at acidic and neutral pH (cf. 8.3.2). Therefore, the degradation of n3 at pH 6.0 was 
monitored by analogy with the CZE experiments performed at pH 4.0 (cf. 8.3.4), and the 
decrease in the concentration of n3 could be quantified by means of a CZE calibration curve. 
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Fig. 8.16 CZE analysis of the degradation of 100 µM HA hexasaccharide (n3) by BTH (200 IE/mL, as 
declared by the supplier; 60 IE/mL measured in the Morgan-Elson assay at pH 6.0) at pH 6.0. Samples 
were incubated for 0 and 60 min, respectively. 
 
The degradation of n3 at pH 6.0 showed a preferential formation of oligosaccharides of higher 
molecular weight (n4 and n5). Intriguingly, no n1 was produced during the degradation of n3 at 
pH 6.0 (exemplarily shown for 100 µM n3 in Fig. 8.16).  
Considering the reactions involved in the degradation process of n3 shown in Eq. 8.8 – Eq. 
8.10, the hydrolysis of n3 into n1 and n2 (Eq. 8.8) can therefore be excluded from the 
processes occurring at pH 6.0. The decrease in n3 at the initial stage of the reaction was thus 
exclusively caused by the transglycosylation activity of BTH, which is known to occur 
preferentially at higher pH values (Gorham et al. 1975).  
At pH 6.0 an increase in the initial degradation velocity of n3 was observed up to 
concentrations of ca. 800 µM, then the velocity of degradation decreased fast and at 
concentrations > 1 mM no conversion of the substrate was observed any more (Fig. 8.21). 
These results are consistent with the substrate/product inhibition observed at pH 4.0. 
However, at pH 4.0 the inhibition occurred at lower substrate concentrations (> 200 µM). The 
apparent KM and vmax values of the degradation of n3 by BTH at pH 6.0 were calculated for 
the low concentration range from the initial velocities of n3 degradation (cf. 8.3.4.5).  
8.3.4.3. Time-dependent degradation of n3 and n4 by Hyal-1 
Recombinant human Hyal-1 produced by DS-2 cells was incubated with n3 as a substrate at 
pH 3.5, the optimum pH of Hyal-1 activity (cf. Chapter 5). Surprisingly, the incubation 
mixtures analyzed after different periods of incubation by CZE revealed no conversion of the 
HA hexasaccharide (Fig. 8.17). Although a wide range of n3 concentrations (20 µM – 6 mM) 
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similar to those assayed for the digestion with BTH was analyzed, Hyal-1 exhibited no 
catalytic activity against n3 (Fig. 8.17.b). 
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Fig. 8.17 a) CZE analysis of the incubation of 100 µM HA hexasaccharide (n3) with Hyal-1 (100 
IE/mL measured in the Morgan-Elson assay at pH 3.5) at pH 3.5. Samples were incubated for 0 and 60 
min, respectively. b) Time-dependent curves of increasing concentrations of n3 incubated with 100 
IE/mL Hyal-1 at pH 3.5. n3 concentrations were calculated from CZE peaks by means of a calibration 
curve.  
 
Thus, the active site of Hyal-1 seems to differ from BTH with respect to the catalytic activity 
towards small oligosaccharides. The inability of Hyal-1 to degrade n3 indicates either a very 
low affinity for HA fragments of three disaccharide units or a low catalytic activity towards 
bound n3. However, two facts hint to a low affinity of n3 towards the binding site: first, BTH 
is known to exhibit lower affinity towards n3 than n4, suggesting the existence of a site S3’ 
being relevant for binding (Highsmith et al. 1975). Possibly, the importance of this site in the 
binding pocket of Hyal-1 is even more distinctive. A second hint can be drawn from the 
observation, that n3 inhibited the degradation of high molecular weight HA by Hyal-1 very 
weakly (30 % inhibition at 3 mM) (personal communication by M. Spickenreither).  
 
In a second approach various concentrations of HA octasaccharide (n4) were used as substrate 
of Hyal-1 at pH 3.5. In contrast to the hexasaccharide (n3), the octasaccharide (n4) was 
converted quickly at substrate concentration between 25 µM and 1 mM. At concentrations 
higher than 1 mM weak substrate inhibition was observed (Fig. 8.21.a). Furthermore, the 
reaction products formed, varied significantly, depending on the substrate concentration. At 
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low n4 concentrations (< 500 µM) no transglycosylation products were observed, while at 
higher n4 concentrations (> 500 µM) fragments larger than the substrate were observed and 
the disaccharide (n1) occurred at concentrations close to the detection limit of the CZE (Fig. 
8.18).  
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Fig. 8.18 CZE analysis of the incubation of 100 µM (a) and 1 mM (b) of HA octasaccharide (n4) with 
Hyal-1 (100 IE/mL measured by the Morgan-Elson assay at pH 3.5) at pH 3.5. Samples were 
incubated for 0 and 60 min, respectively. 
 
At low substrate concentrations the reactions catalyzed by Hyal-1 seem to be restricted to 
hydrolysis of the octasaccharide (n4): 
n4 → n1 + n3        Eq. 8.11 
n4 → 2 n2        Eq. 8.12 
When the substrate concentration increased above ca. 500 µM transglycosylation reactions 
occurred at a higher frequency than at low substrate concentrations, enabling the production 
of HA fragments larger than the substrate: 
  2 n4 → n3 + n5        Eq. 8.13 
  2 n4 → n2 + n6        Eq. 8.14 
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Other transglycosylation reactions were omitted due to the occurrence of fragments other than 
n4 in very low concentrations. Although substrate inhibition was observed at high substrate 
concentrations (> 1 mM) apparent KM and vmax values were calculated (Fig. 8.21.b and Tab. 
8.3), which were significantly increased compared to the values observed during degradation 
of the HA hexasaccharide (n3) by BTH.  
8.3.4.4. Time-dependent degradation of n3 and n4 by PH-20 at pH 4.5 
Partially purified human PH-20, expressed by DS-2 cells (cf. Chapter 6), was analyzed for its 
degradation behavior in respect of low molecular weight HA oligosaccharides. Although BTH 
and PH-20 refer to the same hyaluronidase isozymes from different species, recombinant 
human PH-20 did not recognize the HA hexasaccharide as a substrate molecule. In 
accordance with the observations described for Hyal-1, increasing concentrations of HA 
hexasaccharide (25 µM – 2 mM) incubated for various time periods with PH-20 resulted in no 
conversion of the putative minimum substrate (Fig. 8.21.a).  
Therefore, the HA octasaccharide (n4) was offered as substrate and was found to be degraded 
very efficiently. Intriguingly, the conversion of HA octasaccharide (n4) proceeded very 
quickly, with hexa- (n3) and tetrasaccharides (n2) forming the major final reaction products 
(Fig. 8.19, t = 60 min). 
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Fig. 8.19 CZE analysis of the incubation of 100 µM of HA octasaccharide (n4) with PH-20 (94 IE/mL 
determined by the Morgan-Elson assay at pH 4.5) at pH 4.5. Samples were incubated for 0, 10 and 60 
min, respectively. 
 
In the course of the degradation significant amounts of HA fragments larger than the 
octasaccharide (n4) were formed, indicating the occurrence of transglycosylation reactions. 
Yet these deca- (n5) and dodecasaccharides (n6) were obviously preferred as substrate 
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molecules since they were hydrolyzed again during the incubation period (Fig. 8.19, t = 10 
min and 60 min).  
 
Thus, the reactions occurring during degradation of n4 by PH-20 are generally identical to 
those catalyzed by Hyal-1, but with a much stronger influence of the transglycosylation 
reactions. The hydrolysis of n4 (Eq. 8.11 and Eq. 8.12) seems to be of minor importance as 
concluded from the formation of low concentrations of n1 and n2 during the initial phase of 
degradation (Fig. 8.19, t = 10 min). Moreover, the transglycosylation reactions shown in Eq. 
8.13 and Eq. 8.14 seem to account for the major decrease in the concentration of n4, as the 
reaction products observed after 10 min of incubation were n3 and n5, and only to a minor 
extent n6 and n2. At elevated substrate concentrations (> 500 µM) higher molecular weight 
oligosaccharides (up to n8) were detected, confirming the preference of transglycosylation 
reactions catalyzed by PH-20. The formation of HA disaccharide (n1) was observed during the 
conversion process of the octasaccharide (n4) only in very low concentrations as shown in 
Fig. 8.19 or not at all.  
Since no significant difference was observed between the kinetics of the degradation of high 
molecular weight HA catalyzed by PH-20 at pH 4.5 and pH 5.5, i.e. at the pH optima of the 
colorimetric and the turbidimetric hyaluronidase activity assays (8.3.2.3), the conversion of n4 
was merely observed at pH 4.5. 
8.3.4.5. Calculation of kinetic parameters 
The time-consumption curves of the hexasaccharide (n3) and the octasaccharide (n4) by the 
action of the hyaluronidases exhibited linear parts at the initial stage the reactions, referring to 
the steady-state conditions of the Michaelis-Menten kinetics. Quantification of the substrate 
was performed by CZE calibration curves (8.3.3.2). As an example, the degradation kinetics 
of the hexasaccharide (n3) by BTH at pH 4.0 is shown in Fig. 8.20. The slope of the time-
consumption curves represents the initial degradation velocity of the substrate molecule. 
Fig. 8.21 shows the initial reaction velocity at various substrate concentrations for BTH at pH 
4.0 and 6.0, for Hyal-1 at pH 3.5 and for PH-20 at pH 4.5. Both, BTH and Hyal-1, were 
inhibited by the substrate at increasing concentrations: BTH was inhibited by n3 
concentrations above 200 µM at pH 4.0 and at pH 6.0 by n3 concentrations above 800 µM, 
Hyal-1 was inhibited by n4 concentrations above 1 mM. In contrast to the other 
hyaluronidases, PH-20 was not inhibited by the HA octasaccharide (n4) at concentrations up 
to 2 mM reaching a maximum degradation velocity of 1.9 nmol/min. 
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Fig. 8.20 Linear part of the time-consumption curves of the digestion of increasing concentrations of 
n3 with 60 IE/mL BTH at pH 4.0. n3 concentrations were calculated from CZE peak area/time ratios 
using a calibration curve. The left graph shows a zoomed section of the n3 concentration range 0 – 90 
µM, the right graph shows the whole concentration range up to 1 mM n3 as substrate.  
 
Due to the occurrence of substrate inhibition at higher concentrations only the region not 
influenced by the inhibitory effects of the substrate was used for the calculation of apparent 
Michaelis-Menten kinetics (Fig. 8.21.b). 
For BTH the apparent KM values determined at the acid and the pH optimum around neutral 
were very similar (100 – 150 µM), but the maximum velocity (vmax) differed by a factor of 4 
(Tab. 8.3). The KM value of n4 degradation by PH-20 was found to be very similar to the KM 
values of n3 cleavage by BTH, though the maximum degradation velocity (vmax) of the 
minimum substrate of PH-20 outnumbered vmax of BTH by a factor of 10 at acid pH 
conditions. The vmax and KM values calculated for Hyal-1 were significantly increased 
compared to BTH.  
Using the molecular mass of the main fraction of BTH (58 kDa) (Hoechstetter 2005) and a 
specific enzymatic activity of 50,000 IE/mg (according to the supplier) the turnover-number 
(kcat) as well as the catalytic efficiency kcat/KM could be calculated. For the calculation of kcat 
of Hyal-1 a molecular mass of 54 kDa and a specific enzymatic activity of 10 U/mg (100,000 
IE/mg) were assumed (cf. Chapter 5). Since PH-20 was only partially purified (cf. Chapter 6) 
the catalytic efficiency kcat of PH-20 (56 kDa) was estimated using the specific enzymatic 
activity of BTH (50,000 IE/mg).  
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Fig. 8.21 Initial degradation velocity plotted against the substrate concentration for the degradation of 
n3 and n4, respectively, by different hyaluronidases: degradation of n3 by BTH at pH 4.0 (filled circles) 
and at pH 6.0 (open circles), degradation of n3 (filled squares) and n4 (open squares) by PH-20 at pH 
4.5 and degradation of n3 (open triangles) and n4 (filled triangles) by Hyal-1 at pH 3.5. a) Complete 
curves showing the inhibition of the reaction velocity at higher substrate concentrations for BTH and 
Hyal-1. b) Calculation of apparent KM and vmax values by curve fitting. 
 
Tab. 8.3 Comparison of apparent KM, vmax, kcat and kcat/KM values calculated from the time-dependent 
degradation of HA oligosaccharides by BTH, Hyal-1 and PH-20.  
 
Enzyme (pH) 
 
Substrate 
 
Apparent KM 
[µM] 
Apparent vmax 
[nmol/min] 
kcat 
[s-1] 
kcat/KM 
[min-1M-1] 
BTH  (4.0) n3 103 ± 33  0.16 ± 0.03  0.76  0.44 · 106  
BTH (6.0) n3 154 ± 24  0.63 ± 0.04  1.5  0.59 · 106  
PH-20 (4.5) n3 - - - - 
PH-20 (4.5) n4 130 ± 18  1.9 ± 0.06  9.3 #  4.3 · 106 #  
Hyal-1 (3.5) n3 - - - - 
Hyal-1 (3.5) n4 824 ± 150  1.6 ± 0.17  14.4  1.0 · 106 
 
Obviously, PH-20 and Hyal-1 turn over their minimum substrate, n4, about ten times faster 
than BTH turns over the hexasaccharide (n3). The turnover-number (kcat) can be considered as 
a rate constant for the velocity of substrate cleavage once it is bound to the enzyme, i.e. PH-
                                                 
# values including an estimation of the specific enzymatic activity. 
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20 and Hyal-1 catalyze the cleavage of a bound octasaccharide (n4) much faster than BTH 
catalyzes the cleavage of a bound hexasaccharide (n3). Additionally, the catalytic efficiency 
kcat/KM of Hyal-1 and PH-20 towards n4 is increased compared to the catalytic efficiency of 
BTH towards n3 indicating a faster binding of the substrate moiety to the binding pocket 
(kcat/KM).  
 
8.4. Discussion 
8.4.1. Degradation of high molecular weight HA 
The degradation of high molecular weight HA by different hyaluronidase isoenzymes was 
qualitatively characterized using a colorimetric assay for the detection of reducing GlcNAc 
ends and a CZE method for separation of the HA fragments. In the CZE high molecular 
weight HA (n2500 – n5000, MW 1 – 2 Mio Da) migrated as a single, broad peak (Grimshaw et 
al. 1994, Grimshaw et al. 1996), but fragments consisting of less than 9 disaccharide units 
were detected as separate peaks. 
 
When high molecular weight HA was degraded by BTH at pH 4.5, the formation of reducing 
GlcNAc ends decreased continuously with incubation time following double-exponential 
kinetics. In CZE a continuous decrease in the molecular weight of the substrate could be 
observed. At pH 5.5 the formation of GlcNAc residues followed a similar time course as 
observed at pH 4.5. However, as detected by CZE high molecular weight HA was only 
degraded partially to low molecular weight oligosaccharides with higher molecular weight 
HA fragments remaining in the incubation mixture. 
Obviously, the velocity of GlcNAc formation slows down steadily indicating a faster 
hydrolysis of high molecular weight HA chains compared to low molecular weight HA. The 
fact that the formation of GlcNAc residues can not be described by a mono-exponential 
equation as in the case of Hyal-1 (cf. 8.3.2.4) is an indication of the existence of several 
factors influencing the degradation process, e.g. transglycosylation and changes in the affinity 
for high and low molecular weight HA fragments.  
The simultaneous occurrence of higher molecular weight HA chains and HA oligosaccharides 
around neutral pH could be a consequence of an increased transglycosylation activity of the 
enzyme at higher pH (Gorham et al. 1975, Takagaki et al. 1994). The transfer of HA 
fragments comprising at least one disaccharide unit from one non-reducing HA chain end to 
another (Weissmann 1955, Highsmith et al. 1975) was mainly shown for low molecular 
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weight oligosaccharides (Highsmith et al. 1975, Takagaki et al. 1994, Saitoh et al. 1995) up to 
now. However, Bystricky et al. (Bystricky et al. 2002) described the formation of higher 
molecular weight HA chains as a result of transglycosylation under specialized conditions. A 
theoretical calculation of the HA fragments formed by hydrolysis and transglycosylation 
reactions showed an approximation to the fragment pattern observed by degradation of HA 
through the action of BTH at approximately neutral pH. However, these results must be 
considered as a mere hint, as several simplifications were necessary for the simulation. 
In fact, the observed differences in the degradation products of hyaluronan produced at acidic 
and at neutral pH provide an explanation for the shift in the pH optima in the turbidimetric 
and in the colorimetric assay. While the number of GlcNAc residues produced during the 
incubation period is larger at pH 4.5 than at pH 5.5, the amount of fragments falling below the 
detection limit (< 8 kDa) of the turbidimetric assay is larger around neutral pH. As only 
fragments of sizes > 8 kDa, i.e. comprising more than 20 disaccharide units, are detected in 
the turbidimetric assay, most fragments separated by CZE fall below the level of detection. 
Apparently, the high molecular weight HA is degraded faster to a size of < 8 kDa at nearly 
neutral pH than at acid pH, thus resulting in a pH optimum of pH 6.0 in the turbidimetric 
assay. 
 
The situation observed during degradation of high molecular weight HA by recombinant, 
human PH-20 was similar to BTH, but with the difference between the two pH optima at pH 
4.5 and pH 5.5 being much less pronounced. Thus, the shift in the pH optima measured in the 
two hyaluronidase activity assays (cf. Chapter 6) can be explained by the same principle as 
described for BTH. However, the existence of different enzymatically active isoforms in BTH 
preparations (Oettl et al. 2003) seems to facilitate the pH dependent changes in the 
degradation mechanism of HA.  
Though all results were obtained by in vitro experiments, it can be speculated if the specific 
pattern of hyaluronan fragments observed at pH 5.5 might be of any biological importance. 
Intriguingly, pH values > 5.3 were found during mammalian fertilization in the environment 
of the sperm before and after the acrosome reaction (Nakanishi et al. 2001). Possibly, the 
sperm hyaluronidase generates a pathway through the cumulus extracellular matrix of the 
oocyte by degradation of high molecular weight HA chains without complete destruction of 
the HA network, i.e. with higher molecular weight HA chains remaining as observed in vitro. 
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The situation observed with Hyal-1 was much simpler than in the case of the PH-20 
isoenzymes: the time-dependent liberation of reducing GlcNAc ends during the degradation 
of high molecular weight HA could be described by a first-order reaction. The size of the 
produced HA fragments decreased sequentially until HA di- (n1) to hexasaccharides (n3) 
accumulated as the final products. The observed degradation kinetics might thus be explained 
by cleavage of the HA chains in a random fashion without any preferences for high or low 
molecular weight HA.  
Although the HA fragment pattern produced by Hyal-1 showed no residual higher molecular 
weight HA and roughly resembled the situation calculated by sole random hydrolysis of an 
HA chain, the occurrence of transglycosylation in addition to hydrolysis can not be excluded. 
 
8.4.2. Degradation of HA oligosaccharides 
Much more specific insight into the catalytic mechanism of BTH, Hyal-1 and PH-20 was 
gained from the quantitative analysis of the time-dependent conversion of defined pure HA 
oligosaccharides.  
 
BTH converted its well-known minimum substrate, the HA hexasaccharide (n3), mainly by 
hydrolysis at acidic pH (pH 4.0). Around neutral pH the preferential formation of fragments 
larger than the substrate indicated a higher frequency of transglycosylation events. In contrast 
to the degradation at pH 4.0, no HA disaccharide (n1) was detected as reaction product at pH 
6.0. Thus, hydrolysis of the hexasaccharide (n3) was excluded.  
Due to the lack of crystal structures, information about the active site of mammalian 
hyaluronidases is only available from the x-ray structure of the mammalian-type BVH 
(Markovic-Housley et al. 2000). Based on experimental data of the reactions catalyzed by 
BTH, specific sites of binding and catalysis were postulated (Highsmith et al. 1975, Takagaki 
et al. 1994). The current view of the catalytic site of BTH comprises a E residue acting as an 
acid/base catalyst (cf. Chapter 1) and several binding sites (S) on both sides of the cleavage 
site, each occupied by one disaccharide unit of the HA chain. Highsmith et al. (Highsmith et 
al. 1975) proposed a site S2 – S1 – S1’ – S2’ – S3’ according to the terminology of Schechter 
and Berger (Schechter and Berger 1966) with the reducing terminus of the sugar chain located 
on the right hand side, and the cleavage occurring between S1 and S1’. Based on the 
observation, that at pH 5.0 HA tetrasaccharides (n2) are insufficient substrate molecules for 
BTH, hexasaccharides (n3) are the minimum substrate moieties and octasaccharides (n4) are 
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better substrates than hexasaccharides differential affinities of the disaccharide binding sites 
were proposed: weak binding affinity of the sites S1 and S1’, high affinity of S2’ in contrast 
to a very weak binding affinity of S2 and an important, but not essential binding affinity of 
S3’ (Highsmith et al. 1975) (Fig. 8.22). 
Binding of n3 encompasses the sites S1 – S1’ – S2’ with n1 leaving the site S1 and n2 the sites 
S1’-S2’ after hydrolysis at pH 4.0. At pH 6.0, however, n1 does not, or only to a minor extent, 
leave the site S1, but remains bound until transglycosylation to another acceptor molecule like 
n3 has occurred. Therefore, the increased transglycosylation activity around neutral pH might 
be explained by an increase in the affinity of the site S1 at pH 6.0 compared to pH 4.0.  
pH 4.0
pH 6.0
BTH
BTH
pH 4.5PH-20
S2 – S1 – S1‘ – S2‘ – S3‘
S2 – S1 – S1‘ – S2‘ – S3‘
S2 – S1 – S1‘ – S2‘ – S3‘
pH 3.5Hyal-1 S2 – S1 – S1‘ – S2‘ – S3‘  
 
Fig. 8.22 HA binding site model 
adapted from Highsmith et al. 
(Highsmith et al. 1975). Each subsite S 
binds one disaccharide unit, the 
cleavage site is marked by an arrow. 
The affinity of the subsites towards the 
substrate moieties as concluded from 
kinetic measurements are marked by the 
grey circles. An increase in affinity is 
represented by a darker shade of grey.  
 
The degradation of HA oligosaccharides by BTH or ovine testicular hyaluronidase has often 
been observed before. However, the reaction products as well as the kinetic parameters 
determined differ significantly due to the use of various detection methods and buffer 
conditions. The formation of the HA disaccharide (n1) as reaction product was reported by 
some authors (Weissmann 1955, Takagaki et al. 1994, Saitoh et al. 1995), while others could 
not detect any n1 (Highsmith et al. 1975, Cramer et al. 1994, Kinoshita et al. 2001). As all the 
results were obtained in buffer systems at pH 5.0 – 5.3 other factors such as the nature of the 
buffering ions as well as the overall salt concentrations seem to influence the degradation 
behavior of BTH (Saitoh et al. 1995, Asteriou et al. 2006).  
Asteriou et al. (Asteriou et al. 2006) described substrate inhibition for the degradation of high 
molecular weight HA at low ionic strengths, but no substrate inhibition was described up to 
now for the degradation of low molecular weight HA oligosaccharides (Gorham et al. 1975, 
Highsmith et al. 1975, Cramer et al. 1994). The recording of CZE kinetics at higher salt 
concentrations (> 0.1 M) had to be abandoned due to interferences with the CZE method at 
increased salt concentrations. 
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The recombinant human enzymes PH-20 and Hyal-1 exhibited a completely different 
catalytic behavior than BTH with respect to HA oligosaccharides as substrates. Both enzymes 
were not able to catalyze any conversion or degradation of the supposed minimum substrate, 
the HA hexasaccharide (n3). Although experimental evidence for the identity of the minimum 
substrate of human hyaluronidases was missing, the HA hexasaccharide (n3) was generally 
believed to be the smallest substrate moiety for all mammalian-type hyaluronidases (Stern and 
Jedrzejas 2006). However, the HA octasaccharide (n4) could be proven to be the minimum 
substrate for both, recombinant, human PH-20 and Hyal-1. 
In terms of the substrate binding site model the hexasaccharide, occupying the sites S1 – S1’ 
– S2’, seems to exhibit insufficient affinity towards the binding site of PH-20 and Hyal-1. 
Thus, the affinity of the subsite S2’, which provides the essential affinity for binding of the 
hexasaccharide to BTH (Highsmith et al. 1975), is significantly decreased in PH-20 and Hyal-
1 (Fig. 8.22).  
 
The conversion of the octasaccharide by PH-20 can be explained by assuming a shift of the 
essential binding site from position S2’ to position S3’ (Fig. 8.22). The site S1 seems to 
exhibit considerable affinity since transglycosylation reactions were preferentially catalyzed 
by PH-20 (cf. BTH at pH 6.0). However, the model can not provide a satisfactory explanation 
for the formation of n2 and n3 as the major reaction products, but n1 in extremely low 
concentrations. Presumably, the enzyme catalyzed mainly the transglycosylation reaction 
shown in Eq. 8.13 as concluded from the occurrence of the decasaccharide (n5) as the main 
transglycosylation product. The fast degradation of the decasaccharide in the course of time 
indicated a preferential hydrolysis of n5, which could provide the major reaction products n2 
and n3. 
 
The following binding site model is proposed to explain the reactions catalyzed by Hyal-1: 
the octasaccharide (n4) was degraded to di-, tetra- and hexasaccharides, thus suggesting the 
binding of the octasaccharide in two different position, one covering the sites S2 – S1 – S1’ – 
S2’ (Eq. 8.12) and the other one covering the sites S1 – S1’ – S2’ – S3’ (Eq. 8.11). Assuming 
that the affinity of the hexasaccharide is insufficient for binding (cf. 8.3.4.3), the binding 
affinity of the octasaccharide might be dependent on the occupation of at least two binding 
sites with medium affinity, i.e. two of the sites S2, S2’ and S3’ (Fig. 8.22). 
Hyal-1 is able to catalyze transglycosylation of the HA octasaccharide (n4), albeit only in the 
presence of high substrate concentrations (n4 > 500 µM). In contrast to Hyal-1 the 
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transglycosylation activity of BTH was pH dependent without any significant effect of the 
substrate concentration.  
An explanation for the concentration-dependent changes in the catalytic process might be 
provided by the affinity of the disaccharide unit occupying the subsite S1 (and S2). For 
transglycosylation at least the site S1 has to stay occupied while the product on the other side 
of the cleavage site leaves the site S1’ – S2’ – S3’ and a new acceptor molecule is bound. 
Thus, if the rate constant for the release of the disaccharide unit in position S1 (koff) is in the 
same time range as the diffusion-controlled encounter and binding of enzyme and acceptor 
molecule, the occurrence of concentration-dependent transglycosylation events might be 
explained as follows: at low substrate concentrations (< 500 µM) the position S1 releases the 
disaccharide unit before a new acceptor molecule is bound; at high substrate concentrations (> 
500 µM), however, the probability for the encounter and binding of another acceptor 
molecule within the time-range of koff is increased, resulting in transglycosylation.  
 
Interestingly, the maximum concentration of HA fragments, i.e. disaccharide units, present in 
the incubation mixture* during observation of the degradation of high molecular weight HA 
by Hyal-1 (8.3.2.4) was in the low concentration range (139 µM). Provided that the results 
observed with the HA oligosaccharide can be transferred to the catabolism of high molecular 
weight HA, the occurrence of transglycosylation events during the degradation of HA 
observed in the Morgan-Elson assay and in the CZE can be excluded. This hypothesis is 
supported by the kinetics of the GlcNAc formation through the action of Hyal-1 as described 
previously.   
If the concentration-dependent shift from mere hydrolysis to higher transglycosylation 
activity has any biological importance in the catabolism of hyaluronan is questionable. The 
main function of Hyal-1 seems to be the hydrolysis of high molecular weight hyaluronan to 
low molecular weight oligosaccharides at acid pH values.  
 
The analysis of the degradation of high molecular weight HA as well as of HA 
oligosaccharides provided new insights into the catalytic mechanism of different 
hyaluronidase isozymes within the family of mammalian hyaluronan hydrolases. The 
differences between the hyaluronidase isoenzymes were much more pronounced than 
                                                 
* concentration of disaccharide units = 55 µg/mL (concentration of high molecular weight HA)/397 g/mol 
(molecular weight of one disaccharide unit) = 139 µM. 
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expected. Obviously, the different hyaluronidase isozymes have evolved into very specialized 
enzymes with respect to their mechanism of HA degradation. 
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Hyaluronidases and their substrate, hyaluronic acid, are known to play a role in signal 
transduction events directly correlated with tumor growth and cell migration. Yet correlations 
with disease progression are controversial due to scarce information on enzymatic properties 
and the lack of specific inhibitors as pharmacological tools. Therefore, the aim of this thesis 
was the establishment of recombinant expression systems for the human hyaluronidase 
subtypes, purification of the enzymes and their characterization with respect to biochemical 
and catalytic properties.  
 
In a first approach the human hyaluronidase subtypes PH-20, Hyal-1, Hyal-2 and Hyal-4 were 
efficiently expressed in E. coli. All human hyaluronidases formed inclusion bodies in the 
cytoplasm of E. coli due to the presence of disulfide bridges in the native proteins. Only Hyal-
1 could be re-folded in vitro into an enzymatically active protein with the folding yields 
strongly depending on the kind of denaturing agent used, the disulfide shuffling system and 
the presence of arginine in the folding buffer. However, both the yield of active protein and 
the specific enzymatic activity of Hyal-1, purified by Ni-IMAC under denaturing conditions, 
were extremely low. 
 
As in vitro folding of the human hyaluronidases posed major problems, the human 
hyaluronidases Hyal-1, PH-20 and Hyal-2 were alternatively expressed into the culture 
medium of Drosophila Schneider-2 cells (DS-2 cells) enabling the correct formation of 
disulfide bonds and mammalian-like glycosylation.  
 
Native Hyal-1 was expressed by DS-2 cells and purified by ammonium sulfate precipitation, 
cation exchange chromatography and Ni-IMAC. During purification the use of detergents was 
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required because of the extraordinarily high adsorbance of the protein to surfaces. Highly 
pure, homogeneous Hyal-1 (54 kDa with 4 kDa comprising glycosidic residues) with a 
specific enzymatic activity comparable to human plasma hyaluronidase was isolated in 
quantities sufficient for biophysical characterization studies. Although characteristic features 
such as the pH profile showed a similar catalytic behavior of Hyal-1, expressed in the 
prokaryotic and the eukaryotic system, the glycosylation of Hyal-1 was shown to improve the 
catalytic efficiency of the enzyme in solution. A truncation of Hyal-1 by the C-terminal 
domain failed to yield enzymatically active protein in both expression systems. 
 
Human PH-20 (56 kDa) was stably expressed by DS-2 cells and purified by chelating-IMAC. 
As determined previously for bovine testicular hyaluronidase (BTH), a commercially 
available hyaluronidase preparation, human PH-20 exhibited the typical assay-dependent shift 
in the pH activity optimum. Furthermore, recombinant Hyal-1 and PH-20 recognized 
chondroitin sulfate A and C as alternative substrates with pH-dependent activities similar to 
the preferred substrate, hyaluronic acid.  
 
In contrast to PH-20 and Hyal-1, no catalytic activity was detected with recombinant human 
Hyal-2 (54 kDa), expressed by DS-2 cells. Since the hydrolytic activity of human Hyal-2 is 
discussed controversially in the literature, a variety of hyaluronidase activity assays, including 
electrophoretic and viscosimetric techniques, was explored. However, none of the methods 
proved any hyaluronidase or chondroitinase activity of recombinant Hyal-2 under acid, 
neutral or basic pH conditions. 
 
To gain more detailed insight into the catalytic mechanism of the recombinant human 
hyaluronidases Hyal-1 and PH-20 in comparison to BTH a capillary zone electrophoresis 
method was established for the qualitative and quantitative detection of degradation products 
of hyaluronic acid. BTH and, less significantly, recombinant human PH-20 produced different 
degradation products of hyaluronic acid at acidic and nearly neutral pH, explaining the assay-
dependent shift of the pH activity profiles. Human Hyal-1 was found to degrade high 
molecular weight hyaluronic acid consecutively into di- to hexasaccharides as final products. 
The quantitative analysis of the conversion of hyaluronan hexa- and octasaccharides revealed 
specific properties of the hyaluronidase subtypes: the minimum substrate of BTH, the 
hexasaccharide, was not accepted as a substrate by Hyal-1 and PH-20, albeit the 
octasaccharide; transglycosylation, which was catalyzed to a significant extent by BTH and 
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PH-20, occurred with Hyal-1 only in the presence of a great excess of substrate. The 
calculation of enzymatic parameters by Michaelis-Menten kinetics revealed additional 
features of the hyaluronidase subtypes. A model of an array of disaccharide unit binding sites 
framing the active site was employed to explain the pH- and subtype-specific properties of the 
hyaluronidases. 
 
Taken together, the recombinant production of human hyaluronidases provides the basis for 
enzymological studies, crystallization and the structure-based development of specific 
inhibitors, which can be used, for example, as pharmacological tools. 
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Appendix 1: Hyaluronidase cDNA sequences 
Bases printed in bold and underlined designate mutations in the sequences compared to the 
reference sequences. 
Hyal-1: RZPD clone I.D. IRAKp961O1779Q2  
Reference sequence: BC035695 
        1 ggtgcagctg gggtggaatc tggccaggcc ctgcttaggc ccccatcctg gggtcaggaa 
       61 atttggagga taaggccctt cagccccaag gttgtcctcg accagtcccg tgccatggca 
      121 gcccacctgc ttcccatctg cgccctcttc ctgaccttac tcgatatggc ccaaggcttt 
      181 aggggcccct tgctacccaa ccggcccttc accaccgtct ggaatgcaaa cacccagtgg 
      241 tgcctggaga ggcacggtgt ggacgtggat gtcagtgtct tcgatgtggt agccaaccca 
      301 gggcagacct tccgcggccc tgacatgaca attttctata gctcccagct gggcacctac 
      361 ccctactaca cgcccactgg ggagcctgtg tttggtggtc tgccccagaa tgccagcctg 
      421 attgcccacc tggcccgcac attccaggac atcctggctg ccatacctgc tcctgacttc 
      481 tcagggctgg cagtcatcga ctgggaggca tggcgcccac gctgggcctt caactgggac 
      541 accaaggaca tttaccggca gcgctcacgg gcactggtac aggcacagca ccctgattgg 
      601 ccagctcctc aggtggaggc agtagcccag gaccagttcc agggagctgc acgggcctgg 
      661 atggcaggca ccctccagct ggggcgggca ctgcgtcctc gcggcctctg gggcttctat 
      721 ggcttccctg actgctacaa ctatgacttt ctaagcccca actacaccgg ccagtgccca 
      781 tcaggcatcc gtgcccaaaa tgaccagcta gggtggctgt ggggccagag ccgtgccctc 
      841 tatcccagca tctacatgcc cgcagtgctg gagggcacag ggaagtcaca gatgtatgtg 
      901 caacaccgtg tggccgaggc attccgtgtg gctgtggctg ctggtgaccc caatctgccg 
      961 gtgctgccct atgtccagat cttctatgac acgacaaacc actttctgcc cctggatgag 
     1021 ctggagcaca gcctggggga gagtgcggcc cagggggcag ctggagtggt gctctgggtg 
     1081 agctgggaaa atacaagaac caaggaatca tgtcaggcca tcaaggagta tatggacact 
     1141 acactggggc ccttcatcct gaacgtgacc agtggggccc ttctctgcag tcaagccctg 
     1201 tgctccggcc atggccgctg tgtccgccgc accagccacc ccaaagccct cctcctcctt 
     1261 aaccctgcca gtttctccat ccagctcacg cctggtggtg ggcccctgag cctgcggggt 
     1321 gccctctcac ttgaagatca ggcacagatg gctgtggagt tcaaatgtcg atgctaccct 
     1381 ggctggcagg caccgtggtg tgagcggaag agcatgtggt gattggccac acactgagtt 
     1441 gcacatattg agaacctaat gcactctggg tctggccagg gcttcctcaa atacatgcac 
     1501 agtcatacaa gtcatggtca cagtaaagag tacactcagc cactgtcaca ggcatattcc 
     1561 ctgcacacac atgcatactt acagactgga atagtggcat aaggagttag aaccacagca 
     1621 gacaccattc attccatgtc catatgcatc tacttggcaa ggtcatagac aattcctcca 
     1681 gagacactga gccagtcttt gaactgcagc aatcacaaag gctgacattc actgagtgcc 
     1741 tactctttgc caatccccgt gctaagcgtt ttatgtggac ttattcattc ctcacaatga 
     1801 ggctatgagg aaactgagtc actcacattg agagtaagca cgttgcccaa ggttgcacag 
     1861 caagaaaagg gagaagttga gattcaaacc caggctgtct agctccgggg gtacagccct 
     1921 tgcactccta ctgagtttgt ggtaaccagc cctgcacgac ccctgaattt gttgagaggc 
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     1981 accagtccag caaataaagc agtcatgatt tacttaaaaa aaaaaaaaaa aaaaaaaaaa 
     2041 aaaaaaaaaa aaaaaaa 
 
Hyal-4: RZPD clone I.D. IMAGp958H01139Q2  
Reference sequence: NM_012269 
The 5’-end of the sequence (crossed) is replaced in the RZPD clone by a short nucleotide 
sequence (ggcacgagg). 
        1 cgcccgggca ggtctttatt ttatttatgc tatctatttc ttttcctttt tttttttttt 
       61 tttttgagat gaagtcttac tctgttgccc aggctggagt gtagtggtgt gatctcggct 
      121 cgctgcagcc actgcctcct gggttcaggt gattctcctg acttagcctc ctgagtggct 
      181 gggactgcag gagcatgcca tcatgcccag ctgatttttg tatttttagt agagatgggg 
      241 tttcaccgtg ttggccagaa tggtttgcat tcctgacctc aagtgatctg cctgcctcag 
      301 cctcccaaaa tgttgggtac aggggtgagc caccgtgcct tgctattaat gccatctatt 
      361 tcactgaaga ttccgcctct catttcttga gtcatttttt ttaaatttcc ttaaattgga 
      421 cttcacattt tctgatgcct ccttgtttag cttaataact gaccttctga attctttttt 
      481 aggaaaatca ggaatttctt cttggtttgg agccattgct ggacatcctt tgccattcaa 
      541 cctctgattt gcacaaggtg actaaaggac cagcagcaaa caaaacgttt ggtcttctag 
      601 agtgcactaa agcagaagat acgtaacatt tttatcttac catgaaagta ttatctgaag 
      661 gacagttaaa gctttgtgtt gttcaaccag tacatctcac ttcatggctc cttatatttt 
      721 ttattctaaa gtctatctct tgtctaaaac ctgctcgact tccaatttat caaaggaaac 
      781 cttttatagc tgcttggaat gctccaacag atcagtgttt gataaaatat aatttaagac 
      841 taaatttgaa aatgtttcct gtgattggaa gcccactggc caaggccagg gggcaaaatg 
      901 tcactatatt ttatgtcaac agattgggat actatccgtg gtatacatca caaggggtcc 
      961 ccattaatgg aggtctccca cagaacataa gtttacaagt acatctggaa aaagctgacc 
     1021 aagatattaa ttattacatc cctgctgaag atttcagtgg acttgctgtt atagattggg 
     1081 aatattggcg accacagtgg gcccggaact ggaactcaaa agatgtttac agacagaagt 
     1141 caagaaagct tatttccgat atgggaaaga atgtatcagc taccgatatt gaatatttag 
     1201 ccaaagtgac ctttgaagaa agtgcaaaag ctttcatgaa ggaaaccatc aaattgggaa 
     1261 ttaagagccg acccaaaggc ctttggggtt attatttata tcctgattgc cacaattata 
     1321 acgtttatgc cccaaactac tctgggtcat gcccagaaga cgaagtcttg aggaacaatg 
     1381 agctctcttg gctctggaac agcagtgctg ctttatatcc ttctatctgt gtctggaaat 
     1441 cccttggaga cagtgaaaac attttgcgct tctccaaatt tcgggtgcat gaatccatga 
     1501 ggatctccac catgacatct catgattatg ctctgcctgt atttgtctac acaaggctag 
     1561 ggtacagaga tgaaccttta tttttccttt ctaagcaaga tctagtcagc accataggag 
     1621 aaagtgctgc cttgggagct gcaggcattg ttatttgggg agacatgaat ttaactgcat 
     1681 ccaaggccaa ctgtacaaag gtgaagcagt ttgtgagttc tgatttaggg agctacatag 
     1741 ccaatgtgac cagagctgct gaggtatgca gccttcacct ctgcaggaac aatggcaggt 
     1801 gcataaggaa gatgtggaac gcgcccagtt accttcactt gaaccctgca agttaccaca 
     1861 tagaggcctc tgaggacggg gagtttactg tgaaaggaaa agcatctgat acagacctgg 
     1921 cagtgatggc agatacattt tcctgtcatt gttatcaggg atatgaagga gctgattgca 
     1981 gagaaataaa gacggctgat ggctgctctg gggtttcccc ttctcctggt tcactaatga 
     2041 cactttgtct actgctttta gcaagttatc gaagcattca gttgtgagat aattgagttt 
     2101 aaagggaatt gtgtggcctc tagcctagtc atttaaagaa ggatgtaact tataacattt 
     2161 tttttctctt atgaattcta ttgagagata ttataagtag acattatgta tgtcacttaa 
     2221 cataaacaga aacattattt tatttgcctc cagtctggct aggaaaccag atctggggta 
     2281 aagtcaatgt acacttcctc cttattggaa tatttaagtt gcatttaaac taaaactagt 
     2341 ataatttagt cttttcatga atgtacatac ataaaattat acataaaaat attaaattat 
     2401 tcatttcaaa aaaa 
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Appendix 2: Recombinant hyaluronidases expressed by DS-2 cells 
Amino acid sequences were determined by translation of the DNA sequences, which had been 
confirmed by sequencing.  
Underlined:    BiP signal peptide (cleaved off during maturation of the protein) 
Bold:     V5 epitope 
Bold and underlined:  His-tag 
 
BiP/Hyal-1/L/V5/His 
MKLCILLAVVAFVGLSLGRSPWPGFRGPLLPNRPFTTVWNANTQWCLERHGVDVDVSVFDVVANPGQT
FRGPDMTIFYSSQLGTYPYYTPTGEPVFGGLPQNASLIAHLARTFQDILAAIPAPDFSGLAVIDWEAW
RPRWAFNWDTKDIYRQRSRALVQAQHPDWPAPQVEAVAQDQFQGAARAWMAGTLQLGRALRPRGLWGF
YGFPDCYNYDFLSPNYTGQCPSGIRAQNDQLGWLWGQSRALYPSIYMPAVLEGTGKSQMYVQHRVAEA
FRVAVAAGDPNLPVLPYVQIFYDTTNHFLPLDELEHSLGESAAQGAAGVVLWVSWENTRTKESCQAIK
EYMDTTLGPFILNVTSGALLCSQALCSGHGRCVRRTSHPKALLLLNPASFSIQLTPGGGPLSLRGALS
LEDQAQMAVEFKCRCYPGWQAPWCERKSMWRPLESRGPFEGKPIPNPLLGLDSTRTGHHHHHH 
 
BiP/Hyal-1/S/V5/His 
MKLCILLAVVAFVGLSLGRSPWPGFRGPLLPNRPFTTVWNANTQWCLERHGVDVDVSVFDVVANPGQT
FRGPDMTIFYSSQLGTYPYYTPTGEPVFGGLPQNASLIAHLARTFQDILAAIPAPDFSGLAVIDWEAW
RPRWAFNWDTKDIYRQRSRALVQAQHPDWPAPQVEAVAQDQFQGAARAWMAGTLQLGRALRPRGLWGF
YGFPDCYNYDFLSPNYTGQCPSGIRAQNDQLGWLWGQSRALYPSIYMPAVLEGTGKSQMYVQHRVAEA
FRVAVAAGDPNLPVLPYVQIFYDTTNHFLPLDELEHSLGESAAQGAAGVVLWVSWENTRTKESCQAIK
EYMDTTLGPFILNVTSGALLGRPLESRGPFEGKPIPNPLLGLDSTRTGHHHHHH 
 
BiP/PH-20/V5/His 
MKLCILLAVVAFVGLSLGRSLNFRAPPVIPNVPFLWAWNAPSEFCLGKFDEPLDMSLFSFIGSPRINA
TGQGVTIFYVDRLGYYPYIDSITGVTVNGGIPQKISLQDHLDKAKKDITFYMPVDNLGMAVIDWEEWR
PTWARNWKPKDVYKNRSIELVQQQNVQLSLTEATEKAKQEFEKAGKDFLVETIKLGKLLRPNHLWGYY
LFPDCYNHHYKKPGYNGSCFNVEIKRNDDLSWLWNESTALYPSIYLNTQQSPVAATLYVRNRVREAIR
VSKIPDAKSPLPVFAYTRIVFTDQVLKFLSQDELVYTFGETVALGASGIVIWGTLSIMRSMKSCLLLD
NYMETILNPYIINVTLAAKMCSQVLCQEQGVCIRKNWNSSDYLHLNPDNFAIQLEKGGKFTVRGKPTL
EDLEQFSEKFYCSCYSTLSCKEKADVKDTDAVDVCIADGVCIDAFLKPPMETEEPQIFYNASPSTLSG
PFEGKPIPNPLLGLDSTRTGHHHHHH 
 
BiP/Hyal-2/V5/His 
MKLCILLAVVAFVGLSLGRSPWPGMELKPTAPPIFTGRPFVVAWDVPTQDCGPRLKVPLDLNAFDVQA
SPNEGFVNQNITIFYRDRLGLYPRFDSAGRSVHGGVPQNVSLWAHRKMLQKRVEHYIRTQESAGLAVI
DWEDWRPVWVRNWQDKDVYRRLSRQLVASRHPDWPPDRIVKQAQYEFEFAAQQFMLETLRYVKAVRPR
HLWGFYLFPDCYNHDYVQNWESYTGRCPDVEVARNDQLAWLWAESTALFPSVYLDETLASSRHGRNFV
SFRVQEALRVARTHHANHALPVYVFTRPTYSRRLTGLSEMDLISTIGESAALGAAGVILWGDAGYTTS
TETCQYLKDYLTRLLVPYVVNVSWATQYCSRAQCHGHGRCVRRNPSASTFLHLSTNSFRLVPGHAPGE
PQLRPVGELSWADIDHLQTHFRCQCYLGWSGEQCQWDHRQAAGGRPLESRGPFEGKPIPNPLLGLDST
RTGHHHHHH 
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Appendix 3: Abbreviations 
aa   amino acid 
Arg   L-arginine · HCl 
BSA    bovine serum albumin 
BTH   bovine testicular hyaluronidase 
BVH   bee venom hyaluronidase 
CD   circular dichroism 
ChS   chondroitin sulfate 
ChS A   chondroitin 4-sulfate 
ChS B   dermatan sulfate 
ChS C   chondroitin 6-sulfate 
CIP   calf intestine alkaline phosphatase 
CTAB   cetyltrimethylammonium bromide 
CV    column volume 
CZE   capillary zone electrophoresis 
DAB   diaminobenzidine 
DMSO  dimethylsulfoxide 
DS-2   Drosophila Schneider-2 
DTT   dithiothreitol 
ECM   extracellular matrix 
E. coli   Escherichia coli  
EDTA   ethylene diamine tetraacetate 
ER   endoplasmic reticulum 
ESI-MS  electrospray ionisation mass spectrometry 
GAG   glycosaminoglycane 
GdmCl  guanidinium chloride 
GlcNAc  N-acetyl-D-glucosamine 
GlcUAc  D-glucuronic acid 
GPI-anchor  glycosylphosphatidylinositol-anchor 
GSH   reduced glutathione 
GSSG   oxidized glutathione 
HA    hyaluronic acid 
HOAc   acetic acid 
HRP   horseradish peroxidase 
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IAM    inner acrosomal membrane 
IBs   inclusion bodies 
IdoAc   idoronic acid 
IMAC   ion metal affinity chromatography 
IPTG   isopropylthiogalactoside 
LB-medium  Luria-Bertani medium 
MALDI-TOF MS matrix assisted laser desorption ionization – time-of-flight mass 
spectrometry 
MCS   multiple cloning site  
MW    molecular weight 
MWCO  molecular weight cut-off 
NTA   nitrilotriacetic acid 
nx   hyaluronic acid oligosaccharide containing x disaccharides units  
OD   optical density 
ORF   open reading frame 
pI   isoelectric point 
PAGE   polyacrylamide gel electrophoresis 
PAS   periodic acid – Schiff 
PBS   phosphate buffered saline 
PFGE   pulsed field gel electrophoresis 
PIPES   piperazine-1,4-bis(2-ethanesulfonic acid) 
SDS    sodium dodecyl sulfate 
SEC   size exclusion chromatography 
SEM   standard error of means 
TCA   trichloro acetic acid 
Tris   tris(hydroxymethyl)aminomethane 
UTR   untranslated region 
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